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SUMMARY IN DANISH 
Spondylartritis (SpA) er en gruppe reumatologiske sygdomme, der kan være 
alvorlige og invaliderende og ofte debuterer i ung alder. Da der ikke findes 
specifikke tests til at foretage en præcis diagnose af SpA, er diagnosen i stedet 
baseret på den kliniske præsentation, blodprøver og billeddiagnostiske fund. I 
2009 blev et nyt sæt klassifikations-kriterier for SpA udarbejdet af ’Assessment in 
SpondyloArthritis international Society’ (ASAS). Kriterierne kombinerer kliniske 
tegn, såkaldte SpA karakteristika, blodprøver og billeddiagnostik af 
bækkenleddene i form af røntgen fund og som noget nyt også fund på magnetisk 
resonans (MR) scanning. Selvom MR scanninger i stigende grad anvendes til at 
diagnosticere SpA er der flere usikkerheder relateret til den diagnostiske 
anvendelighed. I en systematisk litteratur gennemgang, der indgår i denne 
afhandling, blev der kun fundet to undersøgelser af høj kvalitet og den 
forskningsmæssige baggrund for brugen af MR til diagnosticering af SpA 
vurderedes begrænset. Dette understreger et behov for undersøgelse af en større 
kohorte af patienter med vedvarende lændesmerter. De to overordnede formål 
for ph.d.-studiet var i en kohorte af unge patienter med vedvarende 
lændesmerter 1) at vurdere forekomsten af MR fund og kliniske karakteristika for 
SpA og 2) at undersøge sammenhængen mellem MR fund og SpA karakteristika. 
Fra marts 2011 til oktober 2013 blev 1037 patienter inkluderet i Region 
Syddanmarks Rygsmerte Kohorte. Kohorten omfattede patienter i alderen 18-40 
år, henvist til Rygcenter Syddanmark med vedvarende lændesmerter uden 
forudgående mistanke om SpA. Dataindsamlingen omfattede MR scanning af hele 
rygsøjlen og bækkenleddene, blodprøver og spørgeskemaer. Tre erfarne 
radiologer deltog i vurdereingen af MR scanningerne med anvendelse af et 
standardiseret evalueringsskema, testet for reproducerbarhed. 
Studiet frembragte flere interessante resultater. Af de undersøgte patienter 
opfyldte 10% ASAS kriterier for SpA. Fund og symptomer, der er blevet betragtet 
som specifikke for SpA, viste sig at være relativt almindeligt forekomne i denne 
kohorte f.eks. inflammatorisk rygsmerte, bestemte SpA karakteristika og 
knoglemarvsødem ved bækkenleddene. Af de tre mest almindelige SpA 
karakteristika, var kun én svagt forbundet med erosioner i bækkenleddene, mens 
ingen andre sammenhænge blev fundet mellem MR fund relateret til SpA og disse 
tre SpA karakteristika. Desuden var let knoglemarvsødem i bækkenleddene 
relativt hyppig, men uden sammenhæng med SpA karakteristika. Udtalt 
knoglemarvsødem og strukturelle forandringer i bækkenleddene havde imidlertid 
sammenhæng med et eller flere SpA karakteristika. Resultaterne fra denne 
afhandling understreger et behov for en datagenreret revurdering af ASAS 
kriterierne for SpA, både i forhold til den diagnostiske værdi af SpA karakteristika 
og minimumskravene til MR fund til diagnosticering af SpA.  
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SUMMARY IN ENGLISH 
Spondyloarthritis (SpA) can be a serious and disabling disease often first 
appearing at a young age. Since there are no specific symptoms or tests available 
to make a precise diagnosis of SpA, the diagnosis is instead based on a composite 
of clinical presentation and serological and imaging findings. In 2009, Assessment 
of SpondyloArthritis International Society (ASAS) proposed a new set of 
classification criteria for axial SpA. The criteria combine clinical features, so called 
SpA features, blood samples and imaging in the form of radiographic findings of 
the sacroiliac joints and as new addition also MRI findings of the sacroiliac joints. 
Although, MRI is used increasingly in the diagnosis of SpA, several uncertainties 
remain about the diagnostic utility of this imaging modality. In a systematic 
review, included in this thesis, only two high quality studies were identified and 
the evidence for the utility of MRI in the diagnosis of SpA was considered limited. 
The results from the review underline a requirement for larger cohort studies 
investigating patients with persistent low back pain. The two main objectives of 
the PhD study were, in a cohort of secondary care patients aged 18-40 years with 
persistent low back pain to 1) estimate the prevalence of MRI findings and clinical 
characteristics previously associated with SpA and 2) investigate the associations 
between MRI findings and clinical characteristics suggesting SpA. 
From March 2011 to October 2013, a total of 1037 patients were included in The 
Back Pain Cohort of Southern Denmark. The cohort included patients aged 18-40 
years referred to the Spine Centre of Southern Denmark, with persistent low back 
pain and without previous suspicion of SpA. The data collection included MRI of 
the whole spine and the sacroiliac joints, blood samples and questionnaires. Three 
experienced radiologists participated in the reading of the MRI, using a 
standardised evaluation form, which was tested for inter- and intra-observer 
agreement.  
Several interesting results were found. The ASAS criteria for axial SpA were met by 
10% of the investigated patients. Furthermore, signs and symptoms, which have 
been regarded as relatively specific for SpA, such as inflammatory back pain 
characteristics, certain other SpA features and bone marrow oedema at the 
sacroiliac joints, were found to be relatively common in this cohort. In relation to 
the association between MRI findings and clinical characteristics, the three most 
common SpA features were generally not associated with MRI findings related to 
SpA. Moreover, slight bone marrow oedema by MRI was also common but not 
associated with any of the SpA features. These results imply a need for a data-
driven re-evaluation of the ASAS criteria for axial SpA regarding the diagnostic 
utility of SpA features and the minimum requirements of MRI findings for the 
diagnosis of sacroiliitis. 
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INTRODUCTION  
Background 
Spondyloarthritis (SpA) is a group of rheumatological disorders, which result in 
back pain and stiffness of the spine due to inflammatory and structural changes in 
the spine and the sacroiliac joints (SIJ). Since there is no specific symptom or test 
available to make a precise diagnosis, the diagnosis of SpA is instead based on a 
composite clinical presentation as well as serological and imaging findings. 
Ankylosing spondylitis (AS) is regarded as the prototype disease in the spectrum 
of SpA and different classification criteria have been proposed over time for both 
AS and SpA [1-3].  
In 2009, new classification criteria for axial SpA were proposed by the Assessment 
in Spondyloarthritis International Society (ASAS), combining imaging findings and 
11 clinical SpA features, consisting of extra-spinal findings, hereditary factors and 
pain characteristics of inflammatory back pain (IBP) regarded as essential for the 
diagnosis of SpA by leading experts [4]. As a new addition, magnetic resonance 
imaging (MRI) and/or conventional radiographic findings of sacroiliitis and positive 
human leukocyte antigen (HLA)-B27 constitute the cornerstones of the criteria [4] 
(Table 1). The development of the classification criteria from 2009 had the 
purpose of improving the diagnosis of early disease [4, 5]. However, the criteria 
were primarily based on expert opinion, and the validity of the criteria has, so far, 
rarely been investigated [4, 6, 7] , and not in a representative prospective cohort 
of patients with persistent low back pain (LBP) and a low a priori suspicion of SpA.  
For decades, conventional radiography has played a leading role in the diagnosis 
of AS. However, it takes several years before the structural findings visualised on 
conventional radiographs become evident [8, 9] and consequently, there is often 
a substantial delay in diagnosing the disorder [10, 11].  MRI is a newer imaging 
modality, which has the capability of displaying both inflammatory and structural 
findings in the SIJ and spine. However, several uncertainties still remain about the 
diagnostic utility of MRI [12-14]. Especially in the early stages when the clinical 
signs of SpA can be difficult to distinguish from non-specific LBP and the MRI signs 
of SpA, it can be difficult to distinguish from the much more common findings of 
degeneration. Signal changes related to degeneration in the spine such as 
vertebral endplate signal (Modic) changes are important pitfalls in the assessment 
of SpA [15] and some studies have shown substantial variation in the extent of 
MRI findings in the SIJ previously considered to be specific for SpA [16-18]. Hence, 
to validate the utility of this new imaging modality for the diagnosis of SpA, there 
is a requirement for studies using MRI protocols, that include both SpA-related 
and degenerative findings in unselected patient populations including early stages 
of SpA and persistent LBP patients. 
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IBP characteristics have been considered as other key features of SpA. The first 
criteria for IBP were published in 1977 by Calin et. al [19] and a second set of IBP 
criteria was proposed in 2006 [20]. In 2009, ASAS proposed a new set of IBP 
criteria to be incorporated into the classification criteria for axial SpA [21]. In 
contrast to previous criteria for SpA [1-3], the ASAS criteria did not include IBP as 
an entry criterion, but as one of the 11 SpA features which all have equal clinical 
value. The utility of IBP characteristics for identifying those with SpA among 
patients with persistent LBP is, nevertheless, uncertain [22]. 
In general, the focus of previous research in the diagnosis of SpA has been 
performed in highly selected patients with advanced stages of SpA or AS and small 
control groups of LBP patients, using expert opinion as the reference standard for 
SpA. However, to promote early diagnosis of SpA, there is a need for evaluation of 
disease-related characteristics and imaging findings in a large unselected back 
pain population [14, 22]. On the basis of this background, the Back Pain Cohort of 
Southern Denmark (BaPa Cohort) was initiated in 2011. 
Table 1. ASAS criteria of axial SpA [4] 
  
In patients with back pain >3 months and age at onset <45 years: 
 
Sacroiliitis on imaging plus ≥1 SpA feature 
or 
HLA-B27 plus ≥2 SpA features 
SpA features: 
Peripheral arthritis  
Heel enthesitis  
Uveitis 
Dactylitis 
Psoriasis  
Inflammatory bowel disease 
Family disposition 
Good response to NSAID 
IBP according to ASAS 
HLA-B27 
Elevated CRP 
Sacroiliitis on imaging: 
Active (acute) inflammation 
on MRI highly suggestive of 
sacroiliitis associated with 
SpA  
or 
Definite radiographic 
sacroiliitis according to the 
modified New York criteria 
SpA: Spondyloarthritis, NSAID: Non-steroid anti-inflammatory 
drugs, HLA-B27: Human leukocyte antigen B27, CRP: C reactive 
protein, IBP: Inflammatory back pain 
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Aim and objectives 
The overall aim of this thesis was to investigate the use of MRI in the early 
diagnosis of SpA. The specific objectives were, in patients aged 18-40 years 
referred with persistent LBP to a secondary care centre: 
1. To estimate the prevalence of SpA-related MRI findings in the spine and 
SIJ.  
2. To estimate the prevalence of ASAS criteria for axial SpA. 
3. To analyse the classification utility of IBP characteristics relative to SpA 
according to ASAS criteria for axial SpA. 
4. To investigate the association between MRI findings suggestive of SpA 
and clinical SpA features. 
Each of the five manuscripts included in this thesis deals with one or more of the 
four objectives. Paper I, the systematic review, describes the current evidence for 
Objective 4 and Paper II, the agreement study, is a method paper dealing with the 
development and testing of the MRI protocol to be used in the pursuit of all the 
objectives. The results from the cohort study are presented in Manuscripts III-V; 
Manuscript III relates to Objective 1, Manuscript IV to Objective 3 and Manuscript 
V to Objectives 2 and 4.  
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METHOD 
Systematic review 
Inclusion criteria  
Inclusion criteria were cross-sectional or longitudinal case-control or cohort MRI 
studies. The studies required a case-group with either SpA or IBP and a non-case 
group of people without SpA or IBP. Each group required a minimum of 20 
participants. The included articles had to report results containing raw numbers 
suitable for the construction of two-by-two tables or report results by sensitivity 
and specificity for cross-sectional studies or odds ratios (OR), relative risk ratios, 
or likelihood ratios for longitudinal studies.  For details in the search strategy, see 
Paper I, Method section, page 2. 
Data collection 
Initially, the first author (BA) reviewed the titles and abstracts of the search 
results for identification of relevant articles to be retrieved in full text. The full 
texts were screened for relevance, and duplicate publications were excluded at 
this stage. Subsequently, the identified articles were reviewed in full text for data 
extraction by the first and third authors (BA and TSJ). These authors 
independently extracted data from the relevant articles according to a checklist 
specifying the information needed. 
Assessment of methodological quality 
The quality of the included articles was assessed using a set of quality criteria, 
based on the QUADAS tool for quality assessment of diagnostic accuracy studies 
[23]. The quality assessment was subdivided into four topics: (a) study sampling, 
(b) clinical diagnosis, (c) MRI evaluation, and (d) data analysis and results. Each 
item was rated from 0 to 2, resulting in a maximum of 8 points per article. See 
Table 3 in the Results section of this thesis for details. For longitudinal studies, the 
reporting on dropout rates and reasons for dropping out were also to be 
assessed. The same two authors performed the assessments independently. Any 
disagreements in the assessments were settled by consensus and discussion with 
the second author. Articles with a quality score of more than 5 points were 
regarded as high-quality studies. Only results from high-quality studies were 
further reviewed. 
Cohort study 
Study design 
This research was a cross-sectional observational cohort study. 
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Study sample 
The study was conducted at the Spine Centre of Southern Denmark, which is an 
outpatient, non-surgical unit that specialises in managing non-inflammatory back 
pain in a secondary care public hospital setting. The hospital is located in the 
Region of Southern Denmark, which has a population of 1.2 million. The referral 
criteria to the Centre comprise an episode of back pain with a duration of 2 to 12 
months and insufficient effect of conservative treatment. Patients thought to 
have specific LBP conditions such as SpA, fracture, cancer or infection are not to 
be referred to the Centre, but instead to the relevant clinical specialty. 
From March 2011 to October 2013, booking secretaries allocated Caucasian 
patients aged 18 to 40 years with LBP as their primary complaint to a dedicated 
multidisciplinary ‘project team’. Sixteen clinicians (medical doctors including 
rheumatologists, physiotherapists and chiropractors) were allocated to the 
project during the study period. The treating clinicians excluded patients from the 
project who did not understand Danish, had undergone an MRI scan within the 
previous year, or were deemed unlikely to tolerate the one-hour MRI.  
The study was conducted according to the Declaration of Helsinki-II and Danish 
legislation and, before study inclusion, each patient gave written informed 
consent for research use and publication of their data. The Regional Scientific 
Ethics Committee for Southern Denmark determined that under the Danish legal 
framework, this study did not require formal ethics approval (reference number S-
2010200-58).  
Questionnaires 
As a part of the standard procedure, patients at the Spine Centre completed an 
electronic questionnaire before their first consultation. Data from the 
questionnaire were stored in a clinical database, the SpineData database. From 
this database, demographic data and clinical descriptive characteristics containing 
items on back and leg pain intensity [24], activity limitation [25], general health 
[26], present work situation, etc. were exported. Based on the first consultation, 
clinicians also completed an electronic form containing items from the 
standardised clinical investigation, as a part of the standard procedure.  
For patients allocated to the project, an additional IBP questionnaire was 
incorporated into the electronic patient questionnaire and a SpA questionnaire 
was incorporated into the clinician questionnaire. The IBP questionnaire covered 
items related to IBP characteristics [19-21] and the SpA questionnaire covered 
SpA features (present/absent) included in the ASAS criteria for axial SpA [4], as 
well as a question on preceding infection, an item included in a previous set of 
criteria for SpA [2]. The clinician completed this part of the questionnaire, based 
on the first consultation. In the case of computer illiterates and during database 
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breakdowns, paper questionnaires were used, and subsequently backfilled 
manually into the electronic database by a research secretary or the primary 
investigator (BA). The IBP and SpA feature questionnaires were completed prior 
to blood samples and MRI. See Appendix 1 for details of the IBP and SpA feature 
questionnaires. 
Blood samples 
Blood samples were analysed for human leukocyte antigen (HLA) B27 
(EuroImmun Microarray, D) and high sensitive C-reactive protein (hsCRP) (ABX 
pentra 400, Horiba, F). The blood samples were sent for analysis to the King 
Christian 10th Hospital for Rheumatic Diseases as part of a research collaboration. 
The apparatus used for the analyses was calibrated on a daily basis and managed 
under the quality assurance programs of the provider (Triolab, DK) and an 
external quality assurance provider (Labquality, FI, Nequas, UK).  
If hsCRP was above 6 mg/L, the clinician annotated the SpA questionnaire to 
indicate if they were aware of a known reason for the elevated level.   
MRI technique and evaluation 
MRI of the whole spine and SIJ was performed with a 1.5 T unit (Philips Achieva, 
Best, The Netherlands) MRI System using a SENSE spine coil. The following 
sequences were performed for the SIJ: Semicoronal T1-weighted turbo spin-echo, 
semicoronal T1-weighted Spectral Pre-saturation with Inversion Recovery (SPIR) 
and semiaxial Short-Tau Inversion Recovery (STIR) with long echo time. For the 
spine, the following sequences were implemented in three steps (cervical, 
thoracic and lumbar) and subsequently fused: Sagittal STIR and sagittal T1-
weighted turbo spin-echo. An additional sagittal T2-weighted VISTA (3D turbo 
spin-echo T2-weighted sequence) and an axial turbo spin-echo T2-weigthed 
sequence were performed for the lumbar spine. For more details of the scanning 
protocol, see Paper II, Method section, page 2. 
The reading of the MRI was performed by three SpA expert radiologists, who were 
blinded to all clinical and serological information except patient age and gender. 
The images were read on dedicated radiological workstations with two 21-inch 
high-resolution screens.   
A web-based evaluation form with entry directly into the SpineData database was 
developed for used in the cohort study. The evaluation form consisted of two 
parts: 1) evaluation of the SIJ and 2) evaluation of the spine. According to a 
previously described method of evaluation of the SIJ [27], each joint was 
subdivided into four osseous locations: the cartilaginous part of the iliac and the 
sacral bones, and the ligamentous portion of the iliac and sacral bones, 
respectively (eight regions in total). The presence of each of the SIJ findings was 
defined as a minimum of two findings on a single SIJ slice, or one finding in the  
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Figure 1. MRI examples of the slices and sequences used in the study 
  
A: Semicoronal T1-weigthed SPIR 
B: Semiaxial STIR 
C: Semicoronal T1-weigthed 
D: Sagittal STIR  
E: Sagittal T1-weigthed 
F: Axial T2-weighted 
G: VISTA (3D) 
A 
B 
C 
D E 
F G 
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same SIJ quadrant in at least two consecutive slices. This corresponded to the 
minimum requirement for bone marrow oedema (BMO) in the definition of 
sacroiliitis used in the ASAS criteria for axial SpA [28]. The spine was divided into 
23 disco-vertebral units from C2-C3 to L5-S1. A disco-vertebral unit was defined as 
the region between two virtual horizontal lines through the centre of two 
adjacent vertebrae. Furthermore, each vertebral endplate and subjacent bone 
marrow area of a disco-vertebral unit were assessed separately for variables 
related to signal changes or erosions.  
For a detailed definition of the assessed MRI findings and gradings, see Appendix 
2. 
Agreement study of the MRI evaluation  
The analysis included 48 MRI sets sampled from a subset of patients (n=350) of 
the BaPa cohort enrolled between March 2011 and February 2012. The primary 
investigator selected the patients without involvement of the evaluating 
radiologists. To increase the number of ‘positive’ MRI findings, thereby ensuring 
sufficient statistical power to calculate reliable kappa values, 38 patients with 
different levels of spinal and SIJ changes were chosen on the basis of data from 
previous systematic evaluations of the MRI scans. Additionally, 10 patients were 
randomly selected from the remaining 312 patients. Of the patients included in 
the agreement study, the mean age was 31 years (range 18 – 40 years) and 60% 
were women. 
All MRIs were anonymised and blinded from all clinical information including the 
patient’s previous MRI reports, age, and gender. Prior to the study, two consensus 
sessions between the radiologists were conducted. All MRIs were evaluated 
independently, once by all three readers and then re-evaluated by two of the 
readers after 4-12 weeks. Agreement was measured using kappa statistics (κ) [29]. 
The following standard interpretation of the kappa coefficient for strength of 
agreement given by Landis and Koch were used: slight κ <0.2, fair 0.2 ≤κ <0.4, 
moderate 0.4 ≤κ <0.6, substantial 0.6 ≤κ <0.8 and almost perfect 0.8 ≤κ <1 [30] 
The following MRI findings were excluded from the kappa analysis because of too 
few positive ratings: erosion in the vertebral corner, BMO at the costovertebral 
joints, fatty marrow deposition (FMD) at the apophyseal joints, and soft tissue 
oedema around the apophyseal joint. 
The inter-observer agreement had kappa values >0.6 corresponding to 
‘substantial’ or ‘almost perfect’ agreement for the following MRI findings in the 
SIJ: BMO, depth of BMO, FMD, sclerosis, and ankylosis. In the spine: type of signal 
change, location of signal changes, size of signal change, disc degeneration and 
disc contour, syndesmophytes or vertebral fusion, and BMO at the apophyseal 
joint had kappa values >0.6 in the inter-observer agreement study. All kappa 
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values of the intra-observer agreement were >0.6. For details of the level of 
agreement, see Paper II, Table 4-7. 
In general, the MRI findings included in the analyses described below all had 
kappa values of >0.6 for inter- and intra-observer agreement. However, six 
variables: spinal corner lesion, erosions in the vertebral corner, BMO at the 
costovertebral joints, FMD at the apophyseal joints, soft tissue oedema around 
the apophyseal joint, and erosions at the SIJ were included without meeting the 
criterion for a kappa value of more than 0.6, because they are widely regarded to 
be key MRI findings in the assessment of SpA [15, 28]. 
Data analysis 
All analyses were conducted with STATA 11.2 (StataCorp, 2000, College Station, 
TX: Stata Corporation, USA). 
Prevalence of the MRI findings 
Prevalence estimates of spinal and SIJ MRI findings were calculated as proportions 
and presented with standard error of the mean (SEM). Statistically significant 
levels of difference concerning gender and age groups were tested with Pearson’s 
Chi Square Test and between anatomical regions with a two-sample proportion 
test using a significance level of 5%. 
Prevalence of ASAS criteria for axial SpA 
All prevalence estimates were calculated as proportions and presented with 95% 
confidence intervals (CI), using information about sacroiliitis on MRI, HLA-B27 
status and the presence of SpA features. Fulfilment of the ASAS criteria for axial 
SpA was determined after data collection and strictly based on the presence of 
the collected items included in the criteria. 
Classification utility of inflammatory back pain 
Only patients from the BaPa Cohort, who reported LBP for more than 3 
consecutive months, were included in the analysis of the classification utility of 
IBP. Patients were categorised as ‘SpA according to ASAS’ if they fulfilled the ASAS 
criteria for axial SpA [4]; the rest were categorised as ‘non-SpA LBP’ patients. To 
avoid circularities, IBP was not included as a SpA feature in the definition of SpA 
according to ASAS. Fulfilment of the Calin, Berlin and ASAS IBP criteria was made 
based on the presence of the single characteristics in the self-reported IBP 
questionnaire.  
Sensitivity, specificity, positive predictive value (PPV) and negative predictive 
value (NPV) were estimated from non-missing values for each single item of the 
IBP characteristics and for each of the three sets of IBP criteria and presented as 
percentages with 95% CI. The area under the receiver operator characteristic 
curve (ROC area), was used to assess classification utility and reported with 95% 
CI. For binary predictions, ROC area equals balanced accuracy, (sensitivity + 
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specificity)/2 [31]. The following standard interpretation of ROC area was used: 
0.5-0.6 ‘no clinical value’, 0.6-0.7 ‘limited value’, 0.7-0.8 ‘modest value’, and >0.8 
‘discrimination adequate for genuine clinical utility’ [32]. Pearson’s chi square test 
was used to evaluate significance level using a criterion alpha level of 5%.  
Association between MRI findings and SpA features 
In the SIJ, the following four MRI findings that have been reported to be 
potentially associated with SpA were used: BMO, erosions, sclerosis and FMD 
[28]. With the purpose of exploring the importance of the severity of the SIJ MRI 
findings, sum-scores were generated for each finding by adding the grading of the 
relevant findings (0: none / 1: slight / 2: moderate / 3: severe) in all eight regions 
(max sum-score 24). The sum-score was used to create pre-defined categorical 
variables. The number of categories created for each finding was determined by 
the distribution of the sum-score for the relevant findings, as each category 
should arbitrarily include at least 5% of the patients. Four categories were created 
for BMO: sum-score of 0 (no BMO findings), sum-score of 1 (one region with slight 
BMO findings), sum-score of 2 (two regions with slight or one region with 
moderate BMO findings) and sum-score of 3+ (> sum-score of 2). All BMO 
categories met the ASAS definition of sacroiliitis. Three categories were created 
for FMD: sum-score of 0, sum-score of 1-2 and sum-score of 3+. Erosions and 
sclerosis were classified as present or absent due to their low prevalence. A BMO 
sum-score of 1 corresponded to fulfilment of the ASAS definition for sacroiliitis. 
In the spine, the following MRI findings potentially associated with SpA [15] were 
assessed as present or absent: BMO corner lesion, FMD corner lesion, mixed type 
(both BMO and FMD) corner lesion, BMO at the apophyseal joints, FMD at the 
apophyseal joints, soft tissue oedema around the apophyseal joint, BMO at the 
costovertebral joints, syndesmophytes or fusion, and erosion in the vertebral 
corner. 
The association between the SpA features and the SIJ MRI were estimated by 
multivariable logistic regression for each of the four SIJ MRI findings and with 
adjustment for gender and age. These models were reduced by backward 
elimination using a significance level of 5%. Multinomial logistic regression was 
used for the categorical and binomial logistic regression for dichotomous 
dependent variables. Associations were reported as OR with 95% CI.  
Correlations between the four SIJ MRI findings were tested with scatter plots, 
correlations matrix and regression analysis. This analysis showed a correlation 
between all four SIJ findings, the strongest being between BMO, erosions and 
FMD, which had correlation coefficients of between 0.6-0.7. The correlation 
coefficients between sclerosis and the other structural findings ranged from 0.3-
0.4.  
  
 THE USE OF MRI IN THE EARLY DIAGNOSIS OF SPONDLOATHRITIS 13 
 
MAIN RESULTS 
Systematic review 
Description of studies 
In all, 1.336 articles were found in MEDLINE, and 2.359, in EMBASE. After 
elimination of duplicates, 2.395 articles were reviewed by title and abstract and 
76 articles were identified for assessment in full text. After full-text review, nine 
cross-sectional articles met the inclusion criteria [17, 33-40], Table 2. For a flow 
chart of the review process, see Paper I, Figure 1. No longitudinal studies met the 
inclusion criteria. For details about reasons for exclusion, see Paper I, Table 2 and 
3.  
Table 2. Descriptive data for studies fulfilling the inclusion criteria 
 Study type n Total AS SpA IBP NILBP No LBP 
Sacroiliac joint        
Bollow  (1995) 
[33] 
Prospective 
case-control 
125 
 
36 
(3.1 y) 
36 
(5.9 y) 
- 
 
53 
(5.7 y) 
- 
 
Klauser  (2005) 
[34] 
Prospective 
case-control 
133 
 
- 
 
- 
 
103 
(NR) 
- 
 
30 
 
Brandt  (2007) 
[35] 
Prospective 
cohort 
158 
 
32 
(NR) 
58 
(NR) 
- 
 
68 
(NR) 
- 
 
Weber  (2010) 
[17] 
Prospective 
case-control 
187 
 
75 
(6.1 y) 
- 
 
27 
(29 m) 
26 
(NR) 
59 
 
Wick (2010) 
[36] 
Retrospective 
cohort 
156 
 
27 
(NR) 
101 
(NR) 
- 
 
28 
(NR) 
- 
 
Spine        
Kim (2008)  
[37] 
Retrospective 
case control 
104 
 
52 
(NR) 
- 
 
- 
 
52 
(NR) 
- 
 
Weber (2009) 
[38] 
Prospective 
case-control 
85 
 
35 
(8 y) 
- 
 
25 
(10 m) 
- 
 
35 
 
Bennett  (2009) 
[39] 
Retrospective 
cohort 
185 
 
- 
 
64 
(8.5 y) 
- 
 
110 
(NR) 
11 
 
Bennett (2009) 
[40] 
Retrospective 
cohort 
185 
 
- 
 
64 
(8.5 y) 
- 
 
110 
(NR) 
11 
 
Values are number of patients with mean disease duration in parentheses  
SpA: Spondyloarthritis, AS: Ankylosing spondylitis, IBP: Inflammatory back pain, NILBP: 
Non-inflammatory low back pain, no LBP: No low back pain, y: years, m: months, NR: 
Mean disease duration not reported  
  
14 THE USE OF MRI IN THE EARLY DIAGNOSIS OF SPONDLOATHRITIS 
 
Methodological quality assessment 
The quality score of the nine studies ranged from 1 to 7 points out of a maximum 
of 8 points. Two articles were rated more than 5 points and were considered of 
high quality [17, 38], and three articles were rated less than 3 points [33-35], 
Table 3.  
Table 3 Quality scores for studies fulfilling the inclusion criteria 
 
Association between MRI findings and the clinical diagnosis of SpA 
Because of a substantial heterogeneity in the included studies, it was not possible 
to perform a meta-analysis. Instead, a descriptive assessment of the results based 
on the extracted data was performed. Of the nine included articles, one article of 
high quality reported results from evaluation of the SIJ [17], and another article of 
high quality reported results from the spine [38]. Both articles were from the same 
research team. 
 Bollow 
[33] 
Klauser 
[34] 
Brandt 
[35] 
Weber 
[17] 
Wick 
[36] 
Kim 
[37] 
Weber 
[38] 
Bennett 
[39] 
Bennett 
[40] 
Study sampling 
(0-2) 
1 0 1 2 1 1 2 1 1 
Diagnosis  
(0-2) 
1 0 0 1 0 1 1 0 0 
MRI evaluation  
(0-2) 
0 0 0 2 2 1 2 2 1 
Data analysis/result 
presentation (0-2) 
0 1 1 2 0 1 2 1 1 
Total (max 8 point) 2 1 2 7 3 4 7 4 3 
0: Non-acceptable 1: Reasonable 2: Good  
Study sampling: Representative study sample (patients with SpA or IBP vs. patients with 
back pain without SpA or IBP), study sample well described (both cases and controls), 
suitable sampling method used (both for cases and controls - randomised or consecutive) 
and for case-control studies matching performed adequately (sex, age, n controls >/= n 
cases). 
Diagnosis: IBP or SpA diagnosed by criteria (best) or expert opinion (second best), same 
diagnosis performed on whole sample, diagnosis independent of MRI, diagnosis blinded 
for MRI and reproducibility tested (inter- and intra-observer agreement tested and 
reported). 
MRI evaluation: Clear definition of each relevant MRI finding, MRI blinded from diagnosis, 
inter- and intra-observer agreement tested and reported and short time between the MRI 
scan and diagnosis. 
Data analysis/result presentation: Statistical significance test and confidence intervals 
reported where relevant and results presented in an understandable way. 
 
SpA: Spondyloarthritis, IBP: Inflammatory back pain 
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The high quality study evaluating the SIJ was a case-control study of four groups: 
75 patients with AS according to the modified New York criteria [3], 27 patients 
with IBP according to the Calin or Berlin IBP criteria [19, 20], 26 patients with non-
specific LBP, and 59 healthy controls without back pain [17]. Positive associations 
for BMO, erosions, FMD, and global assessment of sacroiliitis were reported for 
both AS and IBP patients when compared with the non-specific LBP and no-LBP 
groups. As expected, the highest combined values of sensitivity and specificity 
were found when comparing AS patients with healthy controls, and the lowest 
values were found when comparing IBP with non-specific LBP [17]. For details see 
Paper I, Table 6. 
The high quality study evaluating the spine was a case-control study of 35 patients 
with AS according to the modified New York criteria [3], 25 patients with IBP 
according to the Berlin IBP criteria [20] in addition to one or more SpA features, 
and 35 healthy controls without back pain [38]. The MRI findings under evaluation 
were BMO findings of varying number and location in the spine. When comparing 
AS patients with healthy controls, a number of positive associations were 
identified for BMO findings in vertebral corners and in the lateral spine, 
corresponding to the costovertebral joints. However, when comparing IBP 
patients with healthy controls, the strength of the associations was decreasing 
[38]. For details see Paper I, Table 7. 
Cohort study 
Approximately 5000 patients aged 18-40 years were referred with LBP in the 
study period and 1619 of them were invited to participate in the study. One 
hundred and sixty patients were excluded before, and 422 after, the first visit, 
Figure 2. In total, 1037 patients with a median age of 33 years (IQR: 27-37) were 
included in the study, 558 (54%) of whom were women. The median duration of 
LBP was 10 months (IQR 4-39 months). Of the 1037 included patients, 17 had 
complete MRI evaluation, but had missing clinical data and therefore were only 
included in Manuscript III. In all 763 (75%) reported having had back pain for more 
than 3 months and of these, 759 had completed the IBP questionnaire and were 
included in Manuscript III. Descriptive data of the patients included in the cohort 
are present in Manuscript III, Table 1.  
Of the patients not included in the study, who were in the same age range and 
referred with LBP in the study period, the median age was 34 years (IQR: 28-38), 
and 54% were women. 
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Figure 2. Flow-chart of the study inclusion  
 
 
 
  
Patients initially allocated to study (n=1619) 
Patients attended first consultation (n=1459) 
Patients included in Manuscript III (n=1037) 
  Reasons for exclusion before first consultation:  
• Patient non-attendance (n=60) 
• Attended clinician outside the ‘project team’ of 
clinicians (n=100) 
Reasons for exclusion after first consultation: 
• Declined participation (n=94) 
• Less than 18 years or more than 40 years (n=12) 
• Did not speak or understand Danish (n=10)  
• MRI within the last year (n=64) 
• Primary complaint not low back pain (n=37) 
• Contraindications for MRI (n=78) 
• Predicted unfit for the one-hour MRI (n=40) 
• Incomplete MRI due to logistic or technical 
difficulties (n=65) 
• Patient non-attendance at MRI (n=19) 
n = 160 
n = 422  
Patients included in Manuscript V (n=1020)  
Patients included in Manuscript IV (n=759) 
Back pain <3 months (n=247) 
No IBP questionnaire (n=4) 
Missing clinical data  
n = 17  
n = 261  
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Prevalence of MRI findings 
Of the included patients, 91.3% (± SEM 0.9) had at least one of the assessed MRI 
findings, 88.2% (±0.1) at least one spinal finding, 27.5% (±1.4) at least one SIJ 
finding and 24.4% (± 1.3) at least one SIJ and spinal MRI finding. 
In the SIJ, BMO was the most frequent finding, present in 21.4% (±1.3). FMD, 
sclerosis, and erosions occurred in 14.5% (±1.1), 8.0% (±0.8), and 7.7% (±0.8) of 
the patients respectively. Ankylosis was only present in three patients. In general, 
SIJ MRI findings were more frequent in women than in men. The greatest 
difference was found for sclerosis, present in 13.2% (±1.4) of women and in only 
1.9% (±0.6) of men, and for FMD, present in 18.6% (±1.7) of women and in 9.6% 
(±1.3) of men. There was no statistically significant difference between genders 
for the remaining SIJ MRI findings. SIJ erosions were statistically significantly more 
frequent in patients aged 18-29 years than in those aged 30-40 years. BMO was 
more frequent in patients aged 30-40; however, only borderline statistically 
significant. 
The spinal MRI findings previously shown to be associated with SpA were less 
frequent, spinal corner lesions, erosions in the vertebral corner, the posterior 
element findings, BMO in the costovertebral joints and syndesmophytes or fusion, 
were each present in 0.1%- 2.2% of patients. Due to this low prevalence, 
difference between gender and age could not be evaluated for these findings.  
Prevalence estimates of all the assessed MRI findings in the SIJ and spine are 
presented in Manuscript III, in Tables 2 and 4. 
Prevalence of ASAS criteria for axial SpA 
In total, 52% (95% CI 49-56) of the patients had more than one SpA feature and 
19% (17-22) had more than two SpA features. The prevalence of the three most 
common SpA features: IBP according to ASAS, good response to NSAID and family 
disposition, ranged from 15-17%. The prevalence of the two serological SpA 
features, positive HLA-27 and elevated CRP, were 10% (9-12) and 8% (6-10), 
respectively. The rest of the SpA features had a prevalence of <6%. The 
prevalence of sacroiliitis on MRI according to the ASAS definition was 21% (19-24). 
Of the MRI-positive patients, 42% (35-49) had only slight BMO in one region. The 
prevalence of patients meeting the complete ASAS criteria for axial SpA was 10% 
(8-12). Of these, 91% (85-97) had sacroiliitis on MRI as the major criterion, 
whereas 22% (14-30) had HLA-B27 as the major criterion. There were no 
statistically significant differences between men and women for the fulfilment of 
the ASAS criteria for axial SpA. 
Prevalence estimates of all items in the ASAS criteria for axial SpA are presented 
in Manuscript V, Table 2. 
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Classification utility of inflammatory back pain 
Of the 759 patients from the BaPa Cohort included in the current analysis, 86 
were categorized as SpA according to ASAS and 673 as Non-SpA LBP. Patient 
categorised as SpA according to ASAS had a statistically significant higher activity 
limitation score (Roland Morris Disability Questionnaire [25] calculated as a 
proportional score [41], 0-100) than patients categorised as non-SpA (65 vs. 57). 
No other significant differences in the descriptive characteristics between the two 
study groups were found, for detail see Manuscript IV, Table 2. 
In all, the included patients four single IBP characteristics were positively 
associated with ‘SpA according to ASAS’: ‘no improvement with rest’, 
‘improvement with exercise/not rest’, ‘night pain’, and ‘alternating buttock pain’. 
Of these, ‘night pain’ had the highest sensitivity, 87% (78-93), with a 
corresponding specificity of 28% (24-31). ‘Improvement with exercise/not with 
rest’ had the highest specificity, 85% (82-88) with a corresponding sensitivity of 
24% (15-34). The PPV for these single characteristics ranged from 13 to 17%. The 
ROC area ranged from 0.54 to 0.57, which corresponds to a classification utility of 
‘no clinical value’. For details of the prevalence and assessed diagnostic 
parameters for the single IBP characteristics, see Manuscript IV, Table 3. 
Of the patients included in the current analysis, 67% (62-69) met at least one of 
the three sets of criteria for IBP and 16% (14-19) met all three. All three sets of IBP 
criteria were positively associated with ‘SpA according to ASAS’. The Calin criteria  
Table 4. Classification utility of three sets of IBP criteria in relation to SpA 
according to ASAS. 
 Total 
prevalence 
Sensitivity Specificity PPV NPV ROC area 
Calin 52 
(48-55) 
64 
(53-74) 
50 
(46-54) 
14 
(11-18) 
92 
(88-94) 
.57 
    (.52-.62)  * 
Berlin 42 
(39-46) 
59 
(48-69) 
60 
(56-64) 
16 
(12-21) 
92 
(89-94) 
.60 
    (.55-.66)  * 
ASAS IBP 23 
(20-26) 
35 
(25-46) 
79 
(75-82) 
17 
(12-23) 
90 
(88-93) 
.57 
    (.51-.62)  * 
All three IBP 
criteria 
17 
(14-19) 
33 
(23-44) 
86 
(83-88) 
22 
(15-31) 
91 
(88-93) 
.59 
    (.54-.64)  * 
With the exception og ROC area, values are presented as percentages with 95% 
confidence intervals in parentheses  
n SpA according to ASAS=86,  n non-SpA LBP=673, (n varies in each analysis due to missing values)  
* p<0.05, **p<0.01 
PPV: positive predictive value, NPV: negative predictive value, (pre-test probability for 
ASAS SpA: 11 %), ROC area: area under the receiver operating characteristic curve, 
equals (sensitivity + specificity)/ 2 
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had the highest sensitivity, 64% (53-74), with a corresponding specificity of 50% 
(46-54). The highest specificity, 86% (83-88), was found for simultaneous 
fulfilment of all three sets of IBP criteria with a corresponding sensitivity of 33% 
(23-44). The PPV for the IBP criteria ranged from 14 to 22%. The ROC area ranged 
from 0.57 to 0.60, which corresponds to a classification utility of ‘no clinical 
value’, see Table 4 for details. 
Association between MRI findings and SpA features 
In the multivariable analysis, a BMO sum-score of 1 was positively associated with 
higher age but not with any of the SpA features. A sum-score of 2 was positively 
associated with peripheral arthritis and higher age, and negatively associated with 
IBP according to ASAS. A sum-score of 3+ was positively associated with positive 
HLA-B27 and preceding infection, see Table 5 for details. 
Table 5. Association between sacroiliac joint bone marrow oedema and SpA 
features, assessed with multivariable logistic regression analysis, adjusted for age 
and gender. 
Of the structural SIJ findings, erosions were positively associated with good 
response to NSAID and younger age and strongly associated with positive HLA-
B27. Sclerosis was associated with positive HLA-B27 and preceding infection and 
strongly associated with female gender. An FMD sum-score of 1-2 was only 
 
BMO sum-score of 1 
n=87 
BMO sum-score of 2 
n=58 
BMO sum-score of 3+ 
n=68 
Positive HLA-B27 
1.4 
(0.7-3.0) 
2.1 
(0.9-4.7) 
9.0 
      (5.1-15.8)** 
Peripheral 
arthritis 
2.3 
(0.7-7.2) 
5.4 
     (1.8-16.0)** 
1.0 
(0.2-5.2) 
IBP according to 
ASAS 
1.1 
(0.6-1.9) 
0.3 
   (0.1-0.9)* 
1.7 
(0.9-3.1) 
Preceding 
infection 
1.5 
(0.4-5.2) 
0.8 
(0.1-6.5) 
3.3 
   (1.2-9.7)* 
Gender (female) 
1.3 
(0.8-2.1) 
1.2 
(0.7-2.1) 
1.2 
(0.7-2.2) 
Age (years) 
1.1 
    (1.0-1.1)** 
1.1 
  (1.0-1.1)* 
1.0 
(0.9-1.0) 
Values are odds ratios, with 95% confidence intervals in parentheses.  
BMO sum-score of 0 is used as reference, n=786 
* p<0.05, ** p<0.01 
BMO: Bone marrow oedema, HLA: Human leukocyte antigen, IBP: Inflammatory back 
pain 
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associated with female gender, whereas an FMD sum-score of 3+ was associated 
with positive HLA-B27, female gender and younger age, see Table 6 for details.  
Table 6. Association between structural MRI findings at the sacroiliac joints and 
SpA features, assessed with multivariable logistic regression analysis, adjusted for 
age and gender. 
Due to a low prevalence of BMO (1.6%), FMD (1.1%) and mixed type (0.9%) of 
spinal corner lesions, BMO at the apophyseal joints (0.8%), and FMD at the 
apophyseal joints (1.7%), it was only possible to calculate crude ORs of the 
association with HLA-B27. BMO, FMD and mixed type of spinal corner lesions and 
BMO at the apophyseal joints were associated with positive HLA-B27 with ORs of 
4.9 (95% CI 1.8-13.5), 24.5 (6.2-96.9) and 18.0 (4.3-74.8) and 14.9 (3.4-64.2), 
respectively. Soft tissue oedema around the apophyseal joint, BMO at the 
costovertebral joints, syndesmophytes or fusion, and erosion of the vertebral 
corner could not be assessed due to a very low prevalence (<0.5%).  
 
 
 
 
 
 
  
   Fatty marrow deposition 
 
Erosions 
n =77§ 
Sclerosis 
n= 79§ 
Sum-score of 1-2 
n=65§ 
Sum-score of 3+ 
n=81§ 
Positive HLA-B27 
8.1 
     (4.7-13.7)** 
3.1 
     (1.7-5.6)** 
1.9 
(0.9-4.0) 
6.1 
    (3.6-10.4)** 
Good response to 
NSAID 
1.9 
   (1.1-3.5)* 
- 
 
- 
 
- 
 
Preceding infection - 
2.8 
   (1.1-7.0)* 
- 
 
- 
 
Gender (female) 
1.2 
(0.7-1.9) 
7.6 
    (3.8-16.0)** 
1.9 
   (1.1-3.2)* 
2.2 
  (1.3-3.7)* 
Age (years) 
1.0 
  (0.9-1.0)* 
1.0 
(1.0-1.1) 
1.0 
(1.0-1.0) 
1.0 
  (0.9-1.0)* 
Values are presented as odds ratios with 95% confidence interval in parentheses 
§Reference group is patients without any of the relevant MRI finding, for erosions;
n=943, sclerosis; n=939, and fatty marrow deposition; n=874 
*p< 0.05, **p<0.01  
– not included in the final model 
HLA: Human leukocyte antigen, NSAID: Non-steroid anti-inflammatory drugs 
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DISCUSSION  
Summary of main results 
In this thesis, the use of MRI in the early diagnosis of SpA was investigated in a 
cross-sectional cohort study of young patients with persistent LBP attending a 
secondary care centre.  
Of the patients included in the cohort, 10% met the ASAS criteria for axial SpA. 
Interestingly, signs and symptoms, which have been regarded as specific for SpA, 
were found to be common in this cohort. One in five patients in this cohort had 
MRI findings suggesting SpA and the three most commonly used criteria for IBP 
were even more common. The classification utility of both single IBP 
characteristics and IBP criteria in relation to the diagnosis of SpA were found to 
have no clinical value.  
The systematic review identified several MRI findings in the spine and SIJ 
associated with SpA. However, it was not possible to quantify the association at a 
meta-level as only two high quality studies were identified – one for each of the 
two anatomical regions. Hence, the evidence for the utility of MRI in the diagnosis 
of SpA was considered limited.  
In the analysis of the association between MRI findings and clinical characteristics 
in the cohort study, the three most common SpA features were generally not 
associated with MRI findings related to sacroiliitis. BMO sum-score of 1 was also 
common, but not associated with any of the SpA features. However, BMO sum-
score of 2 or 3+ and several structural MRI findings in the SIJ were each found to 
be positively associated with one or more SpA features. Collectively, these results 
imply a need for a data-driven re-evaluation of the ASAS criteria for axial SpA 
regarding the diagnostic utility of SpA features and the minimum requirements of 
MRI findings for the diagnosis of sacroiliitis. 
Discussion of main results 
Prevalence of MRI findings 
Historically, the focus in MRI findings at the SIJs has been in patients with IBP or 
SpA and only few studies have reported on MRI findings at the SIJ in patients with 
non-inflammatory back pain [14]. In the only high-quality study on the SIJ 
identified in the systematic review, the prevalence of BMO, FMD, erosions and 
ankylosis in the SIJ, were 23%, 15%, 4%, and 0%, respectively, in the group of 
patients with non-specific LBP [17]. Additionally, two small case-control studies 
reported prevalence of 27% and 22%, respectively, for BMO at the SIJ in non-
inflammatory back pain control groups [16, 18]. In general, these results 
correspond to ours, even though they are not directly comparable due to 
differences in the definition of MRI findings and study samples.   
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In the current study population, 21% had BMO at the SIJ, which is comparable to 
the studies mentioned above. This prevalence is high considering that BMO at the 
SIJ is thought to be almost exclusively related to SpA. Previous research has 
shown associations between BMO and degenerative/load-related changes at 
different locations such as the spine (Modic type I changes) [43, 44] and knee [45, 
46]. However, at the SIJ, the presence of BMO is most often described as highly 
indicative of sacroiliitis related to SpA [28]. Supported by BMO being more 
prevalent in the oldest patients in the current study, it nevertheless seems 
reasonable to assume that BMO at the SIJ can also be related to 
degenerative/load-related changes. Another interesting result from the analysis 
of the prevalence of MRI findings was that FMD and sclerosis at the SIJ were 
noticeably more common in women than in men, which also has been reported 
for sclerosis identified using conventional radiography [47]. This could be 
explained by a correlation between SIJ findings and pregnancy/birth-related strain 
[48]. However, pregnancy/birth-related pathoanatomical changes in the SIJ have 
only been investigated with MRI in few studies [49, 50]. Hence, there seems to be 
a need for further investigation of the clinical importance of both BMO and 
structural MRI findings at the SIJ in LBP populations, and not only in relation to 
SpA. 
The prevalence of spinal MRI findings previously related to SpA (corner lesions, 
posterior element lesion, costovertebral joint BMO, syndesmophytes or fusion, 
and erosions in the vertebral corner) has, to our knowledge, not previously been 
investigated in a comparable population. In the current study, the prevalence of 
these findings was very low, and therefore differences between gender and age 
were not evaluated.  
Prevalence of ASAS criteria for axial SpA 
In the current study population, 10% fulfilled the ASAS criteria for axial SpA. The 
prevalence of the ASAS criteria for axial SpA has not previously been investigated 
in a similar study sample and setting. However, a recent study from the 
Netherlands has reported on the prevalence of SpA according to ASAS in primary 
care. Of 364 chronic LBP patients aged 18-45 years consulting general 
practitioners in the Netherlands, 24% fulfilled the criteria for axial SpA [51]. The 
lower prevalence found in our cohort of secondary care patients could be 
explained by the primary care physicians directly referring patients whom they 
suspected had SpA to rheumatological specialists and not to the Spine Centre, as 
this is the recommended referral pathway. In patients referred with chronic LBP 
or IBP to specialised rheumatological care, the prevalence of ASAS criteria for SpA 
has been reported to be 38% [6] and 67%, [52], respectively. 
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Classification utility of inflammatory back pain  
The concept of IBP has been widely used in the diagnosis of SpA since its 
introduction by Calin et al in 1977 [19] and many clinicians may expect patients 
who meet a set of criteria for IBP to have a high probability of having SpA. The 
results from the current study demonstrate that these expectations may need to 
be reassessed. Several of the single IBP characteristics and all three sets of IBP 
criteria were found to be statistically significantly associated with SpA according 
to ASAS. However, the IBP characteristics that had a high sensitivity were also 
common in patients without SpA and two-thirds of the entire study sample met at 
least one of the IBP criteria. Consequently, the classification utility of these 
characteristics and criteria in relation to SpA in this cohort of patients with 
persistent LBP was below the pre-defined clinical value.  
Several studies have evaluated the classification utility of IBP in patients referred 
to or treated in, specialised rheumatological care with a relatively high pre-test 
probability of SpA and using expert opinion as the reference standard [2, 4, 20, 
51, 53-56]. The classification utility for the identification of SpA for some of the 
IBP criteria and single characteristics was moderately better in some of these 
studies, with ROC areas ranging from 0.37-0.76 for single IBP characteristics [2, 4, 
20, 53-56] and from 0.57-0.79 for the three sets of IBP criteria [2, 4, 20, 51, 53-
56]. However, caution should be taken in applying these results to daily clinical 
practice in the early diagnosis of SpA among patients with persistent LBP. Firstly, 
outside specialised rheumatological care, SpA is a rare disease compared with 
persistent LBP. This situation sets high demands for the diagnostic capability of 
clinical tests used in the diagnostic process of identifying SpA. When the a priori 
possibility of having the disease is low, the test must be very precise in order to 
result in a high pre-test probability of the disease in the case of a positive test 
(PPV). Furthermore, case-control design with evaluation of patients with AS or 
long-lasting established SpA compared with selected LBP controls [2, 20, 53, 56] is 
not representative of the diagnostic challenges associated with the early stages of 
the disease in daily clinical practice. Finally, the use of expert opinion as the 
reference standard in research introduces a high risk of incorporation bias, 
because the IBP characteristics that are evaluated are likely to be the same as 
those used in the diagnosis of SpA. This risk of bias is further enhanced when the 
same clinicians who diagnose SpA also evaluate the presence of IBP. 
The results from the current evaluation of IBP raise the question of whether 
characteristics thought to be specific to IBP are simply characteristics of persistent 
back pain in general. It is likely that pain in non-SpA LBP patients also has an 
inflammatory component [57], for example caused by Modic type 1 changes [58, 
59] or inflammatory reaction associated with tissue damage in disc herniations or 
nerve root compression [60, 61]. Since these MRI findings are relatively common 
in LBP pain patients [62, 63], this is an important aspect to consider. 
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Unfortunately, the lack of good reference standards not only for SpA but also for 
subgroups of LBP, compromises the possibility of testing the classification utility 
of IBP characteristics.  
Systematic review of the association between MRI findings and the 
diagnosis of SpA 
This systematic review identified several MRI findings in the spine and SIJ 
associated with SpA. However, only two high quality studies were identified when 
the review was conducted, and the amount of relevant data was insufficient to 
give a reliable quantification of this association. Therefore, the evidence for the 
utility of MRI in the diagnosis of SpA was considered limited. On the basis of the 
identified methodological shortcomings of the included articles, the review 
highlights important issues in the investigation of the diagnostic utility of MRI in 
relation to SpA.  
Firstly, the sampling method was either insufficient or not fully described in the 
majority of the included studies, which makes preclusion of selection bias difficult. 
In general, there was a tendency to underestimate the importance of the controls 
or non-case group in their sampling, description and number. A sufficient sample 
size is crucial for the transferability of study results to clinical practice, since small 
study samples give imprecise estimation with broad confidence intervals. 
Regarding the MRI evaluation, there was little homogeneity in the definitions of 
the assessed MRI findings and only five of the nine articles reported testing of the 
reproducibility of the MRI evaluation. It seems that an international agreement on 
definitions of different MRI findings and a threshold minimum reproducibility 
would facilitate comparison with future research results in addition to the 
translation from research to clinical practice.  
Finally, several of the studies did not evaluate representative study samples but 
rather patients with long lasting SpA or AS compared with selected controls of 
either non-SpA LBP patients or non-LBP individuals, which do not match the 
challenge of diagnosis of SpA in daily clinical practice populations. The fact that 
MRI cannot be included in the reference standard, when assessing MRI as a 
diagnostic tool, restricts the possibilities for a good reference standard, especially 
in early stages of the disease. This could be accommodated with longitudinal 
assessment of the development of manifest disease over time. However, none of 
the identified longitudinal studies met the inclusion criteria in the review. 
Association between MRI findings and SpA features  
Due to the cross-sectional nature of the cohort study and the lack of a suitable 
gold standard for the early SpA diagnosis, it was not feasible to evaluate the 
sensitivity and specificity of the ASAS criteria for axial SpA. Instead, we performed 
an exploratory analysis based on the assumption that both sacroiliitis and clinical 
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characteristics are strongly associated with the SpA disease entity, and that MRI 
findings related to sacroiliitis and SpA features would therefore also be 
associated. Although this assumption cannot be fully confirmed from this study, 
the results underline several important aspects in the early diagnosis of SpA, 
which calls for further attention.  
The prevalence of family disposition, good response to NSAID, and IBP according 
to ASAS were notably higher than the rest of the SpA features. Due to their high 
prevalence, these features were often the main reasons for patients being 
classified as having SpA in this study. Similar findings were found in the cohort of 
LBP patients recruited from a primary care setting in the Netherlands [51]. In the 
Spondyloarthritis Caught Early (SPACE) cohort consisting of chronic LBP patients 
referred for specialised rheumatological evaluation, the same three SpA features 
were also the most prevalent [6]. In the SPACE cohort, the prevalence of SpA 
features was in general higher, which is to be expected in a cohort of patients 
with a higher suspicion of SpA. In the current study, good response to NSAID was 
weakly associated with erosions, but no other positive associations with MRI 
findings at the SIJ were found for these SpA features. These results, suggest that 
the role of these three SpA features in the diagnosis of SpA should be re-
evaluated. Of the remaining SpA features, positive HLA-B27, elevated CRR, 
peripheral arthritis, and preceding infection were associated with MRI findings 
suggestive of sacroiliitis. This result suggests that preceding infection could be re-
incorporated into the criteria for SpA. However, this result was based on few 
positive patients and our results require confirmation through other studies.  
Sacroiliitis according to the ASAS definition of SpA-related sacroiliitis was 
identified in 21% of patients in this cohort. Of those patients who were MRI 
positive, a substantial proportion (42%) had only a BMO score of 1. While these 
slight BMO findings were associated with higher age, no associations were found 
with any of the SpA features. Although none of the identified longitudinal studies 
met the inclusion criteria in the review, a few small studies evaluating the 
predictive value of BMO at the SIJ reported that only a minor portion of patients 
with slight or moderate BMO findings developed ankylosing spondylitis over time 
[9, 18, 64]. Even though further longitudinal studies in large cohorts are needed, 
collectively these results should encourage a re-evaluation of the minimum 
requirements of MRI findings for diagnosing sacroiliitis. 
Several of the structural findings, especially erosions, were associated with 
positive HLA-B27 and in addition, FMD and sclerosis were also associated with 
female gender. The association with female gender implies that pregnancy and/ 
or birth-related strain could be another possible cause of FDM and sclerosis, as 
mentioned above [48]. Furthermore, these results support inclusion of erosions as 
a part of the definition of sacroiliitis [36, 65], although the current study was not 
designed to identify the MRI findings with the best diagnostic utility for SpA. 
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Nonetheless, the need for further studies of the diagnostic value of both active 
and structural MRI findings in the SIJ in relation to SpA is stressed by the results in 
this study.  
The spinal MRI changes, which previously have been suggested to be associated 
with SpA, were rare in the current study population. The low prevalence of these 
findings does not per se mean that spinal findings are less important than SIJ 
findings in the diagnosis of SpA. In the current cohort, spinal corner lesions and 
BMO at the apophyseal joints were found to be strongly associated with HLA-B27, 
which supports the association between these findings and SpA which also were 
reported in the high quality study evaluating the spine [38] and also in two of the 
other studies included in the review [39, 40]. The importance of the number of 
corner lesions present and the association with other SpA features could, 
however, not be assessed in the current study due to their low prevalence. 
Clinical implication and future studies 
As mentioned in the introduction to this thesis, the performance of the ASAS 
criteria for axial SpA has only been sparsely investigated. The criteria were 
originally validated in a cohort of LBP patients referred for rheumatological 
assessment using expert opinion of the diagnosis of SpA as the reference standard 
[4]. In that study the authors reported relatively good diagnostic parameters for 
the criteria with a sensitivity of 83% and a specificity of 84%. Similar results have 
been reported in two other cohort studies also using expert opinion as the 
reference standard [6, 7]. However, caution should be taken in transferring these 
results into clinical practice, because the use of expert opinion as the reference 
standard, as was the case in these studies, introduces a risk of incorporation bias, 
as it is likely that clinicians may use the same items that are included in the ASAS 
criteria in their diagnosis of SpA. The possibility of finding a good reference 
standard for cross-sectional studies in the early stages of the disease are further 
restricted as MRI is already widely used in the diagnosis of SpA [66]. 
In general, early diagnosis is associated with more uncertainties than in later 
stages of the disease and the lack of good reference standards, not only for SpA 
but also for subgroups of LBP, compromises the possibility of testing the 
diagnostic utility of items included in the diagnosis of SpA. The results from the 
current study show that several findings included in the classification criteria for 
SpA were relatively common in this population of patients with persistent LBP. 
When symptoms are common and the disease itself is rare, the majority of 
patients presenting with these symptoms are unlikely to have the disease, 
regardless of an apparent association with the manifest disease. Including items 
that are relatively common in back pain patients, but not strongly associated with 
the disease, will therefore reduce the specificity of a SpA classification or 
diagnosis, and should therefore be considered carefully.  
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Collectively, the results from the systematic review and the cohort study 
underline the requirement for further studies in the area. Future studies should 
include large-scale longitudinal studies investigating the predictive value of both 
MRI findings and clinical characteristics regarding development of manifest SpA. 
In the meantime, to avoid over-diagnosing a relatively rare disease with 
potentially serious consequences for the individual [67], high specificity is 
probably preferable to high sensitivity, especially as there is no treatment that has 
been shown to halt the progression of the structural changes related to the 
disease [68]. Another consideration could be to change focus from ‘diagnosis’ to 
‘identifying high-risk patients’ in relation to the development of fulminant SpA. 
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METHODOLOGICAL CONSIDERATIONS 
Systematic review 
The strength of the review is the systematic search method and the rigorous 
assessment of the methodological quality of the included studies. To our 
knowledge, this review is the first to give an overview of the level of evidence for 
the utility of MRI in the diagnosis of SpA, including a quality assessment. 
The weaknesses of the review are firstly, the possibility of relevant articles not 
being included because of the language limitations, the limited number of 
databases used in the search and because only one person selected studies to be 
retrieved in full-text. Furthermore, it might be argued that the threshold for a 
minimum study sample size was either too low or too high. However, it seems 
reasonable to reduce the width of the 95% CI by not setting the cut-point too low; 
in contrast, increasing the cut-point for sample size further would have greatly 
decreased the number of relevant articles that could have been included. 
Cohort study 
The most important methodological strength of the current study is the cohort 
design in a setting representative of the challenges in the early diagnosis of SpA, 
increasing the transferability of the results to clinical practice. Furthermore, the 
large number of patients strengthens the precision of the prevalence estimates of 
both MRI findings and clinical characteristics. Some of the evaluated items were, 
however, rare and the analyses of associations between the MRI findings and the 
very rare SpA features (peripheral arthritis, heel enthesitis, uveitis, dactylitis, 
psoriasis, inflammatory bowel disease, and preceding infection) were 
underpowered and not conclusive, despite the large study sample. The 
prevalence of spinal corner lesions and SIJ erosions and sclerosis were, likewise, 
too low to identify different cut-points in severity. Moreover, the thesis was 
restricted to a cross-sectional design, which precludes investigating the predictive 
value of both MRI findings and clinical characteristics regarding development of 
fulminant SpA over time. 
Data collection 
The methodological strengths of the data collection are the independent 
standardised interpretation of SpA features, blood samples and MRI findings, 
reducing the risk of bias. Secondly, effort was taken to standardise and optimise 
the method used for identifying patients with SpA features. A multidisciplinary 
team of clinicians working at the Spine Centre were allocated to the study, and 
received focused information about the project procedure and the characteristics 
of SpA features before the commencement of the study. During the study period, 
 THE USE OF MRI IN THE EARLY DIAGNOSIS OF SPONDLOATHRITIS 29 
 
sessions were held repeatedly for the project team to ensure a uniform 
interpretation of SpA features.  
There are also limitations in relation to the data collection. Firstly, formulating a 
standardised self-reported patient questionnaire required the creation of 
operational definitions for the IBP characteristics, as no validated questionnaire 
including the assessed items existed, when the study was initiated. It is possible 
that the results regarding IBP would have been different if clinicians, with special 
expertise in musculoskeletal disorders, had collected the IBP characteristics, as is 
common practice in routine care. However, the use of the self-reported patient 
questionnaires precluded bias caused by the clinician’s a priori beliefs and overall 
judgement of the presence of SpA in a particular patient. Secondly, the MRI 
evaluations were not blinded for age and gender, which potentially could have 
affected the analysis of association between MRI findings and gender and age. 
Lastly, to avoid unnecessary exposure to radiation, conventional radiography of 
the SIJ was not included in this study and their contribution to the prevalence of 
fulfilment of the ASAS criteria for axial SpA could not be estimated. 
MRI evaluation 
The methodological strengths of the MRI evaluation are, firstly, the inclusion of 
both the SIJ and the whole spine, making it possible to describe the prevalence 
and distribution of both degenerative and SpA-related MRI findings in the most 
important regions of the axial skeleton in one study. Secondly, all patients were 
scanned with the same MRI equipment and the standardised MRI evaluation, 
which produced acceptable observer agreement results for the majority of the 
assessed findings, increasing the integrity and uniformity of the data. The 
strengths of the inter- and intra-observer agreement study are firstly that three 
independent readers evaluated the MRIs, and intra-observer agreement was 
tested by two of the readers. The involvement of more than two readers 
improves the generalisablity of the evaluation method. Finally, assessing each 
lesion separately creates the potential for describing the development of the 
changes in subsequent studies, and the possibility of analysing location-specific 
alterations. 
There were also potential weaknesses of the MRI evaluation that have to be 
acknowledged. Firstly, some MRI findings (erosion of the corner, BMO at the 
costovertebral joints, FMD at the apophyseal joints, and soft tissue oedema) were 
too rare for the observer agreement of the evaluation to be tested. For spinal 
corner lesions and erosions at the SIJ, the inter-observer agreement was below 
0.6. These findings were nevertheless included in the analysis, because they are 
widely regarded to be key MRI findings in the assessment of SpA [15, 28]. 
However, it cannot be ruled out that improvements in the agreement for these 
findings could affect the prevalence estimates and the analyses of association 
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between these findings and SpA features. Finally, it cannot be ruled out that the 
additional value of structural findings in the definition of sacroiliitis is constrained, 
due to the correlation between the different SIJ findings.  
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CONCLUSIONS 
• One out of five patients in this cohort had BMO MRI findings at the SIJ. This 
suggests the need for further investigation of the clinical value and different 
causes of SIJ MRI findings in persistent LBP populations. 
• The three most common SpA features: family disposition, good response to 
NSAID, and IBP according to ASAS were each found in 15-17% of patients, 
ASAS definition of SpA-related sacroiliitis was met by 21% and the complete 
ASAS criteria for SpA were met by 10%. 
• The classification utility of IBP characteristics in relation to the diagnosis of 
SpA in this cohort was below the pre-defined clinical value. 
• In the systematic review, limited evidence was found for the utility of MRI in 
the diagnosis of SpA, since only two high quality studies were identified. 
• BMO sum-score of 2 or 3+ and several structural findings at the SIJ were each 
positively associated with one or more SpA features. However, the three most 
common SpA features were generally not associated with MRI findings 
suggestive of SpA and 42% of patients with sacroiliitis according to ASAS had 
only BMO sum-score of 1, which were not associated with any SpA features.  
• Collectively, the results suggest the need for a data-driven re-evaluation of 
the ASAS criteria for axial SpA in relation to the diagnostic utility of SpA 
features and the minimum requirements of MRI findings to be present for 
diagnosing sacroiliitis. 
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APPENDIX 1 QUESTIONNAIRES 
Translated wording of the patient inflammatory back pain questionnaire  
 
 
 
Questions Answers 
How did the pain start? Slowly/Suddenly  
Have you ever had back pain for more than 3 consecutive 
months? 
Yes/ No     
Do you feel stiff in your back in the morning? No / 
Yes (less than 30 min.) / 
Yes (between 30 and 60 min.)/ 
Yes (more than an hour.)           
If you wake up at night due to back pain, is it during the last 
part of the night? 
Yes/ No     
If you wake up at night due to back pain, does it help to get up 
and walk around? 
Yes/ No     
Does it help to get up and walk around? Yes/ No     
Have you ever had buttock pain? Yes/ No     
Did it shift from one side to the other? Yes/ No     
How is your pain affected by rest? It gets better/No effect /It gets worse 
How is your pain affected by activity? It gets better/No effect /It gets worse 
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Translated wording of the clinician SpA features questionnaire  
Questions Definitions/  
Help text for the clinician in the 
questionnaire 
Answers 
Does the patient have, or has the patient 
ever had, peripheral arthritis?  
Yes= the patient has or has had a diagnosis of 
peripheral arthritis. 
Yes/ No     
Does the patient have or has the patient 
ever had enthesitis of the heel?  
Enthesitis of the heel is an inflammatory 
reaction localised at the insertion of the Achilles 
tendon or the Plantar fascia at the calcaneus 
Yes/ No    
Is the patient diagnosed with Crohn's 
disease or ulcerative colitis?  
Yes= The patient is diagnosed with Crohn’s 
disease or ulcerative colitis. 
Crohn’s disease and ulcerative colitis are 
inflammatory bowel diseases with chronic 
diarrhoea often associated with blood and 
abdominal pain. The diagnoses require proven 
inflammation of the intestine by either biopsy or 
endoscopy. 
Yes/ No     
Has the patient ever had dactylitis?  Yes= The patient has or has had a diagnosis of 
dactylitis. 
Dactylitis is an inflammatory reaction 
comprising a few fingers or toes, where swelling 
becomes widespread. The swelling appears 
within a few days and persists for weeks or 
months. Dactylitis is usually not painful. 
Yes/ No     
Has the patient ever had anterior 
uveitis?  
Yes= The patient has or has had diagnosed 
anterior uveitis. 
Anterior uveitis is an inflammation of the 
anterior part of the uvea. The symptoms are eye 
pain, redness of the eye, photophobia, watery 
eyes and blurred vision. Anterior uveitis is 
treated with adrenal cortex hormone (eye drops 
or oral treatment). 
Yes/ No     
Does the patient have, or has the patient 
ever had, psoriasis? 
Yes= The patient has or has had a diagnosis of 
psoriasis. 
Yes/ No     
Is anyone in the patient’s family known 
to have: Anterior Uveitis, Crohn's 
disease, Ulcerative Colitis, Psoriasis, 
Ankylosing Spondylitis or Reactive 
Arthritis? 
Yes= Presence in a first-degree or second-
degree relative of any of the following:  
Anterior Uveitis, Crohn’s disease, Ulcerative 
colitis, Psoriasis, Ankylosing Spondylitis or 
Reactive Arthritis  
Yes/ No     
Has the patient had a urogenitial or 
gastrointestinal infection less than one 
month before the onset of back pain? 
Yes= The patient has had a urogenitial or 
gastorintestinal infection less than one month 
before the onset of back pain. For example with 
Chlamydia or Salmonella. 
Yes/ No     
Has the patient used NSAID as an 
analgesic? 
Yes= The patient uses NSAID as an analgesic. 
For example: Bonyl, Ipren, Ibuprofen, Ibumetin, 
Brufen, Naproxen, Diclofenac, Diclon, Toradol, 
Todolac og Voltaren. If you are uncertain the 
drug can be looked up on: www.medicin.dk. 
Yes/ No     
How does it work? At 24 -48 hours after a full dose: 
No effect= No effect 
Moderate effect= The pain is somewhat 
improved 
Good effect = The pain is gone or much better 
No effect 
Moderate 
effect 
Good effect 
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APPENDIX 2 DEFINITION OF THE MRI FINDINGS 
SPINE  
MRI findings Definitions 
Type of vertebral 
endplate signal 
change 
Bone marrow oedema: A subchondral area with increased signal on STIR 
images. 
Fatty marrow deposition: A subchondral area with increased signal on T1-
weighted images compared with normal bone marrow.  
Mixed type: A subchondral area with increased signal on both T1-weighted and 
STIRS images. 
Location of vertebral 
endplate signal 
change 
Anterior localisation: >50 % of the lesion is situated in the anterior part of the 
vertebrae. 
Posterior localisation: >50 % of the lesion is situated in the posterior part of the 
vertebrae. 
Equally widespread: The lesion is equally distributed with approximately 50% 
of the lesion in the anterior and the posterior part of the vertebra, respectively.  
Size of vertebral 
endplate signal 
change 
 
The size is evaluated from the area of the endplate.  
Definition of 100%: The entire subchondral area corresponding to the endplate. 
i.e. the depth of the lesion is not important. 
Small: <25% of the subcortical bone area. 
Medium: 25% to <50% of the subcortical bone area. 
Large: ≥50 % of the subcortical bone area. 
Corner lesions  A signal change that is primarily located in the corner of the vertebra and has 
contact with both edges of the corner. Changes in relation to osteophytes are not 
scored as corner lesions. Three types of corner lesions: 
Bone marrow oedema: A subchondral area with increased signal on STIR 
images. 
Fatty marrow deposition: A subchondral area with increased signal on T1-
weighted images compared with normal bone marrow.  
Mixed type: A subchondral area with increased signal on both T1-weighted and 
STIRS images. 
Erosions in the 
vertebral corner 
Loss of normal marrow signal on T1 with a defect in the overlaying cortical bone.  
Evaluated as located in the corner if a minimum of one of the erosions is located 
in the corner. 
Syndesmophytes or 
vertebral fusion 
Syndesmophytes are new bone formations from the edge of the vertebra. 
Spondylophytes and ambiguous syndesmophytes with a growth angle of >45 
degrees in relation to the anterior vertebral edges should not be considered as 
syndesmophytes. 
Slight: Syndesmophytes between vertebral corners without osseous bridging. 
Moderate: Syndesmophytes and partial osseous bridging between the vertebral 
bodies. 
Severe: Total fusion of two vertebral bodies.  
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Bone marrow oedema 
at the costovertebral 
joints 
An osseous area laterally in the thoracic vertebral bodies with increased signal 
on STIR images. 
Bone marrow oedema 
at the apophyseal 
joints 
Subchondral areas at the apophyseal joint with increased signal on STIR images.  
Fatty marrow 
deposition at the 
apophyseal joints 
 
Subchondral areas at the apophyseal joint with increased signal on T1-weigthed 
images compared with normal bone marrow. 
Soft tissue oedema  An area with increased signal on STIR images in the soft tissue at the apophyseal 
joints, excluding synovial cysts regarded as degenerative.  
Disc degeneration Normal: Normal height and signal intensity in the disc. 
Slight: A slight decrease in height and/or signal intensity in the disc. 
Moderate: Decreased height and fluid signal in the disc. 
Severe: Elimination of the disc height. 
NB: High intensity in the disc due to blood vessel ingrowths is noted in the 
comment box. 
Disc contour 
 
Broad-based protrusion: Herniation involves 25-50% of the disc circumference. 
Focal protrusion: Herniation involves 0-25% of the disc circumference. 
Extrusion: Herniation is longer than it is broad or migration of the herniation 
over or under the level of the disco-vertebral corners. 
Sequestration (free fragment): The herniation fragment is without 
communication with the disc.  
DVU: disco-vertebral unit, STIR: Short-tau inversion recovery  
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SACROILIAC JOINTS 
MRI findings Definitions 
Bone marrow oedema A subchondral or periarticular area with increased signal on STIR images. The 
lesion has to be present at 2 places in 1 slice or at 1 place in 2 consecutive 
slices.  
Definition of 100%: The entire subchondral or periarticular area 
corresponding to the joint facet in the region is affected i.e. the depth of the 
lesion is not important. 
Slight: <25% of the subcortical bone area. 
Moderate: 25% to <50% of the subcortical bone area. 
Severe: ≥50% of the subcortical bone area. 
Erosions Loss of marrow signal on T1 and T1FS with a defect in the overlaying cortical 
bone (often best delineated at T1FS). For subtle findings, erosion has to be 
present at 2 places in 1 slice or at 1 place in 2 consecutive slices.  
Definition of 100%: The entire subchondral or periarticular area 
corresponding to the joint facet in the region is affected.  
Slight: Erosions covering <25% of the joint facet area. 
Moderate: Erosions covering 25% to <50% of the joint facet area. 
Severe: Erosions covering ≥50% of the joint facet area. 
Fatty marrow 
deposition 
A subchondral or periarticular area with increased signal on T1-weigthed 
images compared with normal bone marrow. The lesion has to be present at 2 
places in 1 slice or at 1 place in 2 consecutive slices.  
Definition of 100%: The entire subchondral or periarticular area 
corresponding to the joint facet in the region is affected. i.e. the depth of the 
lesion is not important. 
Slight: <25% of the subcortical bone area. 
Moderate: 25% to <50% of the subcortical bone area. 
Severe: ≥50% of the subcortical bone area. 
Sclerosis A subchondral or periarticular area with low signal, compared to normal bone 
marrow on T1, T1FS (SPIR) and STIR images. The lesion has to be present at 2 
places in 1 slice or at 1 place in 2 consecutive slices. 
Definition of 100%: The entire subchondral or periarticular area 
corresponding to the joint facet in the region is affected. i.e. the depth of the 
lesion is not important. 
Slight: <25% of the subcortical bone area. 
Moderate: 25% to <50% of the subcortical bone area. 
Severe: >50 % of the subcortical bone area. 
Ankylosis Partial: Partial osseous bridging across the joint space. 
Total: Fusion of the joint facets. 
STIR: Short-tau inversion recovery, FS: Fat saturated 
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Abstract
Introduction: Magnetic resonance imaging (MRI) has been proven capable of showing inflammatory and structural
changes in patients with spondyloarthritis (SpA) and has become widely used in the diagnosis of SpA. Despite this,
no systematic reviews evaluate the diagnostic utility of MRI for SpA. Therefore, the objective of this systematic
review was to determine the evidence for the utility of MRI in the clinical diagnosis of SpA. The aims were to
identify which MRI findings are associated with the diagnosis of SpA and to quantify this association.
Methods: MEDLINE and EMBASE were electronically searched. Inclusion criteria were cross-sectional or longitudinal
case-control or cohort MRI studies. The studies required a group with either SpA or inflammatory back pain (IBP)
and a non-case group without SpA or IBP. Each group required a minimum of 20 participants. The included articles
had to report results containing raw numbers suitable for the construction of two-by-two tables or report results
by sensitivity and specificity for cross-sectional studies or odds ratios, relative risk ratios, or likelihood ratios for
longitudinal studies. Method quality was assessed by using criteria based on the QUADAS tool.
Results: In total, 2,395 articles were identified in MEDLINE and EMBASE before November 2011. All articles were
reviewed by title and abstract. Seventy-seven articles were reviewed by full text, and 10 met the inclusion criteria.
Two were considered of high quality: one evaluated the sacroiliac joints, and the other, the spine. Because of the
small number of high-quality studies, a meta-analysis was not performed. The two high-quality studies found a
positive association between MRI findings (bone marrow edema, erosions, fat infiltrations, global assessment of
sacroiliitis, and ankylosis) and the diagnosis of IBP and SpA.
Conclusion: In this review, several MRI findings were found to be associated with SpA. However, because of the
small number of high-quality studies, the evidence for the utility of MRI in the diagnosis of SpA must be
considered limited. Therefore, caution should be taken to ensure that inflammatory and structural MRI findings are
not interpreted as being more specific for SpA than is supported by research.
Introduction
Spondyloarthritis (SpA) is a rheumatologic disease that
comprises the different disease entities of ankylosing
spondylitis (AS), reactive arthritis, psoriasis arthritis,
spondyloarthritis associated with inflammatory bowel
disease, and undifferentiated spondyloarthritis. The
main symptoms are chronic back pain, associated with
extraspinal manifestations and particular laboratory find-
ings. It usually emerges in the second or third decade of
life and, although it is relatively rare, the prevalence
being about 0.25% to 1% in the European population
[1], it is a health condition worthy of attention because
it can be debilitating for those affected, especially if
undiagnosed.
With the introduction of tumor necrosis factor-a inhi-
bitors in the treatment of preradiographic SpA [2,3], the
interest in early and precise diagnosis has increased.
However, the early diagnosis of SpA is often difficult. In
chronic back pain patients, the most common diagnosis
is nonspecific low-back pain (NSLBP), and SpA is esti-
mated to contribute only 5% of the causes of back pain in
primary care patients [4]. Even though plain radiography
can detect structural changes of the spine and sacroiliac
joints (SIJs), patients often have symptoms for several
years before these changes become evident [5].
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Over the past three decades, magnetic resonance ima-
ging (MRI) has proven capable of detecting preradio-
graphic inflammatory lesions seen in SpA patients [6,7],
and optimism exists regarding the opportunities MRI can
offer for early diagnosis of SpA. This is indicated by the
inclusion of MRI of the SIJ in the criteria for axial SpA
developed by the Assessment of SpondyloArthritis inter-
national Society (ASAS) in 2009 [8]. However, to our
knowledge, no systematic critical literature reviews have
addressed the utility of MRI in the diagnosis of SpA.
The objective of this systematic critical review was
therefore to determine the level of evidence for the utility
of MRI in relation to the clinical diagnosis of SpA. The
specific aims of this review were to identify which MRI
findings are associated with the diagnosis of SpA and to
quantify this association.
Methods
Search method for identification of studies
Searches were made in the MEDLINE and EMBASE data-
bases for articles published before November 2011. The
following search terms were used as free text and MeSH
terms: “magnetic resonance imaging,” “spondyloarthritis,”
“ankylosing spondylitis,” “sacroiliitis,” “psoriasis arthritis,”
“reactive arthritis,” “arthritis and inflammatory bowel dis-
ease,” and “inflammatory back pain.” Different forms of
spelling and synonyms for each term were also used.
Inclusion criteria for considering studies for this review
Types of studies
Prospective and retrospective case-control or cohort stu-
dies were accepted. Both cross-sectional and longitudinal
studies were accepted. Articles in English, German,
French, Norwegian, Swedish, and Danish were included,
as these were the linguistic capabilities of the author team.
Study subjects
Studies were required to include a group of cases with
the clinical diagnosis of SpA or inflammatory back pain
(IBP) and a group of noncases without SpA or IBP,
respectively. Each case and noncase group had to contain
more than 20 participants. The criteria for sample size
were set arbitrarily to reduce the risk of imprecise esti-
mates with very wide confidence intervals (CIs). The
mean age of the study sample had to be older than 18
and younger than 65 years.
Index test
The index test under evaluation was MRI of the axial ske-
leton. The field strength had to be a minimum of 1.5 Tesla
to secure a minimal standard of the imaging. No other
limitations were set for the technical equipment used, and
all types of MRI sequences were accepted.
Target condition
The target condition was either SpA, one of the disease
subgroups of SpA (AS, psoriasis arthritis, reactive
arthritis, arthritis associated with IBP, or undifferen-
tiated SpA) or IBP.
Reference standard
The reference standard was the clinical diagnosis of one
of the target conditions defined by a diagnostic criterion
or by expert opinion. The diagnosis had to have been
made from clinical information. Information from plain
radiography and serologic testing was accepted as part of
the diagnosis.
Results presentation
Articles were included only if they reported one of the
following: Results containing raw numbers suitable for
the construction of two-by-two tables, for cross-sec-
tional studies if they reported results by sensitivity and
specificity, and for longitudinal studies if they reported
odds ratios, relative risk ratios, or likelihood ratios.
Data collection and analysis
Selection of studies
Initially, the first author reviewed the titles and abstracts of
the search results for identification of relevant articles to be
retrieved in full text. The full texts were screened for rele-
vance, and double publications were excluded at this stage.
Subsequently, the identified articles were reviewed in full
text for data extraction by the first and third authors.
Data extraction and management
The first and third authors independently extracted the
data from the relevant articles according to a check-list
specifying the information needed regarding the following
factors: (a) study sample(s), (b) clinical diagnosis, (c) MRI
findings, (d) MRI technique, (e) MRI evaluation, (f) data
analysis, and (g) results. In case of disagreements, consen-
sus was reached through discussion.
Assessment of methodologic quality
The quality of the included articles was assessed with a
set of quality criteria, based on the QUADAS tool [9].
The quality assessment was subdivided into four topics:
(a) study sampling, (b) clinical diagnosis, (c) MRI eva-
luation, and (d) data analysis and results. Each item was
rated from 0 to 2, resulting in a maximum of 8 points
per article (Table 1). For longitudinal studies, the
reporting on drop-out rates and reasons for dropping
out were to be assessed.
The assessment was performed independently by the first
and the third authors. Any disagreements in the assess-
ments were settled by consensus and discussion with the
second author. Articles with a quality score of more than 5
points were arbitrarily regarded as high-quality studies.
Only results from high-quality studies were further
reviewed.
Statistical analysis and data synthesis
Sensitivity and specificity were retrieved from the article
where possible and calculated from raw data when not
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reported in the article. The Wilson score method with-
out continuity correction was used to calculate the 95%
CI, if it were not reported in the article. Meta-analysis
was planned to be performed on homogeneous high-
quality studies, but was not performed because of insuf-
ficient data.
Results
Description of studies
In all, 1,336 articles were found in MEDLINE, and
2,359, in EMBASE. After elimination of duplicates,
2,395 articles were reviewed by title and abstract, and 76
articles were identified for assessment in full text. After
full-text review, nine cross-sectional articles met the
inclusion criteria [10-18] (Figure 1). No longitudinal stu-
dies met the inclusion criteria. Reasons for exclusion of
articles reviewed in full text are presented in Table 2 for
articles on cross-sectional studies and in Table 3 for
articles on longitudinal studies.
Description of included articles
The nine articles meeting the inclusion criteria were based
on eight study samples and were published between 1995
and 2010 [10-18]. Two studies were conducted on the
same study population [17,18]. Seven of the nine articles
were designed to address the diagnostic utility of MRI in
the diagnosis of either AS, SpA, or IBP. One article com-
pared ultrasound with MRI in the diagnosis of IBP [11],
and one article evaluated referral recommendations [12].
Five studies reported results for the SIJ [10-14], and four,
the results for the spine; one of the lumbar spine [15] and
three of the whole spine [16-18]. The sample sizes varied
from 85 to 187 participants. The diagnoses under evalua-
tion were AS [10,12-16], SpA [10,12,14,17,18], and IBP
[11,13,16]. The groups of noncases were no LBP
[11,13,16-18] and/or noninflammatory low-back pain,
such as NSLBP, degenerative arthritis, cancer, and LBP of
Table 1 Quality scores for the articles on MRI and SpA fulfilling the inclusion criteria
Bollow
et al.
(1995) [10]
Klauser
et al.
(2004) [11]
Brandt
et al.
(2007) [12]
Weber
et al.
(2010) [13]
Wick et al.
(2010)
[14]
Kim et al.
(2008)
[15]
Weber
et al.
(2009) [16]
Bennett
et al. (2009)
[17]
Bennett
et al. (2009)
[18]
Study sampling (0-1) 1 0 1 2 1 1 2 1 1
Diagnosis (0-1) 1 0 0 1 0 1 1 0 0
MRI evaluation (0-1) 0 0 0 2 2 1 2 2 1
Data analysis and
presentation of
results (0-1)
0 1 1 2 0 1 2 1 1
Total (0-8) 2 1 2 7 3 4 7 4 3
Diagnosis assessed on IBP or SpA diagnosed by criteria (best) or expert opinion (second best), same diagnosis performed on whole sample, diagnosis
independent of MRI, diagnosis blinded for MRI, and reproducibility of diagnosis tested (inter- and intraexaminer reliability tested and reported). MRI evaluation
assessed on clear definition of each relevant MRI finding, MRI blinded from diagnosis, reproducibility (inter- and intraexaminer reliability tested and reported),
and short time between the MRI scan and diagnosis. Data analysis and presentation of results assessed on statistical significance test and confidence intervals
reported where relevant and results presented in an understandable way. 0, Nonacceptable; 1, Reasonable; 2, Good; SpA, spondyloarthritis; IBP, inflammatory
back pain.
PubMed n =1336 
Embase n = 2359 
Reviewed by title 
and abstract 
n=2395 
Full text articles 
reviewed 
n= 76 
Studies included in 
review  
Cross-sectional: 
n = 9 
Longitudinal: 
n = 0 
Excluded 
n =2319 
 
Excluded 
Cross-sectional: 
n = 48 
Longitudinal: 
n = 19 
High quality studies 
n = 2 
 
Duplicates 
n = 1300 
 
Figure 1 Flow chart of the review process.
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Table 2 Reasons for excluding retrieved articles on cross-sectional studies
Study Reasons for exclusion
Ahlstrom H, et al. (1990) [6] < 20 controls
Algin O, et al. (2009) [25] < 20 controls
Algin O, et al. (2010) [26] < 20 controls
Baraliakos X, et al. (2005) [27] No controls
Bejia I, et al. (2004) [28] < 20 cases
Blum U, et al. (1996) [29] Field strength, < 1.5 Tesla
Bochkova AG, et al. (2010) [30] No controls
Bollow M, et al. (1993) [31] Double publication on Bollow et al. [10]
Bollow M, et al. (1994) [32] Double publication on Bollow et al. [10]
Bozgeyik Z, et al. (2008) [33] No controls
Braun J, et al. (1994) [34] < 20 controls
Braun J, et al. (1998) [35] Reference standard (HLA-B27 status) not a clinical diagnosis
Bredella MA, et al. (2006) [36] No controls
Chung H Y, et al. (2011) [37] No controls
Docherty P, et al. (1992) [38] < 20 controls
Friedburg H, et al. (1987) [39] No controls
Gleeson TG, et al. (2005) [40] < 20 cases
Gupta AD, et al. (2009) [41] < 20 controls
Hanly JGJ, et al. (1994) [42] < 20 controls
Heuft-Dorenbosch L, et al. (2006) [43] Reference standard (plain radiographic) not a clinical diagnosis
Heuft-Dorenbosch L, et al. (2006) [44] No controls
Heuft-Dorenbosch L, et al. (2007) [45] No controls
Inanc N, et al. (2005) [46] Reference standard (plain radiographic) not a clinical diagnosis
Jevtic V, et al. (1996) [47] No controls
Liao Z, et al. (2009) [48] No MRI of the control group
Liao Z, et al. (2011) [49] No controls
Luukkainen RK, et al. (2007) [50] No controls
Marc V, et al. (1997) [51] < 20 controls
McNally EG, et al. (2001) [52] < 20 cases
Muche B, et al. (2003) [53] No controls
Murphey MD, et al. (1991) [54] < 20 controls
Orchard TR, et al. (2009) [55] < 20 cases
Peterova V et al. (2006) [56] No controls
Puhakka KB, et al. (2003) [57] No controls
Remy, et al. (1996) [58] No controls
Rennie WJ, et al. (2009) [59] < 20 controls
Rudwaleit M, et al. (2009) [60] < 20 controls
Rudwaleit M, et al. (2009) [8] Insufficient result presentation
Rudwaleit M, et al. (2009) [61] Insufficient result presentation
Sreedhar C, et al. (2006) [62] < 20 cases
Weber U, et al. (2007) [63] < 20 controls
Weber U, et al. (2010) [64] Double publication on Weber et al. [13]
Wecbach et al. (2009) [65] No controls
Wienands K, et al. (1990) [66] No controls
Williamson L, et al. (2004) [67] Reference standard (orthopedic test) not a clinical diagnosis
Wittram C, et al. (1996) [68] < 20 controls
Wittram C, et al. (1996) [69] < 20 controls
Yu W, et al. (1998) [70] < 20 controls
Studies may have met exclusion criteria other than those listed in the table. MRI, magnetic resonance imaging.
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unknown origin [10,12-15,17,18]. For further details of the
included studies, see Table 4.
All studies used an MRI scanner with a field strength
of 1.5 Tesla. Four of the included articles had no
description of the field strength, and the corresponding
authors were therefore contacted for information of the
field strength. Eight of the nine articles reported which
MRI protocol was used [10,11,13-18]. For the SIJ, the
most common sequences were T1-weighted spin-echo in
combination with either a gadolinium sequence
[10,11,14] or a Short Tau Inversion Recovery (STIR)
sequence [13]. The slice orientation was either semicor-
onal or semiaxial or a combination of both. In the
spine, the MRI protocol consisted of fewer sequences.
Three articles reported the use of sagittal T1-weighted
spin-echo and STIR [15,17,18], and one used only sagit-
tal STIR [16]. None of the included studies evaluating
the spine used contrast enhancement in the MRI proto-
col. For more details of the MRI protocols, see Table 5.
Assessment of methodologic quality
The quality score of the nine studies ranged from 1 to 7
points, with a mean score of 3.7. Two articles were
rated more than 5 points and were considered of high
quality [13,16], and three articles were rated less than 3
points [10-12] (Table 1).
In relation to the description of the study samples, five
articles did not fully describe both cases and noncases
with respect to age, gender, and diagnosis [11,14,15,17,18],
three articles had no description of the sampling method
used for the control groups [11,17,18], and for two of
these [17,18], it was not clear whether these groups were
included in the data analyses. Regarding the sampling
Table 3 Reasons for excluding retrieved articles on
longitudinal studies
Study Reasons for exclusion
Althoff CE, et al. (2009) [71] Insufficient result presentation
Aydin SZ, et al (2011) [72] < 20 controls
Baraliakos X, et al. (2008) [73] No controls
Battafarano DF, et al. (1993) [74] < 20 controls
Bennett AN, et al. (2008) [7] No controls
Bigot J, et al. (1999) [75] < 20 control
Brandt J, et al. (1999) [76] No controls
Chiowchanwisawakit P, et al. (2011) [77] No controls
Dougados M, et al. (2001) [78] Insufficient result presentation
Hermann J, et al. (2009) [79] Insufficient result presentation
Madsen K, et al. (2010) [80] No controls
Macsymowych WP, et al. (2010) [81] No controls
Marzo-Ortega H, et al. (2008) [82] < 20 in each control group
Oostveen J, et al. (1999) [83] No controls
Pedersen SJ, et al. (2011) [84] No controls
Puhakka KB, et al. (2004) [85] No controls
Remplik P, et al. (2005) [86] < 20 cases
Shankar S, et al. (2009) [87] Insufficient result presentation
Song IH, et al. (2011) [88] No controls
Studies may have met exclusion criteria other than those listed in the table.
Table 4 Descriptive data for articles on MRI and SpA fulfilling the inclusion criteria
Study type Total
number
Number of AS
patients (DD)
Number of SpA
patients (DD)
Number of IBP
patients (DD)
Number of NILBP
patients (DD)
Number of no
LBP patients
Sacroiliac
joint
Bollow et al.
(1995) [10]
Prospective
case-control
125 36 (3.1 years) 36 (5.9 years) 53 (5.7 years)
Klauser et al.
(2004) [11]
Prospective
case-control
133 103 (NR) 30
Brandt et al.
(2007) [12]
Prospective
cohort
158 32 (NR) 58 (NR) 68 (NR)
Weber et al.
(2010) [13]
Prospective
case-control
187 75 (6.1 years) 27 (29 mo) 26 (NR) 59
Wick et al.
(2010) [14]
Retrospective
cohort
156 27 (NR) 101 (NR) 28 (NR)
Spine
Kim et al.
(2008) [15]
Retrospective
case control
104 52 (NR) 52 (NR)
Weber et al.
(2009) [16]
Prospective
case-control
85 35 (8 years) 25 (10 mo) 35
Bennett et al.
(2009) [17]
Retrospective
cohort
185 64 (8.5 years) 110 (NR) 11
Bennett et al.
(2009) [18]
Retrospective
cohort
185 64 (8.5 years) 110 (NR) 11
MRI, magnetic resonance imaging; SpA, spondyloarthritis; AS, ankylosing spondylitis; DD, mean disease duration;
IBP, inflammatory back pain; NILBP, noninflammatory low-back pain; no LBP, no low-back pain; mo, months; NR, mean disease duration not reported.
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methods used, one article reported the use of consecutive
sampling [16]. The remaining eight either failed to report
on this aspect or used convenience samples. Matching was
performed adequately in relation to age and sex in four
[10,13,15,16] of the five case-control studies. One study
had a case group with a mean age that was more than 20
years older than that of the control group [11].
In relation to the diagnosis of the target condition,
none of the nine articles tested the reproducibility of the
clinical diagnosis. Diagnostic criteria were used as a refer-
ence standard in five articles [10,11,13,15,16], expert opi-
nion in three articles [14,17,18], and both criteria and
expert opinion in one article [12]. In four articles describ-
ing retrospective studies [14,15,17,18], the independence
of MRI from the clinical diagnosis was unclear. In one
prospective study [12], which aimed to test referral
recommendations, MRI was recognized as part of the
diagnosis for the group of preradiographic SpA, thereby
confounding the association observed. In seven articles
[10-12,14,15,17,18], inadequate or no reporting was made
of blinding of the MRI results at the time of the clinical
diagnosis.
In relation to the MRI evaluation, most studies had
acceptable definitions of the MRI findings [13-18]. Five
articles performed reproducibility tests of the MRI eva-
luation [13,14,16-18], and five studies blinded the eva-
luation for the diagnosis [13-17]. None of the nine
articles reported the time interval between MRI and
diagnosis.
In relation to the statistical analysis, one article failed
to report fully the CI, P values, and/or raw data [10],
and one article used an inappropriate statistical method
for the types of data available [14]. Five articles had
shortcomings in the way the results were presented
[10,12,14,17,18], such as uncertainties in relation to
which groups were included in the calculation of the
specificity [17,18] and data primarily presented as gra-
phics and per SIJ joint instead of per person [10].
Association between MRI findings and the clinical
diagnosis of SpA
Because of a substantial heterogeneity in the included
studies regarding the methodologic quality, the MRI find-
ings, the MRI technique used, and the regions under eva-
luation, it was not possible to perform a meta-analysis,
and we decided not to report data systematically. Instead,
a descriptive assessment of the results based on the
extracted data was performed. One article of high quality
was found that evaluated the SIJ [13], and another article
of high quality was found that evaluated the spine [16],
both of which were from the same research team. A sum-
mary of the extracted data from these two studies is pre-
sented in Tables 6 and 7.
Sacroiliac joint
The study by Weber et al. from 2010 [13] included four
groups in a prospective case-control study: 75 patients
with AS included on the basis of the modified New
York criteria [19], 27 patients with IBP based on the
Table 5 Descriptive data for MRI technique used in the included articles
Field
strength
Sequence
1
Sequence 2 Sequence 3 Sequence 4 Sequence 5 Sequence 6
Sacroiliac joint
Bollow et al.
(1995) [10]
1.5 T Semi axial
T1w SE
Dynamic T2*w
GRE, FLASH,
Dynamic T2*w GRE,
FLASH, Gd
Klauser et al.
(2004) [11]
1.5 T Semi axial
T1w, SE
Semi axial T2 w
TSE
Semi axial T1w, SE
FS
Semi cor. T1w, SE Semi cor. TIRM Semi axial + Semi cor.
T1w, SE, FS, Gd
Brandt et al.
(2007) [12]
a1.5 T NR
Weber et al.
(2010) [13]
a1.5 T Semi cor.
T1 w, SE
Semi cor. STIR
Wick et al.
(2010) [14]
1.5 T Semi cor.
T1 w, SE
Semi cor. TIRM Semi cor. T2w,
MEDIC FS
Semi cor. + semi
axial T1w, SE, FS
Semi axial T1w,
SE, FS, Gd
Semi axial T1w, SE, Gd
Spine
Kim et al.
(2008) [15]
1.5 T Sagittal T1w
SE
Sagittal T2w FSE
Weber et al.
(2009) [16]
1.5 T Sagittal
turbo STIR
Bennett et al.
(2009) [17]
a1.5 T Sagittal T1,
SE
Sagittal STIR
Bennett et al.
(2009) [18]
a1.5T Sagittal
T1w, SE
Sagittal STIR
aInformation on field strength not available in the articles. Data obtained by personal contact with authors. T, Tesla; w, weighted; SE, spin-echo; GRE, gradient-
echo; FLASH, fast low-angle shot; Semi cor, semicoronal; Gd, gadolinium; TSE, turbo spin-echo; FS, fat saturated; TRIM, turbo inversion recovery magnitude; NR,
not reported; STIR, short tau inversion recovery; MEDIC, multi echo data image combination; PD, proton density; FSE, fast spin echo.
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Table 6 Associations between MRI finding in the SIJ and the diagnosis of AS and IBP
MRI findings Sensitivity of MRI findings
(95% CI)
Specificity of MRI findings
(95% CI)
Cases, number Controls, number
AS IBP NLSBP No LBP
BMO 0.85 (0.76-0.92) 0.93 (0.84-0.97) 75 59
Erosions 0.91 (0.82-0.95) 0.98 (0.91-1.00) 75 59
Fat infiltration 0.91 (0.82-0.95) 0.86 (0.76-0.93) 75 59
Ankylosis 0.27 (0.18-0.38) 1.00 (0.94-1.00) 75 59
Global assessment 0.99 0.96 75 59
BMO 0.85 (0.76-0.92) 0.77 (0.58-0.89) 75 26
Erosions 0.91 (0.82-0.95) 0.96 (0.81-0.99) 75 26
Fat infiltration 0.91 (0.82-0.95) 0.85 (0.67-0.94) 75 26
Ankylosis 0.26 (0.18-0.38) 1.00 (0.87-1.00) 75 26
Global assessment 0.99 0.92 75 26
BMO 0.67 (0.48-0.81) 0.93 (0.84-0.97) 27 59
Erosions 0.48 (0.31-0.66) 0.98 (0.91-1.00) 27 59
Fat infiltration 0.37 (0.22-0.56) 0.86 (0.76-0.93) 27 59
Global assessment 0.52 0.96 27 59
BMO 0.67 (0.48-0.81) 0.77 (0.58-0.89) 27 26
Erosions 0.48 (0.31-0.66) 0.96 (0.81-0.99) 27 26
Fat infiltration 0.37 (0.22-0.56) 0.85 (0.67-0.94) 27 26
Global assessment 0.52 0.92 27 26
Results from Weber et al. (2010). Sensitivity and specificity based on concordant observations of a minimum of two of five readers. 95% CI calculated from raw
data. MRI, magnetic resonance imaging; SIJ, sacroiliac joint; AS, ankylosing spondylitis; IBP, inflammatory back pain; CI, confidence interval; NSLBP, nonspecific
low-back pain; BMO, bone marrow edema; global assessments, 95% CI not possible to calculate, because of no raw data.
Table 7 Associations between MRI finding in the spine and the diagnosis of AS and IBP
MRI findings Sensitivity of MRI findings
(95% CI)
Specificity of MRI findings
(95% CI)
Cases, number Controls, number
AS IBP No LBP
≥ 1 CIL 0.77 (0.61-0.88) 0.77 (0.61-0.88) 35 35
≥ 2 CIL 0.69 (0.52-0.81) 0.94 (0.81-0.98) 35 35
≥ 3 CIL 0.66 (0.49-0.79) 0.94 (0.81-0.98) 35 35
≥ 1 tCIL 0.69 (0.52-0.81) 0.83 (0.67-0.92) 35 35
≥ 2 tCIL 0.57 (0.41-0.72) 0.94 (0.81-0.98) 35 35
≥ 3 tCIL 0.46 (0.30-0.62) 0.97 (0.85-0.99) 35 35
≥ 1 lCIL 0.51 (0.36-0.67) 0.94 (0.81-0.98) 35 35
≥ 1 NIL 0.06 (0.02-0.19) 0.97 (0.85-0.99) 35 35
≥ 1 LIL 0.31 (0.19-0.48) 0.97 (0.85-0.99) 35 35
≥ 1 FIL/PIL 0.09 (0.03-0.22) 1.00 (0.90-1.00) 35 35
≥ 1 CIL 0.40 (0.23-0.59) 0.88 (0.70-0.96) 25 25
≥ 2 CIL 0.32 (0.17-0.52) 0.96 (0.80-0.99) 25 25
≥ 3 CIL 0.12 (0.04-0.30) 0.96 (0.80-0.99) 25 25
≥ 1 tCIL 0.32 (0.17-0.52) 0.88 (0.70-0.96) 25 25
≥ 2 tCIL 0.24 (0.11-0.43) 0.96 (0.80-0.99) 25 25
≥ 3 tCIL 0.12 (0.04-0.30) 0.96 (0.80-0.99) 25 25
≥ 1 lCIL 0.24 (0.11-0.43) 1.00 (0.87-1.00) 25 25
≥ 1 NIL 0.04 (0.01-0.20) 0.96 (0.80-0.99) 25 25
≥ 1 lCIL 0.12 (0.04-0.30) 0.96 (0.80-0.99) 25 25
≥ 1 FIL/PIL 0.00 (0.00-0.13) 1.00 (0.87-1.00) 25 25
Sensitivity and specificity based on concordant observations of three readers; results from Weber et al. (2009). AS, Ankylosing spondylitis; IBP, inflammatory back
pain; no LBP, no low-back pain; CIL, vertebral corner inflammatory lesion; tCIL, thoracic CIL; lCIL lumbar CIL; NIL, vertebral noncorner inflammatory lesion; LIL,
lateral inflammatory lesion; FIL/PIL, facet or other posterior element inflammatory lesion.
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Calin Criteria [20] or the Berlin Criteria [21], 26 patients
with NSLBP, and 59 healthy controls without back pain.
The AS patients had a mean disease duration of 6.1
years, and IBP patients had a mean disease duration of
29 months. Disease duration for the NSLBP patients
was not reported.
The MRI findings under evaluation were bone marrow
edema (BMO), erosions, fat infiltration, global assess-
ment of sacroiliitis, and ankylosis. Positive associations
for BMO, erosions, fat infiltration, and global assess-
ment of sacroiliitis were shown for both AS and IBP
patients when compared with the NSLBP and no-LBP
groups. Ankylosis was found in only the AS patients, in
20 of 75 patients (26.7%). In general, the highest com-
bined values of sensitivity and specificity were found
when comparing AS patients with the healthy controls,
and the lowest values were found when comparing IBP
with NSLBP (Table 6).
Interestingly, BMO lesions, as defined in the ASAS
diagnostic criteria [8], were found to be relatively fre-
quent in NSLBP and were reported in 6 (23.1%) of 26
subjects and less frequently in healthy controls, with 4
(6.8%) of 59 subjects.
Spine
The study by Weber et al. from 2009 [16] compared 35
patients with AS fulfilling the modified New York criteria
[19], 25 patients with IBP, who fulfilled the Berlin criteria
[21] and who also had one or more characteristic SpA
features, and 35 healthy controls without back pain in a
prospective case-control study. The AS patients had a
mean disease duration of 8.0 years and the IBP patients
had a mean disease duration of 10 months.
The MRI findings under evaluation were BMO lesions
of varied number and location in the spine. When com-
paring AS patients with healthy controls, a number of
positive associations were identified for BMO lesions in
vertebral corners and in the lateral spine. When compar-
ing IBP patients with healthy controls, the associations
were seen to decrease (see Table 7 for details).
Discussion
Summary of main results
The results of the review show that a positive association
exists between certain MRI findings in the axial skeleton
and the diagnosis of both AS and IBP. However, these
results are based on only two high-quality studies, and
the amount of relevant data was insufficient to give a reli-
able quantification of this association.
Implications for research
On the basis of the identified methodologic shortcomings
of the included articles, this review highlights important
issues that should be taken into consideration when con-
ducting studies with the aim of evaluating the diagnostic
utility of MRI in the diagnosis of SpA. The following
issues will be discussed in the subsequent text: Size of
the study sample, selecting the proper study population,
sampling method of the study cohort, independence of
MRI from the reference standard, reproducibility testing
of both the reference standard and the MRI evaluation,
and standardization of the MRI findings.
In this review, the inclusion criterion for the size of
study samples was set to a minimum of 20 subjects per
group. This was because a small sample size often gives
imprecise estimates of diagnostic accuracy. For example,
when the number of patients with SpA is 20, the two-
sided 95% CI of a sensitivity of 80% is 58% to 92%. This
is, however, still a very wide CI, and because wide CIs
make it difficult to determine how informative the
results of the study are, we would recommend that
future studies use larger sample size. For example, if the
number of patients with SpA is 200, the two-sided 95%
CI of a sensitivity of 80% is 74% to 85%.
When choosing the study sample, it is crucial that an
effort be made to make it as comparable to the popula-
tion seen in a clinical setting as possible. Not surprisingly,
the results from the two high-quality studies show that
the association was stronger between patients with AS
and asymptomatic people than the association between
IBP patients and patients with NSLBP [13,16]. However,
for the clinician, the challenge will often be differentiat-
ing between IBP and NSLBP. When investigating the
diagnostic utility of MRI in SpA, it is therefore important
that the study samples be representative of “real” patient
populations, instead of comparing patients with long-
lasting disease and asymptomatic persons. Furthermore,
one of the high-quality studies reports inflammatory MRI
findings in the SIJ to be relatively common in patients
with NSLBP [13]. Because the specificity is estimated
entirely from results from the group of noncases or con-
trols, this, additionally, underlines the need for further
evaluation of the presence of MRI findings also in
patients with NSLBP.
The sampling methods used in the included studies were
either insufficient or not fully described in the majority of
the studies, which makes it difficult to preclude selection
bias. It is mandatory when conducting studies on diagnos-
tic accuracy that both the sampling method and the study
sample are well described, that the selection of study parti-
cipants is performed systematically and unselectively, and,
for case-control studies, that the two groups are compar-
able except for the target condition. Furthermore, in some
of the articles identified in this review, the importance of
the controls seemed to be underestimated, even though
the sampling and description of the controls are just as
important as the sampling and description of the cases.
That no objective gold standard exists for the diagno-
sis of SpA, which is instead based on a composite
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clinical presentation, constrains the possibilities for the
evaluation of the diagnostic accuracy of MRI. However,
it is indisputable that when evaluating a diagnostic test,
independent evaluation of the index test and the refer-
ence standard is essential. When MRI is used in the
decision making of the clinical diagnosis, as seen in
more than half of the included studies, incorporation
bias is highly likely. This was predominantly a problem
in the included retrospective studies. The fact that MRI
is widely used in the diagnosis of SpA restricts the pos-
sibilities of conducting meaningful retrospective studies
on the diagnostic accuracy of MRI.
One way to strengthen the reliability of the diagnosis is
to test the reproducibility of the selected reference stan-
dard. However, none of the nine included articles tested
the reproducibility of the clinical diagnosis. Another way
to strengthen the reliability of the diagnosis would be to
include a longitudinal aspect and to follow the develop-
ment of more-advanced disease stages to confirm the diag-
nosis. Even though several longitudinal studies were
identified in this review, none met the inclusion criteria,
usually because either no or too few controls were used.
Several activity scores for inflammatory and structural
MRI findings have been developed; however, no interna-
tional consensus exists about the definition of diagnostic
MRI findings, which was a factor in our review. In general,
the included studies contained definitions of the MRI find-
ings. However, little homogeneity existed in these defini-
tions, and only five of the nine articles reported testing of
the reproducibility of the MRI evaluation. Before testing
the diagnostic utility of an MRI finding, it is necessary to
define the MRI finding and further to present acceptably
reproducible test results. Furthermore, an experienced
musculoskeletal radiologist should be part of the conduct
and testing of the evaluation protocol. An international
agreement on definitions of different MRI findings and a
threshold minimal reproducibility would facilitate both the
translation from research to clinical practice and a com-
parison with future research results.
In summary, the optimal design for future studies that
investigate the utility of MRI in the early diagnosis of
SpA is a large longitudinal clinical cohort study that
recruits participants consecutively and includes patients
with NSLBP. Furthermore, a well-defined clinical diag-
nosis based on consensus criteria and blinded for MRI
should be used as a reference standard. Similarly, a vali-
dated MRI evaluation with clear definitions blinded to
the clinical information should be used for the MRI
evaluation.
Application of findings to clinical practice
The literature search associated with the current review
revealed no other systematic critical review on the utility
of MRI in the diagnosis of SpA. However, a large
number of commentaries and narrative reviews with or
without transparent search strategies have been pub-
lished, in which it seems that the majority report a posi-
tive view of the value of MRI in the diagnosis of SpA.
The obvious need for optimization of the diagnostic
process of SpA may have contributed to the positive
perception that has developed regarding MRI as a tool
in the SpA diagnosis. The fact that MRI of the SIJ is
included in the new diagnostic criteria developed by
ASAS [8] has led to further optimism in relation to the
diagnostic process of SpA. However, on the basis of the
results from the current review, the limited number of
high-quality studies on the diagnostic utility of MRI in
SpA should preclude MRI being seen as the new gold
standard in the diagnosis of SpA. If inflammatory and
structural MRI findings are interpreted as being more
specific for SpA than the research can support, a real
risk exists of SpA being overdiagnosed.
As mentioned earlier, to be able to make a reasonable
translation of research results to clinical practice, the
representativeness of the study sample to clinical practice
and the standardization and validation of the MRI eva-
luation is important. However, it also is essential that the
MRI protocols used in the studies are relatively easy to
implement and constitute the least health risk for the
patients. Three of the studies included in this review
used gadolinium contrast-enhanced sequences. However,
for future studies, the necessity of gadolinium should be
carefully considered, because other techniques, such as
STIR, have shown a similar capability of visualizing BMO
[22,23], and the use of contrast is more invasive, expen-
sive, and time consuming than is a noncontrast method.
Furthermore, a small but serious risk of contrast med-
ium-induced nephrotoxicity exists [24], which also must
be taken into consideration.
Strengths and weaknesses of the review
The strength of the current review is the systematic
search method and the rigorous assessment of the
methodologic quality of the included studies. To our
knowledge, this review is the first to give an overview of
the level of evidence of the diagnostic utility of MRI,
including a quality assessment.
The weaknesses of the review are first, the possibility
of relevant articles not being included because of the
language limitations, and second, the limited number of
databases used in the search. Furthermore, it might be
argued that the threshold for a minimal study sample
size was either too low or too high. However, it seems
reasonable to reduce the width of the 95% CI by not
setting the cut-point too low; in contrast, increasing the
cut-point for sample size further would have greatly
decreased the number of relevant articles that could be
included.
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Conclusion
Bone marrow edema, erosions, fat infiltrations, global
assessment of sacroiliitis, and ankylosis on MRI were
found to be associated with SpA. However, because
only two high-quality studies were identified, it was
not possible to perform a meta-analytic quantification
of the association. The current systematic critical
review illustrates that only limited evidence exists of
the utility of MRI in the diagnosis of SpA. However,
MRI is already widely used in clinical practice, and
therefore, a strong need exists for more high-quality
studies, cross-sectional as well as longitudinal, without
the shortcomings of the previous work identified in
this review. In the meantime, caution is needed to
avoid overdiagnosing SpA.
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Spondyloarthritis-related and degenerative MRI
changes in the axial skeleton - an inter- and
intra-observer agreement study
Bodil Arnbak1,2*, Tue Secher Jensen1,2, Claus Manniche1,2, Anna Zejden3, Niels Egund3 and Anne Grethe Jurik3
Abstract
Background: The Back Pain Cohort of Southern Denmark (BaPa Cohort) was initiated with the aim of evaluating
the clinical relevance of magnetic resonance imaging (MRI) in the diagnosis of early spondyloarthritis (SpA). In order
to facilitate the collection of MRI data for this study, an electronic evaluation form was developed including both
SpA-related and degenerative axial changes. The objective of the current study was to assess the intra- and inter-
observer agreement of the MRI changes assessed.
Methods: Three radiologists evaluated 48 MRI scans of the whole spine and the sacroiliac joints from a subsample
of the BaPa Cohort, consisting of patients with non-specific low back pain and patients with different stages of SpA
features. The spine was evaluated for SpA-related and degenerative MRI changes and the SIJ for SpA-related
changes. Inter- and intra-observer agreements were calculated with kappa statistics. In the interpretation of the
kappa coefficient, the standards for strength of agreement reported by Landis and Koch were followed.
Results: A total of 48 patients, 40% men and mean age of 31 years (range 18 – 40 years), were evaluated once by
all three readers and re-evaluated by two of the readers after 4-12 weeks. For MRI changes in the spine, substantial
to almost perfect observer agreement was found for the location and the size of vertebral signal changes and for
disc degeneration and disc contour. For the sacroiliac joints, substantial or almost perfect observer agreement was
found for the grading of bone marrow oedema and fatty marrow deposition, the depth of bone marrow oedema
and for subchondral sclerosis. Global assessment of the SpA diagnosis had substantial to almost perfect observer
agreements.
Conclusion: The acceptable agreement for key MRI changes in the spine and sacroiliac joints makes it possible to
use these MRI changes in the BaPa Cohort study and other studies investigating MRI changes in patients with non-
specific low back pain and suspected SpA.
Keywords: Agreement, Ankylosing spondylitis, Arthritis, Diagnosis, Kappa, Low back pain, Magnetic resonance
imaging, Sacroiliac joint, Sacroiliitis, Spine, Spondyloarthropathy, Spondylarthritis
Background
Spondyloarthritis (SpA) is a group of rheumatological
disorders, which result in back pain, and stiffness of the
spine due to inflammatory and structural changes in the
spine and the sacroiliac joints (SIJ). Plain-film radiog-
raphy can detect structural changes but not early
inflammatory changes. Magnetic resonance imaging
(MRI) has been reported to identify both structural and
inflammatory changes [1,2] and is considered essential
in the diagnoses of SpA. However, there are still several
uncertainties regarding the utility of MRI in the diagno-
sis of SpA [3], especially in the early stages when the
clinical signs of SpA can be difficult to distinguish from
non-specific low back pain (LBP) and the MRI signs of
SpA can be difficult to distinguish from the much more
common findings of degeneration. Signal changes related
to degeneration such as Modic changes are an important
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pitfall in the assessment of SpA [4] and some studies
have shown substantial variation in the extent of MRI
lesions in the SIJ previously considered to be specific for
SpA [5]. Therefore, studies encompassing patients
reflecting the target population and using a MRI proto-
col including both SpA-related and degenerative changes
are needed to validate the utility of this new imaging
modality for the diagnosis of SpA.
On this basis, the Back Pain Cohort of Southern
Denmark (BaPA Cohort) was initiated in 2011 at the
Spine Centre of Southern Denmark with the aim of
evaluating the clinical relevance of MRI in the diagnosis
of early SpA. In order to facilitate the quantification of
MRI changes in detail, an electronic evaluation form was
developed for the evaluation of SpA-related and degen-
erative changes in the spine and SpA-related changes in
the SIJ. The electronic MRI evaluation protocol was
based on existing grading systems of active and chronic
SpA changes in the spine [6] and SIJ [7]. These grading
systems have been tested for inter- and intra-observer
agreement in sum-scores with good results [6,7]. How-
ever, the current evaluation form was more detailed and
included both SpA-related and degenerative spinal MRI
changes. Thus, a new assessment of observer agreement
was required.
The objective of the current study was therefore to
assess the intra- and inter-observer agreement of SpA-
related and degenerative changes in the spine and SpA-
related changes in the SIJ assessing each lesion separately.
Methods
The study population
The analysis encompassed 48 sets of whole spine MRI
scans in addition to MRI of the SIJ. All MRI scans were
acquired from a subset of patients (n = 350) of the BaPa
Cohort enrolled between March 2011 and February
2012. The BaPa Cohort consists of randomly selected
patients aged between 18 and 40 years, referred to a sec-
ondary care sector outpatient spine clinic (Spine Centre
of Southern Denmark). Patients were referred to the
Centre for episodes of LBP ranging from 2 to 12 months,
where there had been insufficient effect following con-
servative treatment in the primary care sector and there
was no suspicion of specific LBP conditions such as
SpA, fracture, cancer or infection. All patients who were
included in the BaPa cohort received an MRI scan of the
whole spine and the SIJ.
The patients included in the current analysis were
selected by the primary investigator (BA) without
involvement of the evaluating radiologists. Due to the
low prevalence of some MRI changes to be evaluated in
this cohort, 38 patients were chosen based on data from
previous systematic evaluations of the MRI scans. The
previous systematic evaluations were done at least
4 months prior to the readings in the current study. This
selection method was used to increase the number of
‘positive’ MRI changes, thereby ensuring sufficient sta-
tistical power to calculate reliable kappa values. The
remaining 10 patients were randomly selected from the
remaining 312 patients.
Magnetic resonance imaging technique and evaluation
MRI of the whole spine and the SIJ was performed with
a 1.5 T Philips Achieva (Best, The Netherlands) MRI
System. A SENSE spine coil was used for imaging with
the study participants in the supine position. The whole
spine sequences were performed in three steps (cervical,
thoracic and lumbar) subsequently fused digitally and
encompassing:
 Sagittal short-tau inversion recovery (STIR): time to
repeat (TR)/ time to echo (TE)/ time to inversion
(TI) 2500/60/170 ms and 2 acquisitions; matrix
320 × 231, field of view (FOV) 300 × 300 mm, 16
slices with a thickness of 4 mm and interslice
distance 1 mm; scan time 1 min 55 s.
 Sagittal T1-weighted turbo spin echo: TR/TE 475/
12 ms and 2 acquisitions; matrix 336 × 252, FOV
336 × 252 mm, 16 slices with a thickness of 4 mm
and interslice distance 1 mm; scan time 2 min 3 s.
 Additionally for the lumbar spine: Sagittal T2-
weighted VISTA (3D – turbo spin echo-T2
-weighted sequence): TR/TE 2000/120 ms and 2
acquisitions; matrix 324 × 148, FOV 182 × 325 mm,
73 slices with a thickness of 1 mm; scan time 6 min
22 s. 3D reconstruction was not used in the
current study.
For the SIJ the following sequences were used:
 Semicoronal T1-weighted turbo spin echo: TR/TE
535/14 ms and 4 acquisitions; matrix 512 × 255,
FOV 300 × 300 mm, 18 slices with a thickness of
4 mm and interslice distance 0.4 mm; scan time
5 min 36 s.
 Semicoronal T1-weighted Spectral Pre-saturation
with Inversion Recovery (SPIR): TR/TE 525/8 ms
and 4 acquisitions; matrix 200 × 274, FOV 343 ×
180 mm, 18 slices with a thickness of 4 mm and
interslice distance 0.4 mm; scan time 4 min 53 s.
 Semiaxial STIR long TE: TR/TE/TI 3500/60/155 ms
and 8 acquisitions; matrix 500 × 153, FOV 250 ×
205 mm, 22 slices of 4 mm thickness and interslice
distance 0.4 mm; scan time 8 min 24 s scan time.
The images were read on dedicated radiological work-
stations with two 21-inch high-resolution screens. All
MRIs were anonymised and blinded for all clinical
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information including previous readings and the patient’s
age and gender.
Three observers evaluated the images independently.
They were all senior consultant radiologists at the
Department of Radiology, Aarhus University Hospital,
and were specialised in musculoskeletal imaging and
SpA. Prior to the study, two calibration sessions were
conducted. After a period of 4-12 weeks, two observers
(AJ and AZ) re-evaluated all 48 MRI scans for intra-
observer agreement.
The evaluation form consists of two parts: 1) evalu-
ation of the spine and 2) evaluation of the SIJ. The spine
was divided in 23 disco-vertebral units (DVU) from C2-
C3 to L5-S1. A DVU was defined as the region between
two virtual horizontal lines through the centre of two
adjacent vertebrae (Figure 1). Furthermore, each verte-
bral endplate and subjacent bone marrow area of a DVU
were assessed separately for variables related to signal
changes or erosions. An estimate of the total vertebral
endplate and subchondral bone marrow areas was based
on all sagittal slices creating “3D like picture” of the
changes. The spinal MRI changes assessed are listed in
Table 1. For a detailed definition of the MRI changes
assessed, see Additional file 1.
The SIJs were subdivided in four osseous locations for
each joint: the iliac and sacral bone corresponding to the
cartilaginous and the ligamentous portion of the joint,
respectively. An estimate of the total cartilaginous and
ligamentous joint facets and the adjacent subchondral
bone marrow areas was based on all semicoronal and
semiaxial slices creating a 3D picture of both joint por-
tions. The MRI changes assessed at the SIJ are listed in
Table 2 according to the Danish method described previ-
ously [7]. For a detailed definition of the MRI changes
assessed, see Additional file 1.
Global assessment of the SpA diagnosis was based on
MRI changes in both the spine and the SIJ. Both regions
were assessed at the same session. For each patient, the ob-
server was asked to rate how strongly he/she agreed with
the following: ‘This patient has SpA’. For a detailed defin-
ition of the MRI changes assessed, see Additional file 1.
In the statistical analysis, the number of observations
varied according to the variables assessed. In the spine,
variables related to signal changes (with the exception of
the total size of the signal changes) or erosions were
evaluated for both the upper and lower endplates of 23
DVUs in the 48 patients (2208 endplates). ‘Bone marrow
oedema (BMO) in the costovertebral joints’ was evalu-
ated at 12 vertebral levels in 48 patients (576 levels). The
remaining spinal variables were evaluated in 23 DVUs
from 48 patients (1104 DVUs). In the SIJ, 8 regions in
the 48 patients were evaluated (384 regions).
Data entry
The data were entered directly into a comprehensive
clinical and imaging electronic database (the SpineData
database) using an internet-based evaluation form. Data
were subsequently exported to, and stored in, STATA11
format (StataCorp, 2000, Stata Statistical Software:
Release 11.2, College Station, TX: STATA Corporation,
USA) and checked for logic and consistency using the
STATA ‘do files’ as documentation.
Statistical analysis
To assess the inter- and intra-observer agreement,
ratings from each observer were cross-tabulated and
agreement was measured using kappa statistics [8].
Results were reported as observed agreement, expected
agreement and kappa values with 95% confidence
Figure 1 Discovertebral unit modified from [6].
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intervals (CI) for each pair of observers and combined
for all three observers.
Kappa is defined as the difference between observed
and expected agreement (by chance), expressed as a
fraction of the maximum difference. Kappa = (observed
agreement - expected agreement) / (1 - expected agree-
ment) [8]. Dichotomous and nominal categorical
variables were tested with ordinary kappa statistics and
ordered categorical variables were tested with weighted
Kappa. Quadratic weights were applied according to the
number of categories. The quadratic weights are speci-
fied as 1 - {(i-j)/(k-1)}^2 where i and j index the rows
and columns of the ratings by the two readers and k is
the number of categories. The intra-class correlation co-
efficient (ICC), which is similar to an overall quadratic
weighted kappa [9], was used as a measure of overall
agreement between the three observers with the excep-
tion of two nominal categorical variables which had
more than two categories: ‘type of signal change’ and
‘location of signal change in the vertebral endplate’ which
were analysed with ordinary kappa. ICC was tested in a
one way ANOVA model (absolute agreement).
95% confidence interval (CI) was calculated with an
analytical method in the case of dichotomous variables
[10] and by bootstrap resampling with 3000 repetitions
for categorical variables with more than two categories
[11,12].
In the interpretation of the kappa coefficient the stan-
dards for strength of agreement given by Landis and Koch
were followed defined as slight (κ < 0.2), fair (0.2 ≤ κ < 0.4),
moderate (0.4 ≤ κ < 0.6), substantial (0.6 ≤ κ < 0.8) and
almost perfect (0.8 ≤ κ < 1) [13].
Only endplates where both readers agreed on the pres-
ence of a signal change were included in the analyses for
the following variables: ‘Signal change in the corner’,
‘location of signal change in the vertebral endplate’, and
‘size of signal change’, so the statistical analysis was a
measure of agreement of location and size and not the
presence of the given signal change. Similarly, only
endplates where both readers agreed on the presence of
erosions were included in the analyses for ‘erosions in
the corner’. In relation to intensity and depth of BMO
and the depth of fatty marrow deposition (FMD), only
observations where both readers agreed on the presence
Table 1 Grading of MRI changes in the spine
Name of the MRI changes Grading
Type of signal change BMO
FMD
Mixed
Signal change in the corner1 Yes/No
Location of signal change Anterior
Posterior
Equally widespread
Size of signal change Small
Medium
Large
Total size of BMO in the DVU Small
Medium
Large
Total size of FMD in the DVU Small
Medium
Large
Total size of mixed lesions in the
DVU
Small
Medium
Large
Erosions None
Slight
Moderate
Severe
Erosion of the corner1 Yes/No
Syndesmophytes or vertebral fusion None
Syndesmophytes between
corners
Partial osseous bridging
Total fusion
BMO at the apophyseal joints Yes/No
BMO at the costovertebral joints Yes/No
FMD at the apophyseal joints Yes/No
Soft tissue oedema Yes/No
Disc degeneration Normal height and signal
intensity
Slightly decrease in height and
signal intensity
Decreased height and fluid signal
Elimination of the disc height
Disc contour Broad-based protrusion
Focal protrusion
Extrusion
Sequestration (free fragment)
Table 1 Grading of MRI changes in the spine (Continued)
Disc herniation in the
vertebral endplate
Yes/No
Scheuermann’s changes Yes/No
BMO: Bone marrow oedema, FMD: fatty marrow deposition, DVU:
discovertebal unit, Small/Slight: < 25% of the subcortical bone area, Medium/
Moderate: 25% - <50% of the subcortical bone area, Large/Severe: ≥50% of
the subcortical bone area.
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of BMO or FMD respectively, were included in the
analyses.
Analogous to the requirements for valid inference for
contingency tables, we used a criterion of having at least
5 positive ratings for each variable for inclusion in the
kappa analyses.
For statistical analysis, the STATA11 statistical package
was used.
Ethics
The project was conducted in accordance with the
Helsinki-II declaration. The Regional Scientific Ethical
Committee for Southern Denmark has evaluated the study
as not obligated of notification. Each patient gave written
informed consent for research use and publication of their
data. The establishment of the database is registered at the
Danish Data Protection Agency and all clinical informa-
tion about the participants are kept confidential and in
line with the Danish Act on Processing of Personal Data.
Results
A total of 48 patients, 40% men and a mean age of
31 years (range 18 – 40 years), were evaluated once by
all three readers and re-evaluated by two of the readers
after 4-12 weeks.
Spinal MRI changes
In relation to the combined inter-observer agreement of
the spinal MRI changes, four findings: ‘erosion of the
corner’, ‘BMO at the costovertebral joints’, ‘FMD at the
apophyseal joints’ and, ‘soft tissue oedema’, were excluded
because of too few positive ratings (Table 3).
The strength of the combined inter-observer agree-
ment for spinal MRI changes ranged from slight
(κ = .12) to almost perfect (κ = .90). Almost perfect
agreement was found for ‘location of signal changes
in the vertebral endplate’. Substantial agreement was
found for ‘size of signal change’, ‘disc degeneration’
and ‘disc contour’. Moderate agreement was found for
‘type of signal change’, ‘signal change in the corner’,
‘total size of FMD lesions in the DVU’ and ‘herniation
in the vertebral endplate’. Fair agreement was found for
the ‘total size of BMO in the DVU’ and ‘total size of mixed
lesions in the DVU’. Slight agreement was found for
‘Scheuermann’s changes’. For ‘erosions’, ‘syndesmophytes
or vertebral fusion’ and ‘BMO at the apophyseal joint’, only
single pairwise analyses of inter-observer agreement were
possible because of too few positive ratings. These ana-
lyses showed a fair, moderate and moderate agreement,
respectively (Table 4).
In relation to the intra-observer agreement, four MRI
findings: ‘erosions in the corner’, ‘BMO at the costo-
vertebral joints’ ‘FMD at the apophyseal joints’ and ‘soft
tissue oedema’ were excluded because of too few positive
ratings. Furthermore, ‘erosions’ and ‘BMO at the apo-
physeal joint’ could only be analysed for one reader
because of too few positive ratings (Table 3).
The strength of the intra-observer agreement for the
spinal MRI changes ranged from moderate (κ = .56) to
almost perfect (κ = .98) for reader A and from substan-
tial (κ = .67) to almost perfect (κ = .93) for reader B. In
general, the strength of intra-observer agreement was
notably higher than the strength of inter-observer agree-
ment (Table 5). All kappa values were above 0.7, except
for two MRI changes for reader A (‘total size of BMO in
the DVU’ and ‘total size of FMD in the DVU’) and one
finding for reader B (‘Scheuermann’s changes’).
Table 2 Grading of MRI changes at the sacroiliac joints
and global assessment
Name of the MRI changes Grading
BMO Slight
Moderate
Severe
Intensity of BMO Normal or slightly increased
intensity
Pronounced increased
Depth of BMO Normal to moderate depth
Pronounced
FMD Slight
Moderate
Severe
Depth of FMD Normal to moderate
Pronounced
Erosions Slight
Moderate
Severe
Subchondral sclerosis Slight
Moderate
Severe
Ankylosis Partial
Total
Global assessment: ‘This patient has SpA’1 Strongly disagree
Disagree
Neither agree or disagree
Agree
Strongly agree
BMO: Bone marrow oedema, FMD: fatty marrow deposition, Pronounced
increased: Signal intensity comparable with that of the spinal fluid and
covering an area of ≥1 cm2. Pronounced: Oedema extending ≥1 cm beneath
the joint surface and covering ≥1 cm2. Slight: < 25% of the subcortical bone
area, Moderate: 25% - <50% of the subcortical bone area, Severe: ≥50% of the
subcortical bone area. 1Assessed on the entire MRI examination, not only
the SIJ.
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Changes in the sacroiliac joints
The strength of the combined inter-observer agreement
for evaluation of the SIJ changes ranged from moderate
(κ = .52) to almost perfect agreement (κ = .81) (Table 6).
Almost perfect agreement was found for ‘BMO’ and sub-
stantial agreement was found for ‘depth of BMO’, ‘FMD’
and ‘subchondral sclerosis’. Moderate agreement was
found for ‘depth of FMD’ and ‘erosions’. For ‘intensity of
BMO’ and ankylosis, only single pairwise analyses was
possible because of too few positive ratings (Table 3).
These analyses showed moderate and substantial agree-
ment, respectively.
The strength of intra-observer agreement was stronger
than the inter-observer agreement. For reader A, the
strength of agreement ranged from substantial (κ = .77)
to almost perfect (κ = .96) and for reader B also from
substantial (κ = .75) to almost perfect (κ = .91). For
details, see Table 7.
Global assessment
The combined inter-observer agreement for ‘global
assessment’ was substantial (κ = .61) (Table 6), whereas
the intra-observer agreement was almost perfect
(κ = .89) for reader A and substantial (κ = .79) for reader
B (Table 7).
Discussion
In this study, the agreement of different SpA-related and
degenerative changes in the spine and SpA-related
changes in the SIJ were tested jointly in a sample of
patients with non-specific LBP only and patients with
LBP associated with different stages of SpA. The
Table 3 Prevalence of positive ratings for the MRI changes assessed
Name of the MRI changes Reader A,
first reading
Reader B,
first Reading
Reader C,
first reading
Reader A2,
second reading
Reader B2,
second reading
Spine Type of signal change 114 147 88 118 154
Signal change in the corner1 38 57 13 39 47
Location of signal change1 114 147 88 118 154
Size of signal change1 114 147 88 118 154
Total size of BMO lesions in DVU 36 32 11 12 31
Total size of FMD lesions in DVU 38 39 32 14 41
Total size of mixed lesions in DVU 9 25 10 4 27
Erosions 3 16 11 3 17
Erosion of the corner 1 3 0 0 0
Syndesmophytes or vertebral fusion 5 8 3 7 6
BMO at apophyseal joints 8 4 5 10 5
BMO at costovertebral joints 1 4 1 1 4
FMD at apophyseal joints 4 0 1 1 3
Soft tissue oedema 1 0 0 0 0
Disc degeneration 160 149 109 150 153
Disc contour 122 101 99 111 105
Herniation in the vertebral endplate 23 19 6 21 27
Scheuermann’s changes 12 5 15 9 10
SIJ BMO 71 77 58 70 85
Intensity of BMO1 15 6 0 13 7
Depth of BMO1 27 21 24 27 30
FMD 59 84 60 62 80
Depth of FMD1 36 44 48 33 42
Erosions 32 39 9 35 43
Subchondral sclerosis 19 21 9 15 21
Ankylosis 4 11 8 4 8
The numbers in the table refer to ratings > 0 (not normal) for each of the MRI changes. Only MRI changes with at least 5 positive ratings pr. reading were included
in the kappa analyses. BMO, Bone marrow oedema; FMD, Fatty marrow deposition. 1Only observations where the reader on both the readings agreed on the
presence of a signal change, BMO or FMD, respectively, were kept in the analysis.
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Table 4 Inter-observer agreements for spinal MRI changes
Observers Observed
agreement (%)
Expected
agreement (%)
Pairwise weighted
Kappa (95% CI)
Number of levels1
Type of signal change AB 95.70 88.65 .62 (.56–.68) 2208
AC 96.38 91.13 .59 (.51–.66) 2208
BC 95.70 89.73 .58 (.51–.65) 2208
Combined .60 (.55–.65) 2208
Signal change in the corner2 AB 83.51 56.32 .62 (.46–.79) 97
AC 80.00 61.22 .48 (.28–.69) 70
BC 72.15 64.01 .23 (.00–.46) 79
Combined3 .53 (.42–.64) 114
Location of signal change2 AB 92.78 42.56 .87 (.78–.95) 97
AC 97.14 45.31 .95 (.86–1.00) 70
BC 94.94 46.37 .91 (.79–.98) 79
Combined .90 (.83–.96) 66
Size of signal change2 AB 91.49 75.74 .65 (.45–.80) 97
AC 93.57 74.92 .74 (.54–.89) 70
BC 97.61 90.05 .76 (.64–.86) 79
Combined3 .66 (.58–.75) 114
Total size of BMO in the DVU AB 99.41 98.71 .54 (.32–.74) 1104
AC 99.23 99.07 .16 (.06–.33) 1104
BC 99.62 99.40 .43 (.24–.63) 1104
Combined3 .38 (.34–.41) 1104
Total size of FMD in the DVU AB 99.09 98.12 .52 (.36–.66) 1104
AC 99.25 98.27 .57 (.41–.72) 1104
BC 99.12 98.31 .47 (.32–.63) 1104
Combined3 .52 (.49–.56) 1104
Total size of mixed lesions in the DVU AB 99.39 98.99 .39 (.12–.65) 1104
AC 99.50 99.42 .13 (.00–.36) 1104
BC 99.59 99.19 .49 (.22–.74) 1104
Combined3 .36 (.32–.40) 1104
Erosions AB - - - -
AC - - - -
BC 99.83 99.72 .40 (.17–.56) 2208
Combined3 -
Syndesmophytes or vertebral fusion AB 99.71 99.17 .65 (0.00–.91) 1104
AC - - - -
BC - - - -
Combined3 - -
BMO at the apophyseal joint AB - - - -
AC 99.55 98.83 .61 (.30–.93) 1104
BC - - - -
Combined3 - -
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majority of earlier studies on agreement on SpA-related
and degenerative changes have been focused on separate
regions of the spine, primarily the lumbar spine, whereas
this study included the whole spine and the SIJ. More-
over, for the MRI changes evaluated in the SIJ, this is the
first time agreement has been tested assessing each
lesion separately.
In general, the agreement ranged from slight to almost
perfect. As expected, the level of intra-observer agree-
ment was higher than the inter-observer agreement.
Agreements for MRI changes in the SIJ were generally
stronger than for the spine. For the spinal MRI changes,
‘disc degeneration’ and ‘disc contour’ yielded the highest
level of agreement followed by ‘location of signal changes
in the vertebral endplate’, ‘size of signal change’ and ‘type
of signal change’. In relation to the evaluation of the SIJ,
‘BMO’, ‘depth of BMO’, ‘FMD’, and ‘ankylosis’ were the
changes with the best agreement. Global assessment
showed substantial to almost perfect agreements.
The tendency of better reliability of the SpA-related
findings in the SIJ compared to the spine could be
explained by low prevalence of SpA-related findings in
the spine. In addition, changes in the posterior spinal
elements often are relatively small and can be difficult to
assess on sagittal MRI slices.
Comparison with previously published studies
The number of previous studies on observer agreements
on spinal MRI changes related to SpA is limited. One
previous study evaluated the agreement of structural
SpA-related changes at each vertebral level in 20
patients with established SpA [14]. Kappa value of 0.60,
0.21, and 0.59 were found for ‘non-corner vertebral
endplate erosions’, ‘vertebral corner spurs’ and ‘ankylosis’,
respectively. However, differences in the definitions and
in the study sample preclude a direct comparison with
our results. Furthermore, there are published studies
evaluating the agreement of sum scores for the whole
spine [6,15], which unfortunately preclude comparison
with the evaluation of changes at the endplate level.
In relation to the evaluation of signal changes in the
endplates, these changes are not only observed in pa-
tients with suspected SpA but also in other populations.
Several authors have reported inter-and intra-observer
agreement in the range of .30-.88 [16-25] and .70-.94
[16-20], respectively, for populations of LBP patients
[18,20-23], unspecified patients [17,24], asymptomatic
patients [25] and general populations [16,19]. Of these
studies, four report confidence intervals [16-19] thereby
allowing reliable comparison of results between studies.
In relation to the evaluation of the type of signal
changes, two of the four studies reporting CIs had statis-
tically higher inter-observer agreement [16,19] and two
had comparable results [17,18]. The intra-observer
agreements found in all four studies were comparable
with the results from the current study. However, both
study samples and the definitions of signal changes in
these studies differed from the current study. Agree-
ments regarding location of signal changes were
reported in two of the studies [16,19] and were in con-
cordance with the current study; however these defini-
tions also varied from the one used in the current study.
Table 4 Inter-observer agreements for spinal MRI changes (Continued)
Disc degeneration AB 98.61 94.73 .74 (.67–.79) 1104
AC 98.91 94.98 .78 (.72– .84) 1104
BC 98.97 95.61 .77 (.70–.82) 1104
Combined3 .76 (.74–.78) 1104
Disc contour AB 98.55 95.17 .70 (.63–.76) 1104
AC 98.44 94.29 .73 (.65–.79) 1104
BC 97.36 91.96 .67 (.60–.74) 1104
Combined3 .70 (.68–.73) 1104
Herniation in the vertebral endplate AB 98.73 96.27 .66 (.49–.83) 1104
AC 98.10 97.40 .27 (.06–.48) 1104
BC 98.28 97.75 .23 (.01–.46) 1104
Combined3 .43 (.40–.47) 1104
Scheurmann’s changes AB 98.46 98.47 -.01 (-.01–0.00) 1104
AC 98.92 97.58 .14 (-.05–.32) 1104
BC 98.55 98.20 .20 (-.04–.43) 1104
Combined3 .12 (.08–.15) 1104
BMO; Bone marrow oedema, DVU; Discovertebral unit, FMD; Fatty marrow deposition, - Too few positive ratings for one of the observers to be included in the
analysis 1Discovertebral units or vertebral endplates. 2Only observations where both readers agreed on the presence of a signal change were included in the
analyses. 3Intraclass correlation coefficient.
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Agreements regarding size of signal changes were
reported in one of the four studies, with results in
concordance with the current study [16]. In relation to
the evaluation of signal changes located in the vertebral
corner, agreement of BMO and FMD corner lesions has
been analysed in a previous study sample encompassing
20 patients with established SpA. The reported kappa
values ranged from 0.23 to 0.72 for BMO lesions [26]
and from 0.60 to 0.72 for FMD lesions [14]. However,
differences in the definitions and in the study sample
preclude a direct comparison of results.
Disc degeneration was assessed using Pfirrmann’s
grading system [27] and substantial to almost perfect
inter- and intra-observer agreements, respectively, were
found in accordance with earlier reports on this grading
system [27,28], although no studies with CIs were identi-
fied. In relation to disc contour, similar agreements were
found which are also comparable with previous reports
[29,30].
The inter-observer agreement for herniations in the ver-
tebral endplate was found to be fair. This is slightly infer-
ior to the results of a previous study on LBP patients, but
the intra-observer agreements were comparable [31].
In relation to Scheuermann’s changes, the inter-
observer agreement was slight and the intra-observer
agreement, moderate. To our knowledge, there are no
previous agreement studies regarding Scheuermann’s
changes using MRI.
In relation to the evaluations of the SIJ, either
substantial or almost perfect inter- and intra-observer
Table 5 Intra-observer agreements for spinal MRI changes
MRI changes Observers Observed
agreement (%)
Expected
agreement (%)
Pairwise weighted
Kappa (95% CI)
Number of levels1
Type of signal change AA 98.32 89.88 .84 (.78–.88) 2208
BB 97.96 87.00 .84 (.80–.88) 2208
Signal change in the corner2 AA 89.22 54.61 .76 (.63–.90) 102
BB 87.31 54.81 .72 (.60–.84) 134
Location of signal change2 AA 99.02 42.43 .98 (.94–1.00) 102
BB 96.27 43.54 .93 (.87–.99) 134
Size of signal change2 AA 99.02 87.80 .92 (.85–.97) 102
BB 98.18 91.18 .79 (.64–.91) 134
Total size of BMO in the DVU AA 99.51 98.89 .56 (.23–.78) 1104
BB 99.76 99.16 .71(.48–.88) 1104
Total size of FMD in the DVU AA 99.43 98.64 .58 (.39–.74) 1104
BB 99.81 99.12 .78 (.67–.87) 1104
Total size of mixed lesions in the DVU AA 99.83 99.43 .71 (0.00–.95) 1104
BB 99.61 98.52 .73 (.50–.88) 1104
Erosions AA - - - -
BB 99.91 99.61 .77 (.47–.91) 2208
Syndesmophytes or vertebral fusion AA 99.95 99.19 .94 (.67–1.00) 1104
BB 99.93 99.57 .83 (.40–.98) 1104
BMO at the apophyseal joint AA 99.82 98.38 .88 (.73–1.00) 1104
BB - - - -
Disc degeneration AA 99.58 94.43 .92 (.89–.95) 1104
BB 99.55 95.35 .90 (.87–.93) 1104
Disc contour AA 99.26 94.28 .87 (.82–.91) 1104
BB 99.25 93.36 .89 (.84–.93) 1104
Herniation in the vertebral endplate AA 99.82 96.09 .95 (.89–1.00) 1104
BB 98.91 95.92 .73 (.59–.88) 1104
Scheurmann’s changes AA 99.55 98.12 .76 (.56–.96) 1104
BB 99.55 98.65 .67 (.39–.94) 1104
BMO; Bone marrow oedema, DVU; Discovertebral unit, FMD; Fatty marrow deposition, - Too few positive ratings for one of the observers to be included in the
analysis 1Discovertebral units or vertebral endplates. 2Only observations where both readers agreed on the presence of a signal change were kept in the analysis.
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agreements were found for the majority of MRI changes
in the current study. The exceptions were for the inten-
sity of BMO, the depth of FMD and erosions which had
a moderate inter-observer agreement. To our knowledge,
no earlier studies report on the agreement of these
changes assessed as single lesions. Several studies that
assess each lesion individually were identified. However,
these studies report only results on analysis performed on
combinations of these findings, e.g. sum score of
total findings or anatomical regions [32-36], which
are not comparable with assessing agreement on each
lesion.
Table 6 Inter-observer agreements for MRI changes in the SIJ and global assessment
MRI changes Observers Observed
agreement (%)
Expected
agreement (%)
Pairwise weighted
Kappa (95% CI)
Number of SIJ regions
BMO AB 97.77 89.52 .79 (.69–.86) 384
AC 98.09 91.08 .79 (.68–.87) 384
BC 98.70 91.38 .85 (.79–.90) 384
Combined1 .81 (.78–.84) 384
Intensity BMO2 AB 85.00 72.22 .46 (.19–.73) 60
AC - - - -
BC - - - -
Combined1 - -
Depth BMO2 AB 85.00 53.67 .68 (.49–.87) 60
AC 82.35 50.52 .64 (.43–.85) 51
BC 92.86 53.06 .85 (.71–.99) 56
Combined1 .73 (.63–.82) 65
FMD AB 97.25 83.26 .84 (.77–.89) 384
AC 97.19 87.28 .78 (.69–.85) 384
BC 95.60 84.77 .71 (.60–.80) 384
Combined1 .78 (.74–.81) 384
Depth FMD2 AB 84.91 56.14 .66 (.44–.87) 53
AC 78.05 63.65 .40 (.08–.71) 41
BC 72.55 58.94 .33 (.07–.60) 51
Combined1 .52 (.38–.67) 67
Erosions AB 97.77 92.99 .68 (.49–.81) 384
AC 98.32 96.12 .57 (.30–.76) 384
BC 96.90 94.69 .42 (.20–.63) 384
Combined1 .57 (.51–.62) 384
Subchondral sclerosis AB 98.73 96.29 .66 (.40–.81) 384
AC 99.16 97.21 .70 (.37–.87) 384
BC 98.87 97.15 .60 (.28–.81) 384
Combined1 .65 (.61–.70) 384
Ankylosis AB - - - -
AC - - - -
BC 99.28 97.26 .74 (35–.90) 384
Combined1 - -
Global assessment3 AB 94.2 81.31 .69 (.44–.86) 474
AC 90.75 74.95 .59 (.35–.75) 444
BC 89.39 74.64 .58 (.32–.78) 434
Combined1 .61 (.46–.75) 474
BMO: Bone marrow oedema, FMD: fatty marrow deposition, - Too few positive ratings for one of the observers to be included in the analysis 1 Intraclass
correlation coefficient. 2Only observations where both readers agreed on the presence of BMO/FMD were kept in the analysis. 3Assessed on the entire MRI scan.
4Number of patients assessed.
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Regarding global assessment, one recent study investi-
gated the inter-observer agreement for global evaluation
of MRI of the SIJ in SpA versus non-SpA patients. The
kappa value for inter-observer agreement for 5 categories
of confidence in the SpA diagnosis were found to be .73
(.62-.81) in a cohort of back pain patients referred to a
secondary care outpatient clinic in Switzerland due to
suspicion of SpA and .74 (.65-.80) in cohorts of back pain
patients with anterior uveitis referred to a ophthalmology
department in Canada [37]. This is higher than the inter-
observer agreement found for global assessment in the
current study but with overlapping CI. In general, the
spinal MRI findings related to SpA are not as clearly
defined as the findings related to the SIJ, which is reflected
in the incorporation of only SIJ changes in the ASAS
criteria for SpA. Therefore, one reason for the lower
agreement in the current study could be that the inclusion
of spinal changes in the global assessment increases the
uncertainty of the diagnosis.
Application of the findings
The acceptable agreement for the evaluation of key MRI
changes in the spine and SIJ makes it possible to use
these MRI changes in the BaPa Cohort study and other
studies investigating MRI changes in patients with non-
specific LBP and suspected SpA.
Earlier publications on the evaluation of SpA-related
MRI findings have mainly been focused on grading
systems for active and chronic SpA changes as a meas-
urement of disease severity in already diagnosed SpA
patients. However, the assessment of each lesion sepa-
rately creates the potential for additional analysis of the
diagnostic and prognostic value of each individual MRI
finding. It also creates the potential for describing the
development of the changes in subsequent longitudinal
studies and it provides a possibility for analysing location-
specific alterations, e.g. to compare MRI changes with
pain location. Furthermore, the inclusion of both SpA-
related and degenerative changes in the same evaluation
protocol facilitate an accessible assessment of MRI
findings that could mimic SpA-related findings, assessed
under the same standardized evaluation session.
Strengths and weaknesses of the study
This study has potential weaknesses that have to be
addressed. Firstly, some MRI changes could not be
analysed because of too few positive ratings, and the
agreement of the evaluation of these findings could not
be tested. If this problem were to be addressed, the study
population would have to have contained patients with
more pronounced SpA. However, this would have made
the study sample less applicable to the BaPa Cohort, to
which the evaluation protocol will be applied. For some
Table 7 Intra-observer agreements for MRI changes in the SIJ and global assessment
MRI changes Observers Observed agreement (%) Expected agreement (%) Weighted Kappa (95% CI) Number of SIJ regions
BMO AA 99.57 89.42 .96 (.92–.98) 384
BB 98.99 89.19 .91 (.85–.95) 384
Intensity of BMO1 AA 92.42 67.36 .77 (.58–.96) 66
BB 95.95 83.97 .75 (.47–1.00) 74
Depth of BMO1 AA 95.45 51.93 .91 (.80–1.00) 66
BB 91.89 55.84 .82 (.68–.96) 74
FMD AA 99.33 85.49 .95 (.92–.97) 384
BB 98.06 82.15 .89 (.84–.93) 384
Depth of FMD1 AA 95.57 52.40 .80 (.64–.97) 53
BB 87.88 52.25 .75 (.58–.91) 66
Erosions AA 98.61 93.52 .79 (.60–.92) 348
BB 99.02 91.96 .88 (.80–.93) 384
Subchondral sclerosis AA 99.62 96.84 .88 (.71–.96) 384
BB 99.62 96.48 .89 (.77–.95) 384
Ankylosis AA - - - -
BB 99.54 97.26 .83 (.52–.95) 384
Global assessment2 AA 98.37 84.61 .89 (.82–.95) 463
BB 95.79 80.20 .79 (.52–.93) 463
SIJ: sacroiliac joints, BMO: Bone marrow oedema, FMD: fatty marrow deposition, - Too few positive ratings for one of the observers to be included in the analysis
1Only observations where the reader on both the readings agreed on the presence of BMO/FMD were kept in the analysis. 2Assessed on the entire MRI scan, not
only the SIJ. 3Number of patients assessed.
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of the MRI changes, the inter-observer agreement varied
between reader pairs, despite training and calibration
sessions, indicating that more effort could have been
done in calibration, especially regarding vertebral disc
herniation and Scheuermann’s changes.
This study also has a number of strengths. MRI of the
whole spine and SIJ were read by three independent
readers and intra-observer agreement was tested by two
of the readers. The involvement of more than two
readers improves the generalisablity of the evaluation
method. Moreover, for the MRI changes related to SpA
in both the spine and SIJ, this is the first time agreement
has been tested assessing each lesion separately. This
creates the potential for describing the development of
the changes in subsequent studies, and the possibility
for analysing location-specific alterations. Furthermore,
the readers were highly specialized musculoskeletal
radiologists, and training and calibration sessions were
conducted prior the readings.
Conclusion
The inter- and intra-observer agreement for the evalu-
ation of spondyloarthritis-related and degenerative MRI
changes in the spine and spondyloarthritis-related changes
in the sacroiliac joints were investigated in this study. In
the spine, substantial to almost perfect observer agree-
ment was found for the evaluation of the location and the
size of vertebral signal changes and for disc degeneration
and disc contour. In the sacroiliac joints substantial to
almost perfect observer agreement was found for the
grading of bone marrow oedema and fatty marrow depo-
sition, the depth of bone marrow oedema and for
subchondral sclerosis. Also, ‘Global assessment’ regarding
the spondyloarthritis diagnosis had substantial or almost
perfect observer agreements.
Additional file
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ABSTRACT 
Purpose: To estimate the prevalence of degenerative and spondyloarthritis (SpA)-related 
MRI findings in the spine and sacroiliac joints (SIJ) and analyze its association with gender 
and age. 
Material and method: Patients aged 18-40 years with persistent low back pain (LBP) 
referred to a secondary care Spine Centre were included in the study. All patients received a 
whole spine and SIJ MRI, which was evaluated using a standardised degenerative and SpA-
related protocol.  
Results: 1037 patients were included (median age 33 years, 54% women). Disc degeneration 
and disc contour changes were the most common findings, present in 87% (±SEM 1.1) and 
82% (±1.2) of the patients, respectively.  Vertebral endplate signal (Modic) changes occurred 
in 48% (±1.6). All degenerative spinal findings were more frequent in men and in patients 
aged 30-40. Spinal SpA-related MRI findings were rare. In the SIJ, 28% (±1.4) had at least 
one MRI finding, of which bone marrow oedema was the most common (21% (±1.3)). SIJ 
sclerosis and fatty marrow deposition were associated with female gender. Erosions were 
more prevalent in patients aged 18-29 years and BMO more prevalent in patients aged 30-40. 
Conclusion: Spinal and SIJ MRI findings were common in this cohort. Spinal findings were 
more frequent in men and older patients, whereas SIJ findings were more frequent in women 
and less strongly associated with age. The high prevalence of SIJ findings in this patient 
group reveals a need for further investigation of the clinical importance of MRI findings in 
the SIJ in patients with persistent LBP. 
Keywords: Degeneration, Low Back Pain, Magnetic Resonance Imaging, Sacroiliitis, 
Spondyloarthritis   
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INTRODUCTION  
The prognosis of low back pain (LBP) can vary from mild transient complaints to severe 
debilitating conditions. However, the causes can be difficult to differentiate because of 
similarities in symptoms. Magnetic resonance imaging (MRI) is used increasingly in the 
diagnosis of back pain, both in persistent non-specific LBP, sciatica and inflammatory back 
pain, such as spondyloarthritis (SpA). Various uncertainties remain regarding the diagnostic 
value of both degenerative (1) and SpA-related MRI findings (2, 3). Therefore, further 
investigations are essential to expand the knowledge of pathoanatomical changes seen by 
MRI and, thereby, improve its diagnostic precision in LBP. 
While the lumbar spine has been the focus in previous studies of degenerative MRI findings, 
MRI findings in the sacroiliac joints (SIJ) have mainly been investigated in connection with 
inflammatory back pain. However, recent case-control studies including both patients with 
inflammatory back pain and patients with non-specific LBP have shown that SIJ MRI 
findings previously considered to be specific for SpA, are prevalent in patients with non-
specific LBP (4-6). Similarly, spinal MRI findings associated with SpA can be difficult to 
distinguish from the highly prevalent findings of degeneration and vertebral endplate signal 
changes (VESC), so called Modic changes, which can confound the assessment of SpA(7). 
Nonetheless, in research, degenerative and SpA-related MRI findings are often evaluated in 
separate studies and in different study populations, which may reduce their applicability to 
daily clinical practice. Consequently, a more detailed description of both degenerative and 
SpA-related MRI findings in representative care-seeking LBP populations is needed.  
The Back Pain Cohort of Southern Denmark (BaPa Cohort) was initiated in 2011 and 
includes patients referred with persistent LBP to a Danish public hospital. The aim of the 
current study was to estimate the prevalence of degenerative and SpA-related MRI findings in 
the spine and SIJ and analyse its association with gender and age. 
MATERIAL AND METHOD  
Study sample 
The study was conducted in an outpatient, secondary care and non-surgical department in a 
public hospital specialising in non-inflammatory back pain. The department performs 
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multidisciplinary assessments of patients with back pain, referred from primary care. The 
referral criteria to the Centre are an episode of back pain with a duration of 2 to 12 months, 
where conservative treatment has had insufficient effect. Patients thought to have specific 
back pain conditions such as SpA, fracture, cancer or infections are not to be referred to the 
Centre.  
From March 2011 to October 2013, booking secretaries allocated Caucasian patients aged 18 
to 40 years with LBP as their primary complaint to a dedicated multidisciplinary ‘project 
team’. The treating clinicians excluded patients from the project who did not understand 
Danish, had undergone an MRI scan within the last year or were deemed unlikely to tolerate 
the one hour MRI.  
The study was conducted in accordance with the Declaration of Helsinki-II. The Regional 
Scientific Ethics Committee for Southern Denmark determined that under the Danish legal 
framework, this study did not require formal ethics approval, reference number S-2010200-
58. Each patient gave written informed consent for research use and publication of their data.  
Magnetic resonance imaging technique and evaluation 
MRI of the whole spine and the SIJ were performed with a 1.5T unit (Philips Achieva, Best, 
The Netherlands) MRI System, using a SENSE spine coil. The following sequences were 
performed for the spine, implemented in three steps (cervical, thoracic and lumbar) and 
subsequently fused: Sagittal short-tau inversion recovery (STIR) and sagittal T1-weighted 
turbo spin-echo (TSE). An additional sagittal T2-weighted VISTA (3D TSE T2-weighted 
sequence) and axial T2-weigthed TSE was performed of the lumbar spine. For the SIJ, the 
following sequences were used: Semicoronal T1-weighted TSE, semicoronal T1-weighted 
Spectral pre-saturation with inversion recovery (SPIR) and semiaxial STIR long TE. For more 
details of the scanning protocol, see appendix 1. 
Three senior consultant research radiologists, specialists in musculoskeletal imaging and SpA, 
participated in the evaluation of the MRI scans. They were blinded to all clinical information, 
except for patients’ gender and age.  
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Data collection  
Demographic and clinical characteristics were collected using electronic self-reporting 
questionnaires as part of the Spine Centre’s standard procedure.  
For the evaluation of the spine each intervertebral disc, vertebral endplate and subjacent bone 
marrow area from disc levels C2-C3 to L5-S1 were assessed separately for the following MRI 
findings: VESC and corner lesions of three types: bone marrow oedema (BMO), fatty marrow 
deposition (FMD) and mixed type (area with both BMO and FMD). Also disc degeneration 
(DD), disc contour change (DCC), erosions in the vertebral corner, syndesmophytes or 
vertebral fusion, BMO at the costovertebral joints and, posterior element lesions including 
BMO at the apophyseal joint, FMD at the apophyseal joints, and soft tissue oedema around 
the apophyseal joints were assessed. 
For the evaluation of the SIJ, each joint was subdivided into four osseous locations: the 
cartilaginous part of the iliac and the sacral bones, respectively, and the ligamentous portion 
of the iliac and sacral bones, respectively (eight regions in total). The SIJs were assessed for 
the following findings: BMO, FMD, erosions, sclerosis, and ankylosis.  The presence of 
BMO, FMD or sclerosis was defined as a minimum of two findings on a single SIJ slice, or 
one finding in the same SIJ quadrant in at least two consecutive slices corresponding to the 
definition of BMO used in the Assessment of SpondyloArthritis international Society (ASAS) 
criteria for axial SpA (8).  
A definition of the MRI findings and their grading are provided in Appendix 2. 
Reproducibility of the MRI findings 
The MRI evaluation protocol has previously been tested for inter- and intra-observer 
agreement (9). In general, MRI findings included in the current study had kappa values of 
more than 0.6 for both inter- and intra-observer agreement. However, six variables: vertebral 
corner lesion, erosions in the vertebral corner, BMO at the costovertebral joints, FMD at the 
apophyseal joints, soft tissue oedema around the apophyseal joint, and erosions in the SIJ 
were included without meeting the criterion for a kappa value of more than 0.6, because they 
are widely regarded as key MRI findings in the assessment of SpA (7, 8).  
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Statistical analysis 
The coding of the MRI findings was entered directly into an electronic database (the 
SpineData database) via an electronic evaluation form, and analysed using STATA 11.2  
(StataCorp, 2000, College Station, TX: Stata Corporation, USA). 
Clinical and demographic data were tabulated. Prevalence estimates were calculated as 
proportions and presented with standard error of the mean (± SEM). Two-sample proportion 
test was used to evaluate differences in the prevalence of findings between anatomical 
regions. Difference in grading between regions was not assessed. Pearson’s chi square test 
was used to evaluate differences between the genders and two age groups using a significance 
level of 5%. 
For the graphic presentation of difference in levels and severity of findings, sum-scores were 
generated. Adding the number of spinal disc levels with positive findings generated the sum-
scores for the spine. Sum-scores for the SIJ were generated, by adding the size of the finding 
(0-3), in all eight SIJ regions.  
RESULTS 
Approximately 5000 patients aged 18-40 years were referred with LBP in the study period 
and 1619 of them were invited to participate in the study. One hundred and sixty patients 
were excluded before, and 422 after, the first visit (Figure 1). In total, 1037 patients with a 
median age of 33 years (IQR: 27-37) were included in the study, 558 (54%) of whom were 
women (Table 1). The median age of the men (31.9 years) was a little higher than for the 
women (31.1 years). The self-reported questionnaires were completed by 983 (96%) of the 
included patients. Of the patients not included in the study, who were in the same age range 
and referred with LBP in the study period, the median age was 34 (IQR 28-38) years, and 
54% were women.  
Of the included patients, 91.3% (± 0.9) had at least one of the assessed MRI findings, 88.2% 
(±0.1) at least one spinal finding, 27.5% (±1.4) at least one SIJ finding and 24.4% (± 1.3) at 
least one SIJ and spinal MRI finding. 
Prevalence of MRI findings in the spine 
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Prevalence estimates for the assessed spinal MRI findings are provided in Table 2. DD and 
DCC were the most common findings in the spine, present in 86.6% (±1.1) and 81.9% (±1.2), 
respectively. VESC were found in 47.9% (±1.6). The least prevalent spinal findings were disc 
sequestration, posterior element lesions, erosions in the vertebral corner, BMO at the 
costovertebral joints and syndesmophytes or fusion, each present in 0.1- 2.2% of patients. At 
least one lumbar MRI finding occurred in 79.8% (±1.3), at least one thoracic MRI finding in 
52.2% (±1.6), and at least one cervical MRI finding in 25.0% (±1.3). In general, the assessed 
spinal MRI findings followed this distribution, being most frequent in the lumbar spine and 
least frequent in the cervical spine, with the exception of anteriorly located VESC and corner 
lesions. 
Figure 2A and 2B shows the variation in number of spinal MRI findings at a patient level. Of 
the included patients, 20.6% (±1.3) had more than two VESC, almost half, 49.2% (±1.6), 
more than two levels with DD and 30.5% (±1.4) more than two levels with DCC. 
Table 3 shows the prevalence of the MRI findings in men and women and in patients aged 18-
29 and 30-40 years, respectively. VESC, DD, and DCC were all found to be statistically more 
frequent in men than women and in patients aged 30-40 years compared with patients aged 
18-29 years.  
Prevalence of MRI findings at the sacroiliac joints 
Prevalence estimates of MRI findings in the SIJ are provided in Table 4. BMO were the most 
frequent findings, present in 21.4% (±1.3). FMD, sclerosis, and erosions occurred in 14.5% 
(±1.1), 8.0% (±0.8), and 7.7% (±0.8) of the patients, respectively. Ankylosis was only present 
in three patients. In the cartilaginous part, BMO were significantly more frequent in the 
sacrum than in the ilium, while erosions and sclerosis were more frequent in the ilium than in 
the sacrum. 
Figure 2C displays variations in sum-scores for the assessed SIJ MRI findings at the patient 
level. The prevalence of patients with a sum-score of more than one (more than one region 
with slight findings) were 12% (±1.1), 5.3% (±0.6), 11.1%(±1.1) and 5.3% (±0.6) for BMO, 
erosions, FMD and sclerosis, respectively. 
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In general SIJ MRI findings were more frequent in women than in men, see Table 3. The 
greatest difference was found for sclerosis, present in 13.2% (±1.4) of women and in only 
1.9% (±0.6) of men, and for FMD, present in 18.6% (±1.7) of women versus 9.6% (±1.3) of 
men. There was no statistically significant difference between genders for the remaining SIJ 
MRI findings.  
SIJ erosions were significantly more frequent in patients aged 18-29 years than in those aged 
30-40 years. BMO were more frequent in patients aged 30-40, however, only borderline 
statistically significant (Table 3). 
DISCUSSION 
To our knowledge, this is the first time prevalence estimates of both degenerative and SpA-
related MRI findings in the entire spine and SIJ are presented from a consecutive cohort of 
secondary care patients with persistent LBP. Several associations with age and gender as well 
as regional difference in location of findings were identified and highlight the need for further 
investigation. 
In relation to the spine, lumbar findings were more frequent than thoracic findings, and 
thoracic findings were more frequent than cervical findings in the current study. To our 
knowledge, only one other study, a recent Japanese population-based study, has reported 
prevalence of MRI findings in the entire spine (10). The study investigated DD in a cohort of 
975 participants, aged 21-97 years. In the subsample of patients younger than 50 years 
(n=125), most comparable with the current study sample, lumbar DD was also reported to be 
more common than in the rest of the spine. Patients with cervical DD was, however, more 
common than patients with thoracic DD (10). This difference could be explained by patients 
in the current study all having LBP. 
Spinal degenerative findings were found relatively frequently in the current cohort. The 
prevalence of DD, DCC and VESC in the entire spine was 87%, 82%, and 48%, respectively. 
The occurrence of these findings has been investigated in different back pain populations, 
primarily in the lumbar spine (11-17). In the cervical and thoracic spine, these findings have 
only been sparsely investigated in back or neck pain populations (18-21). To our knowledge, 
only one study has reported the prevalence of degenerative MRI findings in the thoracic spine 
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of back pain patients (21). Differences in study design, age range of the samples, MRI 
techniques, and definition of MRI findings preclude a direct comparison with our results. The 
association between spinal degenerative MRI findings and age found in the current study 
support previous studies (22, 23). The association with male gender could be influenced by 
heavy work being more frequent among Danish men compared with women (24).  
For VESC, it was noted that the anterior location was the most common in the thoracic spine, 
while in the lumbar spine, widespread VESC was the most common. This could be explained 
by differences in load forces at the two regions of the spine. In the thoracic spine, the load is 
mainly on the anterior part of the motion segment due to the kyphosis and vice versa in the 
lumbar region due to the lordosis. Also, the lumbar segments have more degrees of freedom, 
including sagittal angulation and axial rotation, making loading on the entire endplate 
possible as opposed to the thoracic spine, which has a limited range-of-motion due to the rib 
cage. The regional differences in the location of VESC found in this study thereby support the 
hypothesis that the occurrence of VESC is related to mechanical loading (25). However, 
further investigation of the distribution of VESC at the segment level could give additional 
understanding of its etiology. 
The prevalence of spinal MRI findings previously described as related to SpA (vertebral 
corner lesions, costovertebral joint BMO, syndesmophytes or fusion, and erosions in the 
vertebral corner) was very low. To our knowledge, it has not previously been investigated in a 
comparable population. 
Historically, the focus in MRI findings in the SIJs has been in patients with inflammatory 
back pain or SpA and only a few studies have reported on MRI findings in the SIJ in patients 
with non-inflammatory back pain (3). In one recent case-control study, the prevalence of 
BMO, FMD, erosions and ankylosis in the SIJ were 23%, 15%, 4%, and 0%, respectively, in 
a group of 26 patients with non-specific LBP (4). Additionally, two small case-control studies 
reports prevalence of 27% and 22%, respectively, for BMO at the SIJ in non-inflammatory 
back pain control groups (5, 6). These results correspond to ours, even though they are not 
directly comparable due to differences in study designs and study samples.  
Previous research has shown associations between BMO and degenerative/load-related 
changes at different locations such as the spine (Modic type I changes) (11, 23) and knee (26, 
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27). However, at the SIJ, the presence of BMO is most often described as highly indicative of 
sacroiliitis (8). Supported by BMO being more prevalent in the oldest patients in the current 
study, it nevertheless seems reasonable to assume that BMO at the SIJ can also be related to 
degenerative/load-related changes. With the high prevalence of BMO at the SIJ found in this 
study, there seems to be a need for further investigation of the clinical importance of BMO at 
the SIJ in LBP populations. Moreover, prospective, longitudinal studies are needed to 
investigate the predictive value of SIJ findings for fulminant sacroiliitis. 
In this study, FMD and sclerosis were strongly associated with female gender, which has also 
been reported for sclerosis identified using conventional radiography (28). This could be 
explained by a correlation between SIJ findings and pregnancy/birth-related strain (29). 
However, pregnancy/birth-related pathoanatomical changes in the SIJ have been rarely 
investigated with MRI (30, 31). The current study was, however, limited to a cross-sectional 
design and further investigation of the cause of SIJ findings and their relationship to pain is 
needed before any conclusions can be drawn. 
The higher prevalence of erosions at the SIJ in patients less than 30 years could be explained 
by a selection bias, introduced by the Centre specialising in non-inflammatory back pain. 
Patients with advanced stages of SpA, who are expected to have structural findings of 
sacroiliitis, were more likely to be both older and treated elsewhere, according to the Spine 
Centre’s referral criteria. 
The predominance of the MRI findings at the SIJ varied between sacrum and ilium according 
to the findings. BMO were more frequent in the sacrum than in the ilium, while erosions and 
scleroses were more frequent in the ilium than in the sacrum. This regional distribution of 
erosions identified using MRI has been reported previously (32). Erosions and sclerosis seen 
with computed tomography have also been reported to be most common in the ilium (33). 
However, more studies in both inflammatory and non-inflammatory back pain patients are 
needed to explore whether the regional distribution of SIJ findings differs according to the 
cause.  
The fact that all patients in the current study had LBP precludes investigating the association 
between pain and MRI findings. However, the high prevalence of findings in the assessed 
axial regions indicates a need for further investigation of their role in the development of back 
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pain. Pain from the SIJ can be difficult to distinguish from pain due to lumbar involvement 
(34-36) and in this cohort, 28% had MRI findings at the SIJ. This emphasises a need for 
further studies on the clinical importance of SIJ MRI findings in the LBP population, 
investigating the role of pregnancy, birth-related strain, degeneration and SpA.  
The methodological strengths of this study are, firstly, that the MRI evaluation included both 
the SIJ and the whole spine, making it possible to describe the prevalence and distribution of 
both degenerative and SpA-related MRI findings in the most important regions of the axial 
skeleton in one study. Furthermore, the study sample is representative of young patients with 
persistent LBP seen in a secondary care setting and the large number strengthens the 
prevalence estimates obtained. Finally, the standardised MRI protocol used in this study 
increases the integrity and uniformity of the data. 
There are also important limitations to the current study, which should be taken into 
consideration when interpreting the results. Firstly, T2-weighted sequences was only used in 
the lumbar spine, introducing a possible bias in the interpretation of the anatomical 
distribution of the MRI findings, primarily for DD, DCC and posterior element lesions, 
because no axial sequences were available in the thoracic and cervical spine. Furthermore, the 
MRI evaluations were not blinded for age and gender. Finally, not all the included variables 
had kappa values for observer agreement above 0.6, but were, nevertheless, included because 
they were regarded as essential in the assessment of SpA.  
In summary, the study provides the most up-to-date and precise prevalence estimates of 
degenerative and spondyloarthritis-related MRI findings in the spine and sacroiliac joints in a 
secondary care cohort of young patients with persistent low back pain. Both spinal and 
sacroiliac joint MRI findings were common in this cohort of patients. Spinal MRI findings 
were generally more prevalent in men and patients over the age of 30 years. Sacroiliac joint 
findings were more commonly observed in women and less strongly associated with age. The 
high prevalence of sacroiliac joint findings in this cohort of patients without prior indication 
of spondyloarthritis, imply a need for further investigation of the clinical importance of MRI 
findings at the sacroiliac joints in patients with persistent low back pain.   
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Table 1. Demographic and clinical characteristics of the study sample 
 
 
 
 
 
 
 
 
 
 
Characteristics   
Age in years, median (IQR), n Total =1037 33 (27-37) 
Women, n Total=1037 558 (54) 
Body Mass Index (BMI), n Total =938  
   Underweight, BMI <18.5 15 (2) 
   Normal range, BMI 18.5-24.9 422 (45) 
   Overweight or obese, BMI 25-30 333 (36) 
   Obese, BMI >30 168 (18) 
Smoking, n Total =919 272 (30) 
Employed, n Total =963 679 (71) 
Sick leave1, n Total =904 455 (50) 
LBP duration in months2, median (IQR), n Total =973 11 (4-39) 
Previous LBP episodes, n Total =971 723 (74) 
LBP intensity (0-10), median (IQR), n Total =979 6 (5-7) 
Leg pain, n Total =979 791 (81) 
Leg pain intensity3 (0-10), median (IQR), n Total =791 5 (3-6) 
Activity limitation (RMDQ 0-100), median (IQR), n Total =962 57 (39-73) 
General health, EQ VAS, (0-100), median (IQR), n Total= 976 52 (38-75) 
Unless otherwise indicated, data are number of patients with percentages in 
parentheses, n Total varies because of missing values 
BMI: body mass index, LBP: low back pain, IQR: inter quartile range 
LBP intensity is averaged 0–10 Numerical Rating Scales (NRS) on present 
LBP, worst LBP last 14 days and typical LBP last 14 days (37) 
Leg pain intensity measured in the same way as for LBP 
RMDQ: Roland Morris Disability Questionnaire (38) (calculated as a 
proportional score (0% = no activity limitation; 100% = maximum activity 
limitation) (39), EQ VAS: EuroQol visual analogue scale (40) 
1 Sick leave due to back pain three months before first consultation 
2
 Duration of current LBP episode LBP at the first consultation  
3 For patients with leg pain > 0 
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Table 2. Prevalence of patients with spinal MRI findings (minimum of one) 
 
  Whole spine Cervical Thoracic  Lumbar 
Any spinal MRI finding  88.2 (1.0) 24.9 (1.3) 52.2 (1.6)** 79.5 (1.3)** 
Any VESC  47.9 (1.6) 3.5 (0.6) 16.1 (1.1)** 40.0 (1.5)** 
Type of VESC     
   BMO  21.3 (1.3) 2.0 (0.4) 6.4 (0.8) 15.3 (1.1)** 
   FMD  26.8 (1.4) 1.7 (0.4) 7.8 (0.8)** 21.8 (1.3)** 
   Mixed type 20.1 (1.2) 0.1 (0.1) 6.0 (0.7)** 15.8 (1.1)** 
Location of VESC     
   Anterior  22.7 (1.3) 1.5 (0.4) 13.7 (1.1)** 11.9 (1.0) 
   Posterior   12.0 (1.0) 0.9 (0.3) 1.6 (0.4) 10.0 (0.9)** 
   Widespread   32.4 (1.5) 1.9 (0.4) 2.5 (0.5) 30.1 (1.4)** 
Size of VESC     
   Small  40.2 (1.5) 3.0 (0.5) 15.7 (1.1) 31.3 (1.4) 
   Moderate  14.4 (1.1) 1.0 (0.3) 1.1 (0.3) 13.1 (1.0) 
   Large  8.4 (0.9) 0.3 (0.2) 0.2 (0.1) 7.9 (0.8) 
Any vertebral corner lesion 2.2 (0.5) 0.1 (0.1) 1.7 (0.4)** 1.4 (0.4) 
   BMO 1.6 (0.3) 0 1.2 (0.3)** 0.7 (0.3) 
   FMD 1.1 (0.3) 0.1 (0.1) 1.0 (0.3) 0.8 (0.3) 
   Mixed type 0.9 (0.3) 0 0.8 (0.3)* 0.5 (0.2) 
Any disc degeneration 86.6 (1.1) 24.0 (1.3) 48.2 (1.6)** 77.2 (1.3)** 
   Slight 78.3 (1.3) 23.1 (1.3) 45.6 (1.5) 60.9 (1.5) 
   Moderate  36.3 (1.5) 2.1 (0.4) 7.8 (0.8) 31.5 (1.4) 
   Severe   5.6 (0.7) 0.1 (0.1) 0.2 (0.1) 5.3 (0.7) 
Any disc contour change 81.9 (1.2) 22.6 (1.3) 26.5 (1.4)* 74.3 (1.4)** 
   Broad-based disc protrusion 39.6 (1.5) 9.4 (0.9) 6.0 (0.7) 31.8 (1.4) 
   Focal disc protrusion 53.5 (1.5) 12.4 (1.0) 21.2 (1.3) 36.8 (1.5) 
   Disc extrusion 33.8 (1.5) 3.4 (0.6) 2.9 (0.5) 30.9 (1.4) 
   Disc sequestration 1.1 (0.3) 0 0 1.1 (0.3) 
Any posterior element lesions 2.2 (0.5) 0 0.6 (0.2)*  1.8 (0.4)** 
   Apophyseal joint BMO 0.8 (0.3) 0 0.5 (0.2) 0.4 (0.2) 
   Apophyseal joint FMD  1.7 (0.4) 0 0.3 (0.2) 1.5 (0.4)** 
   Soft tissue oedema1 0.1 (0.1) 0 0 0.1 (0.1) 
Costovertebral joint BMO 0.4 (0.2) NA 0.4 (0.2) NA 
Syndesmophytes or fusion 0.5 (0.2) 0.2 (0.1) 0.3 (0.2) 0 
Erosions in the vertebral corner 0.1 (0.1) 0 0 0.1 (0.1) 
Data are percentage with standard error of the mean in parentheses, n total=1037 
Difference in prevalence between regions in adjacent columns: *p <0.05, **p < 0.01 
VESC: vertebral endplate signal changes, BMO: bone marrow oedema, FMD: fatty 
marrow deposition, Mixed type: area with both BMO and FMD. 1 Soft tissue oedema 
around the apophyseal joints, NA: not assessed 
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Table 3. Association of MRI findings with gender and age  
 Gender   Age groups   
 Men  Women   18-29 years  30-40 years  
Any spinal MRI finding 93.7 (1.1)  83.5 (1.6)  ** 80.2 (2.0)  93.2 (1.0)  ** 
   BMO VESC 26.7 (2.0)  18.5 (1.6)  ** 11.7 (1.6)  28.8 (1.8)  ** 
   FMD VESC 32.4 (2.1)  22.8 (1.8)  ** 15.2 (1.8)  34.6 (1.9)  ** 
   Mixed type 27.8 (2.0)  14.9 (1.5)  ** 9.4 (1.5) 28.0 (1.8)  ** 
   Disc degeneration 91.9 (1.3)  82.1 (1.6)  ** 77.9 (2.1)  91.9 (1.1)  ** 
   Disc contour change 87.5 (1.5) 77.1 (1.8)  ** 71.1 (2.3) 88.5 (1.3) ** 
Any SIJ MRI finding 21.5 (1.9) 32.6 (2.0)  ** 26.1 (2.2) 28.3 (1.8)  
   BMO 19.2 (1.8) 23.3 (1.8)  18.3 (1.9) 23.3 (1.7)  # 
   FMD 9.6 (1.3) 18.6 (1.7)  ** 17.0 (1.9)  12.9 (1.3)   
   Sclerosis 1.9 (0.6) 13.3 (1.4)  ** 7.3 (1.3) 8.4 (1.1)  
   Erosions 6.7 (1.1) 8.6 (1.2)   10.2 (1.5)  6.2 (1.1)  * 
Data are percentage with standard error of the mean in parentheses 
 n total=1037, n men= 479, n women= 558, n 18-29 years= 394, n 30-40 years = 643 
Difference in prevalence in the two groups: * p < 0.05, ** p < 0.01, # p= 0.05,  
BMO: bone marrow oedema, VESC: vertebral endplate signal change, FMD: fatty 
marrow deposition, Mixed type: area with both BMO and FMD. 
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Table 4. Prevalence of patients with sacroiliac joint MRI findings (minimum of one) 
 
  Cartilaginous part Ligamentous part 
All regions Ilium Sacrum Ilium Sacrum 
Any sacroiliac joint MRI 
finding 
27.5 (1.4) 19.2 (1.2)   22.4 (1.4) 4.3 (0.6) 3.9 (0.6) 
Bone marrow oedema  21.4  (1.3) 12.3 (1.0)** 17.1 (1.2) 2.9 (0.5) 2.6 (0.5) 
   Slight  20.4 (1.3) 10.1 (0.9) 15.2 (1.1) 2.3 (0.5) 1.9 (0.4) 
   Moderate  3.1 (0.5) 1.4 (0.4) 1.3 (0.3) 0.6 (0.2) 0.6 (0.2) 
   Severe 1.9 (0.4) 1.5 (0.4) 1.3 (0.4) 0.4 (0.2) 0.3 (0.2) 
Fatty marrow deposition 14.5 (1.1) 9.9 (0.9) 12.2 (1.0) 2.2 (0.5) 2.5 (0.5) 
   Slight  12.8 (1.0) 7.1 (0.8) 9.0 (0.9) 1.8 (0.4) 2.1 (0.4) 
   Moderate  4.7 (0.7) 2.5 (0.5) 3.1 (0.5) 0.7 (0.3) 0.3 (0.2) 
   Severe 3.0 (0.5) 1.8 (0.4) 2.1 (0.4) 0.2 (0.1) 0.2 (0.1) 
Sclerosis 8.0 (0.8) 7.0 (0.8)** 2.5 (0.5) 0.3 (0.2) 0.2 (0.1) 
   Slight  6.2 (0.7) 4.5 (0.6) 2.5 (0.5) 0.3 (0.2) 0.2 (0.1) 
   Moderate  2.7 (0.5) 2.6 (0.5) 0.2 (0.1) 0 0 
   Severe 1.2 (0.3) 1.2 (0.3) 0 0 0 
Erosions 7.7 (0.8) 6.9 (0.8)* 4.5 (0.6) 0.2 (0.1) 0.1 (0.1) 
   Slight  6.7 (0.8) 4.8 (0.7) 3.7 (0.6) 0.2 (0.1) 0.1 (0.1) 
   Moderate  2.0 (0.4) 1.6 (0.4) 1.1 (0.3) 0 0 
   Severe 1.2 (0.3) 1.2 (0.3) 0.6 (0.2) 0 0 
Ankylosis 0.3 (0.2) 0.3 (0.2) 0.3 (0.2) 0 0 
Data are percentage with standard error of the mean in parentheses, n total=1037 
Difference in prevalence between sacrum and ilium: *p <0.05, **p < 0.01 
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Figure 1. Flow-chart of the study inclusion  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Patients initially allocated to study (n=1619) 
Patients attended first consultation (n=1459) 
Patients finally included in study (n=1037) 
  Reasons for exclusion before first consultation:  
• Patient non-attendance (n=60) 
• Attended clinician outside the ‘project team’ of 
clinicians (n=100) 
Reasons for exclusion after first consultation: 
• Declined participation (n=94) 
• Less than 18 years or more than 40 years (n=12) 
• Did not speak or understand Danish (n=10)  
• MRI within the last year (n=64) 
• Primary complaint not low back pain (n=37) 
• Contraindications for MRI (n=78) 
• Predicted unfit to one hour MRI (n=40) 
• Incomplete MRI due to logistic or technical 
difficulties (n=68) 
• Patient non-attendance to MRI (n=19) 
 
n = 160 
allocat
n = 422 
allocated 
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Figure 2. Prevalence of patients with various number of spinal MRI findings and sum-scores 
of severity of SIJ MRI findings 
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Abstract 
Objective:  To analyse the classification utility of inflammatory back pain (IBP) characteristics 
relatively to the fulfilment of the Assessment of SpondyloArthritis international Society (ASAS) 
criteria for axial spondyloarthritis (SpA). 
Method: Patients who had low back pain (LBP) for >3 months were selected from a cohort of 
secondary care patients aged 18-40 years.  Data included self-reported IBP questions covering items in 
the Calin, Berlin and ASAS IBP criteria, SpA features, HLA-B27 typing, CRP level, and MRI of the 
sacroiliac joint. Patients fulfilling ASAS criteria for axial SpA were categorised as ‘SpA according to 
ASAS’ and the remainder as ‘non-SpA LBP’.  
Results: Totally, 759 patients were included (median age 32 years, 54% women) and 86 patients 
(11%) were categorised as ‘SpA according to ASAS’. Four single IBP characteristics were positively 
associated with ‘SpA according to ASAS’: ‘no improvement with rest’ (sensitivity 0.82/specificity 
0.29/ ROC area 0.55), ‘improvement with exercise/not rest’ (0.24/0.85/0.54), ‘night pain’ 
(0.87/0.28/0.57), and ‘alternating buttock pain’ (0.35/0.76/0.55). Two-thirds of the patients, 67% (95% 
CI 63-70), met at least one of the three sets of IBP criteria and 16% (14-19) met all three. The IBP 
criteria were all positively associated with ‘SpA according to ASAS’: Calin (0.64/0.50/0.57), Berlin 
(0.59/0.60/0.60) and ASAS IBP criteria (0.33/0.86/0.59).  
Conclusion: In this cohort of persistent LBP patients, IBP characteristics could not differentiate 
patients with SpA according to ASAS from patients with other causes of back pain. These results 
imply that the use of IBP in the diagnosis of SpA may need to be re-evaluated.  
Keywords: Ankylosing Spondylitis, Low Back Pain, Spondyloarthritis  
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Introduction 
Spondyloarthritis (SpA) is a group of rheumatological disorders that lead to inflammatory and 
structural changes in the spine and sacroiliac joints. Unfortunately, differentiating between SpA and 
the much more common unspecific low back pain (LBP) frequently causes difficulties for the clinician 
due to similarities in symptoms and the lack of findings on conventional radiographic images in the 
early stages of SpA [1]. Consequently there is often a substantial delay in accurately diagnosing the 
disorder [2, 3].  
Pain characteristics of inflammatory back pain (IBP) have been considered a key feature of SpA for 
decades.  The first set of criteria for IBP were published in 1977 by Calin et al [4] and modified 
definitions have subsequently been incorporated into the Modified New York, the Amor, and the 
European Spondyloarthropathy Study Group criteria for Ankylosing Spondylitis (AS) and SpA [5-7]. 
A second set of IBP criteria was proposed in 2006, ‘the Berlin criteria’[8], and in 2009, the 
Assessment of SpondyloArthritis international Society (ASAS) proposed IBP criteria to be 
incorporated into new classification criteria for axial SpA [9, 10]. In contrast to previous criteria for 
SpA [6, 7], the ASAS criteria do not include IBP as an entry criterion, but as one of 11 clinical SpA 
features with equal clinical value in combination with findings on imaging and blood samples, 
considered by leading experts to be important in the diagnosis of patients with SpA. 
Even though IBP is regarded as a key feature of SpA, the utility of IBP characteristics for identifying 
SpA patients among those with persistent LBP is uncertain. The majority of studies, which have 
evaluated the association between IBP and SpA, have been performed at centres specialising in SpA 
and have included SpA patients with advanced disease and selected LBP patients as controls [7, 8, 11-
13]. However, if IBP is to be used to screen for, or to diagnose, early-stage SpA in patients with 
persistent LBP, there is a need for evaluating IBP in patient populations that include patients with 
early-stage SpA together with a large unselected control group of patients with back pain [14]. In 
2011, the Back Pain Cohort of Southern Denmark (BaPa Cohort) was initiated, with the purpose of 
evaluating the diagnosis of early-stage SpA in patients with persistent LBP referred to a local 
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secondary care spine centre. The aim of this study was to analyse the classification utility of single 
characteristics of IBP and the Calin, Berlin and ASAS IBP criteria relatively to the fulfilment of 
ASAS criteria for axial SpA. 
Method 
Patients  
The cohort study was conducted at the Spine Centre of Southern Denmark, which is an outpatient, 
non-surgical unit that specialises in managing non-inflammatory back pain in a secondary care public 
hospital setting. The referral criteria to the Centre are an episode of back pain with a duration of 2 to 
12 months, where conservative treatment has had insufficient effect. Patients thought to have specific 
back pain conditions such as SpA, fracture, cancer or infections are not to be referred to the Centre, 
but instead to the relevant clinical speciality. Only patients from the BaPa Cohort who reported LBP 
for more than 3 consecutive months were included in the current study. 
From March 2011 to October 2013, booking secretaries allocated Caucasian patients aged 18 to 40 
years with LBP as their primary complaint to a dedicated multidisciplinary ‘project team’. In all, 16 
clinicians (medical doctors including rheumatologists, physiotherapists and chiropractors) were 
allocated to the project during the study period. The treating clinicians excluded patients from the 
project who did not understand Danish, had undergone an MRI within the last year or were deemed 
unlikely to tolerate the one-hour MRI.  
The study was conducted according to the Declaration of Helsinki-II and, before inclusion each patient 
gave written informed consent for research use and publication of their data. The Regional Scientific 
Ethics Committee for Southern Denmark determined that under the Danish legal framework, this 
study did not require formal ethics approval (reference number S-2010200-58).  
Collection of clinical data and blood samples 
Demographic and clinical characteristics data were collected using electronic self-reported 
questionnaires, part of the Spine Centre’s standard procedure and included items on back and leg pain 
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intensity [15], activity  limitation [16, 17], general health [18], present work situation, etc. At their 
first visit, before consultation, patients completed a questionnaire, which included single 
characteristics of IBP from the Calin, Berlin and ASAS IBP criteria [4, 8, 9]. The questionnaires 
(translated into English) about IBP characteristics used in the study is provided in Table 1. As part of 
the initial consultation with the patient, the clinicians completed a questionnaire, covering SpA 
features (present/ not present) included in the ASAS criteria for axial SpA [10]. 
Blood samples of human leukocyte antigen (HLA) B27 and high sensitive C-reactive protein (hsCRP) 
were analysed.  If hsCRP was above 6 mg/L, the clinician annotated the SpA questionnaire to indicate 
if they were aware of a known reason for the elevated level.   
Magnetic resonance imaging 
MRI of the whole spine and the sacroiliac joints was performed with a 1.5 T unit (Philips Achieva, 
Best, the Netherlands) MRI System. The MRI protocol is published elsewhere [19]. The reading of the 
MRI was performed by three SpA expert radiologists who were blinded to all clinical information 
except the patients’ age and gender. The presence of sacroiliitis was noted according to the definition 
used in ASAS criteria for axial SpA [20]. The reproducibility of this MRI finding have previously 
been tested with kappa values >0.8 for inter- and intra-observer agreement [19]. 
Data analysis 
The data collected from the questionnaires and the MRI evaluation were entered directly into an 
electronic database (the SpineData database) via an electronic evaluation form, and analysed using 
STATA 11.2  (StataCorp, 2000, College Station, TX: Stata Corporation, USA). 
Based on the information of presence/absence of SpA features, HLB-B27 and sacroiliitis on MRI, 
patients were categorised as ‘SpA according to ASAS’ if they fulfilled the ASAS criteria for axial 
SpA [10]; the rest were categorised as ‘non-SpA LBP’. The categorisation of patients was made after 
data collection by a researcher not involved in the care of the patient. To avoid circularities, IBP was 
not included as a SpA feature in the definition of ‘SpA according to ASAS’. Fulfilment of the Calin, 
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Berlin and ASAS IBP criteria was based on the presence of the single characteristic in the self-
reported IBP questionnaire.  
Descriptive data were tabulated. Sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) were estimated for each single item of the IBP characteristics and for each of 
the three criteria sets of IBP criteria from non-missing values and presented as percentages with 95% 
confidence intervals (CI). The area under the receiver operator characteristic curve (ROC area) was 
used to assess classification utility and reported with 95% CI. For binary predictions, ROC area equals 
balanced accuracy, (sensitivity + specificity)/2 [21]. The following general interpretation of ROC area 
was used: 0.5-0.6 ‘no clinical value’, 0.6-0.7 ‘limited value’, 0.7-0.8 ‘modest value’, and >0.8 
‘discrimination adequate for genuine clinical utility’ [22].  
Two-sample Wilcoxon rank-sum test for continuous and ordinal categorical variables and Pearson’s 
chi square test for binary variables were used to test for statistically significant difference between 
groups, using a significance level of 5%.  
Results 
Approximately 5000 patients aged 18-40 years were referred with LBP in the study period and, among 
these, 1619 were invited to participate in the study. One hundred and sixty patients were excluded 
before, and 439 after, the first visit. In total, 1020 patients were included in the BaPa Cohort; 759 
(74%) reported back pain for more than 3 months and completed the IBP questionnaire and were 
included in the analysis for the current study (Figure 1). In the subsample included in this analysis, the 
median age was 32 years (IQR: 26-37), 408 (54%) were women and the median duration the LBP 
episode was 15 months (IQR 6-49 months). A total of 86 patients were categorised as ‘SpA according 
to ASAS’ and 673 as ‘non-SpA LBP’, resulting in a pre-test probability of SpA of 11%. If IBP had 
been included as a SpA feature, an additional 18 patients would have been categorised as SpA. Patient 
categorised as SpA according to ASAS had a statistically significant higher activity limitation score 
(Roland Morris Disability Questionnaire [16] calculated as a proportional score [17], 0-100) than 
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patients categorised as non-SpA (65 vs. 57). No other significant differences in the descriptive 
characteristics between the two study groups were found (Table 2). 
The prevalence of the single IBP characteristic in the whole study sample ranged from 10% (95% CI: 
7-12) for pain worst in the morning to 79% (76-82) for morning stiffness. Four single IBP 
characteristics were positively associated with ‘SpA according to ASAS’: ‘no improvement with rest’, 
‘improvement with exercise/not rest’, ‘night pain’, and ‘alternating buttock pain’. Of these, ‘night 
pain’ had the highest sensitivity, 87% (78-93), with a corresponding specificity of 28% (24-31). 
‘Improvement with exercise/not with rest’ had the highest specificity, 85% (82-88) with a 
corresponding sensitivity of 24% (15-34). The PPV for these single characteristics ranged from 13 to 
17%. The ROC area ranged from 0.54 to 0.57, which corresponds to a classification utility of ‘no 
clinical value’ (Table 3). 
In the whole study sample, 67% (63-70) met at least one of the three sets of criteria for IBP and 16% 
(14-19) met all three. Figure 2 shows the overlap of patients meeting the three different sets of IBP 
criteria. All the sets of IBP criteria were positively associated with ‘SpA according to ASAS’. The 
Calin criteria had the highest sensitivity, 64% (53-74), with a corresponding specificity of 50% (46-
54). The highest specificity, 86% (83-88), was found for simultaneous fulfilment of all three sets of 
IBP criteria with a corresponding sensitivity of 33% (23-44). The PPV for the IBP criteria ranged from 
14 to 22%. The ROC area ranged from 0.57 to 0.60, which corresponds to a classification utility of ‘no 
clinical value’ (Table 4).  
Discussion 
The concept of IBP has been widely used in the diagnosis of SpA since its introduction by Calin et al 
in 1977 [4] and many clinicians may expect patients who meet a set of criteria for IBP to have a high 
probability of having SpA. The results from the current study demonstrate that these expectations may 
need to be reassessed. Several of the single IBP characteristics and all three sets of IBP criteria were 
found to be statistically significantly associated with SpA according to ASAS. However, the IBP 
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characteristics that had a high sensitivity were also common in patients without SpA and two-thirds of 
the entire study sample met at least one of the IBP criteria. Consequently, the classification utility of 
these characteristics and criteria in relation to SpA in this cohort of patients with persistent LBP was 
below the pre-defined clinical value.   
One earlier study conducted in primary care in 315 chronic LBP patients with low a priori possibility 
of SpA evaluated the classification utility of four single characteristics (night pain, improvements with 
rest or activity and insidious onset) using the diagnosis of sacroiliitis from conventional radiography 
as the reference standard [23]. Even though the reference standard differed from ours, the results were 
similar when comparing ROC areas, which ranged from 0.45-0.56 for the four single characteristics 
[23]. The performance of IBP criteria has been rarely investigated in other LBP populations of 
primarily non-inflammatory back pain patients. Studies have reported the prevalence of fulfilment of 
IBP criteria in primary care LBP patients [24, 25], in industrial workers [26]  and in the general 
population [27], but these studies did not evaluate the classification utility of the IBP criteria. 
Several studies have, however, evaluated the classification utility of IBP in patients referred to, or 
treated with, specialised rheumatological care with a relatively high pre-test probability of SpA and 
using expert opinion as the reference standard [7, 8, 10-13, 28, 29]. The classification utility of IBP 
criteria has been evaluated in the ASAS cohort, consisting of 258 non-SpA LBP patients and 391 SpA 
patients categorised according to expert opinion and IBP characteristics assessed by clinicians [10]. 
The sensitivity and specificity were 86% and 40% for the Calin IBP criteria, 63% and 64% for the 
Berlin IBP criteria and 73% and 55% for ASAS IBP criteria [10]. These results correspond to ROC 
areas between 0.63-0.64, i.e. the criteria also had limited clinical value in that study. In general, the 
sensitivity was higher but the specificity was lower, indicating a higher overall prevalence of IBP 
characteristics, which could be explained by patients referred to rheumatologists being more likely to 
have IBP characteristics, as IBP is possibly a part of the reason for referral, according to previous 
recommendations [30]. Similar results were found for ASAS IBP criteria in the SPondyloArthritis 
Caught Early (SPACE)-cohort [28]. A recent case-control study, including 220 patients with 
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established SpA and 66 with mechanical LBP according to expert opinion, evaluated Calin and ASAS 
IBP criteria using a self-reported IBP questionnaire [13]. The overall performance of both Calin and 
ASAS IBP criteria in this study was, again, similar to our results when comparing ROC areas. Other 
studies have been performed on single IBP characteristics and IBP criteria in patients referred to, or 
treated with specialised rheumatological care, using expert opinion as the reference standard [7, 8, 11, 
12, 29]. The classification utility for the identification of SpA for some of the single characteristics 
and sets of IBP criteria was moderately better in some of these studies, with ROC areas ranging from 
0.37-0.76 for single IBP characteristics [7, 8, 11, 12] and from 0.57-0.79 for the three sets of IBP 
criteria [7, 8, 11, 12, 29]. 
However, caution should be taken in applying these results to daily clinical practice in the early 
diagnosis of SpA among patients with persistent LBP. Firstly, outside specialised rheumatological 
care, SpA is a rare disease compared with persistent LBP. This situation sets high demands for the 
diagnostic capability of clinical tests used in the diagnostic process of identifying SpA. Furthermore, 
case-control design with evaluation of patients with AS or long-lasting established SpA compared 
with selected LBP controls [7, 8, 11, 13] is not representative of the diagnostic challenges associated 
with the early stages of the disease in daily clinical practice. Finally, the use of expert opinion as the 
reference standard in research introduces a high risk of selection bias, because the IBP characteristics 
that are evaluated are likely to be the same as those used in the diagnosis of SpA. This risk of bias is 
further enhanced when the same clinicians who diagnose SpA also evaluate the presence of IBP.  
The results from the current study raise the question of whether clinical characteristics thought to be 
specific to IBP are simply characteristics of persistent back pain in general. It is likely that pain in 
non-SpA LBP patients also has an inflammatory component [31], for example, caused by Modic type 
1 changes [32, 33] or inflammatory reaction associated with tissue damage in disc herniations or nerve 
root compression [34, 35]. Since these MRI findings are relatively common in patients with LBP [36, 
37], this is an important aspect to consider. Unfortunately, the lack of good reference standards not 
only for SpA but also for subgroups of LBP, compromises the possibility of testing the classification 
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utility of IBP characteristics. Because there is great overlap in clinical characteristics between these 
groups of patients, it will prove a challenge to define a reference standard for early-stage SpA. 
Furthermore, before progress in the use of IBP characteristics as a diagnostic tool is possible, there is a 
need for clearer definitions of IBP – definitions that can show reproducible test results in ‘real life’. To 
our knowledge, the reproducibility of IBP characteristics has not been extensively investigated. 
However, the agreement between the referring physician and rheumatologist about the presence of 
IBP has been reported to be rather low, with kappa values < 0.2 [38, 39]. This highlights the need for 
reproducibility tests of the assessment of IBP, both with respect to self-reported questionnaires, and 
among rheumatologists diagnosing SpA and caretakers referring for rheumatology assessment. 
The methodological strengths of the current study are firstly the cohort design, which allowed 
estimates of the predictive values in a setting representative of the challenges in the early diagnosis of 
SpA. The PPV is the diagnostic parameter, which is most important for the clinician because it gives 
the probability of having the disease when a given symptom is present. Both PPV and NPV are 
prevalence-dependent and therefore not possible to estimate in case-control studies. Secondly, effort 
was made to avoid bias; the fulfilment of ASAS criteria for axial SpA was based strictly on a 
standardised data collection and the completion of the IBP questionnaire was performed independently 
of the collection of SpA features, blood samples and MRI, which were used in categorising SpA. 
Finally, IBP was not included as a SpA feature to avoid circularities.  
However, the current study also has important limitations, which need to be considered in the 
interpretation of the results. Firstly, formulating a standardised questionnaire required creating 
operational definitions for the IBP characteristics, because no validated self-reported questionnaire 
including the assessed items existed when the study was initiated. Secondly, it is possible that the 
results would have been different if clinicians, with special expertise in musculoskeletal disorders, had 
collected the IBP characteristics. However, the use of the self-reported patient questionnaires 
precluded bias caused by the clinician’s a priori beliefs and overall judgement of the presence of SpA 
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in a particular patient. Finally, the fact that IBP was not included, as a SpA feature could have resulted 
in incorrectly classifying patients as ‘non-SpA LBP’. However, only 18 patients would have been 
categorised as ‘SpA according to ASAS’ if IBP had been a SpA feature. It is possible that a 
reclassification of these patients as ‘SpA according to ASAS’ would have increased the sensitivity, 
which was calculated from the SpA group. It is, however, unlikely that it would have substantially 
changed the results.  
In conclusion, several single characteristics and the three IBP criteria assessed by a self-reported IBP 
questionnaire were found to be statistically significantly associated with SpA according to ASAS, 
excluding eventual IBP characteristics in the classification. However, IBP characteristics, which had a 
high sensitivity, had a correspondingly low specificity, reflecting that IBP characteristics, which were 
common in SpA patients, were also relatively common in patients without SpA. Consequently, 
according to the standard interpretation of the ROC area, the classification utility for SpA was below 
clinical value in this cohort of young patients with persistent LBP. Although, other large cohort studies 
are needed before any final conclusion can be drawn, the results from the current study imply that the 
use of IBP in the diagnosis of SpA may need to be re-evaluated. 
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Table 1 Translated wording of the inflammatory back pain questionnaire used in the study 
 
 
 
 
 
 
Questions Answers options 
How did the pain start? Insidiously/Suddenly  
Have you ever had back pain for more than 3 consecutive 
months? 
Yes/ No     
Do you feel stiff in your back in the morning? No  
Yes (less than 30 min.)  
Yes (between 30 and 60 min.) 
Yes (more than an hour.)           
Do you wake up at night due to back pain? Yes/No     
If you wake up at night due to back pain, is it during the 
last part of the night? 
Yes/ No     
If you wake up at night due to back pain, does it help to 
get up and walk around? 
Yes/ No     
Have you ever had buttock pain? Yes/ No     
Did it shift from one side to the other? Yes/ No     
How is your pain affected by rest? It gets better 
No effect  
It gets worse 
How is your pain affected by activity? It gets better 
No effect  
It gets worse 
At what time of the day is the pain worst? No difference 
Worst in the morning 
Worst in the morning and 
evening 
Worst during the day 
Worst in the evening 
Worst at night  
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Table 2. Demographic and clinical characteristics in ‘SpA according to ASAS’ and ‘Non-SpA 
LBP’ patients 
 
 
 
 
 
Characteristics SpA according to 
ASAS 
Non-SpA LBP 
Age in years, median (IQR) 32 (29-35) 32 (26-37) 
Women  58 (48-69) 53 (49-57) 
Employed 61 (50-72) 68 (65-72) 
Sick leave1 53 (41-65) 48 (44-52) 
LBP duration in months2, median (IQR) 18 (5-61) 15 (6-49) 
Previous LBP episode(s) 80 (71-89) 77 (74-80) 
LBP intensity (0-10)3, median (IQR) 7 (5-8) 6 (5-7) 
Leg pain 81 (73-90) 80 (77-83) 
Leg pain intensity (0-10), median (IQR) 5 (4-6) 5 (2-6) 
Activity limitation (RMDQ 0-100), median 
(IQR) 
65 (48-78) 57 (39-74)  * 
General health, EQ VAS (0-100), median (IQR) 50 (30-66) 50 (35-72) 
Unless otherwise indicated, data are percentages, with 95% confidence intervals in 
parentheses. 
n SpA=86  n non-SpA LBP=673, varies for each item due to missing values, p<0.05 
IQR: inter-quartile range, LBP: Low back pain,  
LBP intensity is averaged 0–10 Numerical Rating Scales (NRS) on present LBP, worst LBP 
last 14 days and typical LBP last 14 days [15] 
Leg pain intensity measured in the same way as for LBP 
RMDQ: Roland Morris Disability Questionnaire [16] (calculated as a proportional score (0% = 
no activity limitation; 100% = maximum activity limitation) [17], EQ VAS: EuroQol visual 
analogue scale [18]  
1: Sick leave due to back pain 3 months before the first consultation 
2: Duration of current LBP episode at the first consultation 
3: For patients with leg pain  > 0 
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Table 3. Classification utility of inflammatory back pain characteristics in relation to ‘SpA 
according to ASAS’ 
 
 Total 
prevalence 
Sensitivity Specificity PPV NPV ROC area 
(95% CI) 
Insidious onset1,2  53 
(49-57) 
58 
(47-69) 
48 
(44-52) 
13 
 (9-16) 
90 
(86-93) 
.53 
(.47-.58) 
Improvement with exercise1,2  21 
(18-24) 
28 
(19-39) 
80 
(77-83) 
16 
 (10-22) 
90 
(87-92) 
.54 
(.49-.59) 
No improvement with rest1  72 
(69-76) 
82 
(72-90) 
29 
(25-33) 
13 
(10-16) 
93 
(88-96) 
.55 
     (.51-.60)  * 
Improvement with exercise/not rest 3  16 
(13-19) 
24 
(15-34) 
85 
(82-88) 
17 
(11-25) 
90 
(87-92) 
.54 
    (.50-.59)  * 
Pain at night  74 
(71-77) 
87 
(78-93) 
28 
(24-31) 
14 
(11-17) 
94 
(90-97) 
.57 
    (.53-.61)  * 
   Improvement upon getting up1  31 
(28-34) 
38 
(27-49) 
70 
(66-73) 
14 
 (10-19) 
90 
(87-92) 
.54 
(.48-.59) 
   Awakening in the 2nd half of night3  40 
(36-44) 
49 
(38-60) 
61 
(57-65) 
14 
(10-18) 
90 
(87-93) 
.55 
(.49-.61) 
Morning stiffness2 79 
(76-82) 
87 
(78-93) 
22 
(19-25) 
13 
(10-15) 
93 
(88-97) 
.55 
(.51-.58)   
   > 30 min 3   53  
(50-57) 
63 
(51-73) 
48 
(44-54) 
13 
(10-17) 
91 
(87-94) 
.55 
(.50-.61)   
   > 60 min  28 
(25-31) 
35 
(25-46) 
73 
(69-76) 
14 
(10-19) 
90 
(87-92) 
.54 
(.48-.59) 
Pain worst in the morning  10 
(7-12) 
11 
(5-21) 
91 
(88-93) 
13 
 (6-24) 
90 
(87-92) 
.51 
(.47-.55) 
Alternating buttock pain3  26 
(22-29) 
35 
(25-46) 
76 
(72-79) 
16 
(11-22) 
90 
(87-92) 
.55 
    (.50-.61)  * 
Unless otherwise indicated, values are presented as percentages with 95% confidence intervals in parentheses  
n SpA according to ASAS=86  n non-SpA LBP=673 (n varies in each analysis due to missing values),  
* p < 0.05, ** p < 0.05 
PPV: positive predictive value, NPV: negative predictive value, (pre-test probability for ASAS SpA: 11 %) 
ROC area: area under the receiver operating characteristic curve, equals (sensitivity + specificity)/ 2 
1: included in ASAS IBP criteria 2: included in Calin IBP criteria 3: included Berlin IBP criteria  
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Table 4. Classification utility of inflammatory back pain criteria in relation to ‘SpA according 
to ASAS’. 
  
 Total 
prevalence 
Sensitivity Specificity PPV NPV ROC area 
Calin 52 
(48-55) 
64 
(53-74) 
50 
(46-54) 
14 
(11-18) 
92 
(88-94) 
.57 
    (.52-.62)  * 
Berlin 42 
(39-46) 
59 
(48-69) 
60 
(56-64) 
16 
(12-21) 
92 
(89-94) 
.60 
    (.55-.66)  * 
ASAS IBP 23 
(20-26) 
35 
(25-46) 
79 
(75-82) 
17 
(12-23) 
90 
(88-93) 
.57 
    (.51-.62)  * 
All three IBP criteria 17 
(14-19) 
33 
(23-44) 
86 
(83-88) 
22 
(15-31) 
91 
(88-93) 
.59 
    (.54-.64)  * 
Unless otherwise indicated, values are presented as percentages with 95% confidence intervals in 
parentheses  
n SpA according to ASAS=86,  n non-SpA LBP=673, (n varies in each analysis due to missing values),  
* p<0.05, **p<0.01 
PPV: positive predictive value, NPV: negative predictive value 
Pre-test probability for ASAS SpA: 11 % 
ROC area: area under the receiver operating characteristic curve, equals (sensitivity + specificity)/ 2 
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Figure 1. Flow-chart of the inclusion in the study 
 
 
 
 
 
 
 
 
 
 
 
 
  
Initially allocated to the study (n=1619) 
Patients attending first consultation (n=1459) 
 Included in the BaPa cohort (n=1020) 
  Reasons for exclusion before the first consultation:  
• Patient non-attendance (n=60) 
• Attended clinician outside the study (n=100) 
Reasons for exclusion after the first consultation: 
• Declined participation (n=94) 
• Less than 18 years or more than 40 years (n=12) 
• Did not speak or understand Danish (n=10)  
• Primary complaint not LBP (n=37) 
• MRI within last year (n=64) 
• Contraindications for MRI (n=78) 
• Predicted unfit for one hour project MRI (n=40) 
• Incomplete MRI due to logistic or technical 
difficulties (n=68) 
• Patient non-attendance at MRI (n=19) 
• No clinical information (n=17) 
 
n =160 
1640allocat
n = 439 
allocated 
Non SpA LBP (n=673) SpA (n=86) 
Back pain > 3 months (n=759) 
Back pain < 3 months (n=257) 
No IBP questionnaire (n=4) 
n = 261 
allocated 
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Figure 2. Venn diagram presenting the overlap of patients meeting the Calin, Berlin and 
ASAS criteria for inflammatory back pain 
  
 
In total 67% met at least one IBP criteria (numbers in the figure add up to 65% due to 
rounding)  
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ABSTRACT 
Objective: 1) To estimate the prevalence of the Assessment of SpondyloArthritis international Society 
(ASAS) criteria for axial spondyloarthritis (SpA), and 2) explore the associations between clinical 
SpA features and MRI findings. 
Method: In patients aged 18-40 years with persistent low back pain, referred to a Spine Centre, 
prevalence and associations of clinical SpA features, HLA-B27, CRP level, and MRI of entire spine 
and sacroiliac joints (SIJ) were analysed.  
Results: 1020 patients were included in the study (median age 33; 54% women). 52% of the patients 
had ≥1 and 19% had ≥2 SpA features. The three most common SpA features were; IBP according to 
ASAS, good response to NSAID and family disposition (15-17% each). Sacroiliitis, according to the 
ASAS definition, occurred in 21% of the patients, 42% of whom had only a bone marrow oedema 
(BMO) sum-score of 1. ASAS criteria for axial SpA were met in 10%. In the multiple regression 
analysis, positive HLA-B27, peripheral arthritis, good response to NSAID, and preceding infection 
were positively associated with MRI SIJ findings. No associations were found between SIJ BMO sum-
score of 1 and any SpA features, while SIJ BMO sum-scores of 3+, SIJ erosions, SIJ sclerosis, and SIJ 
fatty marrow deposition sum-score of 3+, spinal corner lesions and BMO at the apophyseal joints were 
all associated with positive HLA-B27.  
Conclusion: MRI defined sacroiliitis and several SpA features were common in this cohort of young 
patients with persistent LBP. However, the associations between MRI findings and SpA features were 
not consistent. The results from this study imply a need for a data-driven re-evaluation of the ASAS 
criteria for axial SpA regarding the diagnostic utility of SpA features, and the minimum requirements 
of MRI findings for diagnosing sacroiliitis. 
 
Keywords: Ankylosing Spondylitis, Low Back Pain, Magnetic Resonance Imaging, Spondyloarthritis 
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INTRODUCTION  
Spondyloarthritis (SpA) can be a serious and disabling disease and early identification is important in 
order to initiate effective treatment. Since there are no specific symptoms or tests available to make a 
precise diagnosis, this is based on a composite of clinical features and imaging and biochemical 
findings. In 2009, the Assessment of Spondyloarthritis International Society (ASAS) classification 
criteria for axial SpA were proposed. The criteria include 11 clinical SpA features, consisting of extra-
spinal findings, hereditary factors, pain characteristics of inflammatory back pain (IBP) and imaging 
findings [1]. As a new addition, chronic back pain and positive HLA-B27, or chronic back pain and 
MRI and/or conventional radiographic findings of sacroiliitis are the corner stones of the criteria [1]. 
The criteria were primarily based on expert opinion, and the validity of the criteria has only been 
sparsely investigated [1-3], and then, not in a representative prospective cohort of patients with 
persistent LBP and a low a priori suspicion of SpA.  
MRI is used increasingly in the diagnosis of SpA, although several uncertainties still remain about its 
diagnostic utility for SpA [4-6]. Previous studies investigating associations between MRI and SpA 
have been case-control studies, with a focus on patients with ankylosing spondylitis or advanced 
stages of SpA and small control groups of selected LBP patients or non-LBP individuals [5].  
On this background, the Back Pain Cohort of Southern Denmark (BaPa Cohort) was initiated in 2011 
with the purpose of investigating the early diagnosis of SpA in an unselected cohort of secondary care 
patients with persistent LBP. Assuming that both the MRI axial manifestations and the clinical 
characteristics are strongly associated with the disease entity of SpA, we also assumed that the MRI 
findings of SpA and clinical SpA features would be associated. Therefore, the objectives were: 1) to 
estimate the prevalence of single items and the complete set of ASAS criteria for axial SpA, and 2) to 
explore the association between clinical SpA features and MRI findings suggestive of SpA. 
METHOD  
Patients 
The study was conducted in an outpatient, secondary care and non-surgical department in a public 
hospital specialising in non-inflammatory back pain. Referral criteria to the centre are episodes of LBP 
ranging from 2 to 12 months, where there has been insufficient effect of treatment in primary care. 
Patients thought to have specific LBP conditions such as SpA, fracture, cancer or infection are not to 
be referred to the Centre, but to the relevant clinical specialty. From March 2011 to October 2013, 
booking secretaries allocated Caucasian patients aged 18-40 years with LBP as their primary 
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complaint to a dedicated multidisciplinary project team. Sixteen clinicians (medical doctors including 
rheumatologists, physiotherapists and chiropractors) were allocated to the project during the study 
period. The treating clinician excluded patients who did not understand Danish, had undergone an 
MRI scan within the previous year or were deemed unlikely to tolerate the one-hour MRI.  
The study was conducted according to the Declaration of Helsinki-II and Danish legislation and before 
study inclusion each patient gave written informed consent for research use and publication of their 
data. The Regional Scientific Ethics Committee for Southern Denmark determined that under the 
Danish legal framework, this study did not require formal ethics approval (reference number S-
2010200-58).  
Clinical and biochemical data 
Demographic and clinical characteristics were collected using electronic self-reporting questionnaires, 
part of the Spine Centre’s standard procedure.  
Before the first consultation, patients filled in a questionnaire including items covering IBP 
characteristics [7-9]. Based on this questionnaire, it was noted if the patient had IBP according to 
ASAS (present/absent). As part of the initial consultation with the patient, the clinicians filled in a 
questionnaire covering SpA features (present/absent) included in the ASAS criteria for axial SpA [1] 
as well as a question on preceding infection, an item included in a previous set of criteria for SpA [10]. 
The IBP and SpA questionnaires were completed prior to blood samples and MRI. See Appendix 1 for 
details (web only file). 
Blood samples were analysed for human leukocyte antigen (HLA) B27 (EuroImmun Microarray, D) 
and high sensitive C-reactive protein (hsCRP) (ABX pentra 400, Horiba, F).  If hsCRP was above 6 
mg/L, the clinician annotated in the SpA questionnaire to indicate if they were aware of a known 
reason for the elevated level.   
MRI protocol and reading 
MRI of the whole spine and SIJ was performed with a 1.5 T unit (Philips Achieva, Best, The 
Netherlands) MRI System using a SENSE spine coil. For the spine, the following sequences were 
implemented in three steps (cervical, thoracic and lumbar) and subsequently fused: Sagittal STIR and 
sagittal T1-weighted turbo spin-echo. Additional sagittal T2-weighted 3D TSE and axial T2-weighted 
TSE sequences were performed for the lumbar spine. For the SIJ, the following sequences were used: 
Semi-coronal T1-weighted TSE, semi-coronal T1-weighted Spectral Pre-saturation with Inversion 
Recovery (SPIR), and semi-axial STIR with long TE. For more details of the scanning protocol, see 
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previous publication [11].The reading of the MRI was performed by three SpA experienced 
radiologists (AGJ, AZ and NE), which were blinded to all clinical information except patients’ age 
and gender.  
MRI variables used in the data analysis  
In the SIJ, the following MRI findings potentially associated with SpA [12] were used: bone marrow 
oedema (BMO), erosions, sclerosis, and fatty marrow deposition (FMD). In the evaluation of the SIJ 
findings each joint was subdivided into four osseous locations: the cartilaginous part of the iliac and 
the sacral bones, and the ligamentous portion of the iliac and sacral bones, respectively (eight regions 
in total). In each of these SIJ regions the presence of a given finding was defined as a minimum of two 
lesions on a single SIJ slice, or one lesion in at least two consecutive slices, corresponding to the 
minimum requirement for the presence of BMO used in the ASAS definition of sacroiliitis [12]. In 
relation to the evaluation of BMO, care was taken to avoid pitfalls that could mimic subchondral or 
periarticular bone marrow oedema such as ligaments surrounded by blood vessel. 
In the spine, the following MRI findings potentially associated with SpA [13] were assessed as present 
or absent: BMO corner lesion, FMD corner lesion, mixed type (both BMO and FMD) corner lesion, 
BMO at the apophyseal joints, FMD at the apophyseal joints, soft tissue oedema around the 
apophyseal joint, BMO at the costovertebral joints, syndesmophytes or fusion, and erosion in the 
vertebral corner. 
With the purpose of exploring the importance of the severity of the SIJ MRI findings, sum-scores were 
generated by adding the grading of the identified findings (0: none / 1: slight / 2: moderate / 3: severe), 
in all eight regions (max sum-score 24). The sum-score was used to create pre-defined categorical 
variables. The number of categories defined for each finding was determined by the distribution of the 
relevant findings as each category should arbitrarily include a least 5% of the patients. Four categories 
were defined for BMO: sum-score of 0 (no BMO findings), sum-score of 1 (one region with slight 
BMO findings), sum-score of 2 (two regions with slight or one region with moderate BMO findings) 
and sum-core of 3+ (> sum-score of 2). All BMO categories met the ASAS definition of sacroiliitis. 
Likewise, three categories were defined for FMD: sum-score of 0, sum-score of 1-2 and sum-score of 
3+. Erosions and sclerosis were classified as present or absent due to their low prevalence.  
The reading of the MRI protocol has been tested for agreement in a previous study [11]. However, 
FMD at the apophyseal joints, soft tissue oedema around the apophyseal joint, BMO at the 
costovertebral joints, and erosion in the vertebral corner was not tested for agreement because of too 
few positive ratings. The rest of the MRI findings included in this study, all had kappa values of >0.6 
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for inter- and intra-observer agreement, except erosions at the SIJ and spinal corner lesions, which had 
kappa values for inter-observer agreement of 0.53 and 0.57, respectively.  
See Appendix 2 (web only file) for further details of the MRI variables used in the current study. 
Statistical analysis 
The questionnaires and the MRI evaluation were entered directly into an electronic database (the 
SpineData database) via an electronic evaluation form, and analysed using STATA 11.2  (StataCorp, 
2000, College Station, TX: Stata Corporation, USA). 
Prevalence estimates were calculated and presented as raw numbers and proportions. The diagnosis of 
SpA according to ASAS criteria was made after the data collection and strictly based on the collected 
items included in the criteria described above. Pearson’s chi square test was used to evaluate 
difference in prevalence concerning gender.  
The association between the SpA features and the SIJ MRI were estimated by multiple logistic 
regressions for each of the four SIJ MRI findings and with adjustment for gender and age. These 
models were reduced by backward elimination using a significance level of 5%. Multinomial logistic 
regression was used for the categorical variables and binomial logistic regression for dichotomous 
dependent variables. Associations were reported as odds ratios (OR) with 95% confidence intervals 
(CI).  
Correlations between the four SIJ MRI findings were tested with scatter plots, correlations matrix and 
regression analysis. This analysis showed a correlation between all four SIJ findings, the strongest 
being between BMO, erosions and FMD, which had correlation coefficients between 0.6 and 0.7. The 
correlation coefficients between sclerosis and the other structural findings ranged from 0.2 to 0.4.  
RESULTS 
Approximately 5000 patients aged 18-40 years were referred with LBP in the study period, of whom 
1619 were invited to participate in the study. One hundred and sixty patients were excluded before, 
and 439 after, the first visit (Figure 1). In total, 1020 patients with a median age of 33 years (IQR: 27-
37) were included in the study, 546 (54%) of whom were women (Table 1). The median duration of 
LBP at the time of inclusion was 10 months (IQR 4-39 months) and 763 patients (75%) reported 
having had pain for more than 3 months. Of the patients not included in the study who were in the 
same age range and referred with LBP in the study period, the median age was 34 years (IQR: 28-38), 
and 54% were women. 
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Prevalence of the items in the ASAS criteria for axial spondyloarthritis 
In total, 52% (95% CI 49-56) of the patients had ≥1 and 19% (17-22) had ≥2 SpA features (Table 2). 
The prevalence of the three most common SpA features i.e. IBP according to ASAS, good response to 
NSAID and family disposition, ranged from 15-17%. The prevalence of the two serological SpA 
features, positive HLA-27 and elevated CRP, were 10% (9-12) and 8% (6-10), respectively. The rest 
of the SpA features had a prevalence of <6%. Three SpA features were significantly more common in 
women than in men; familiar disposition for SpA (19% versus 14%, p<0.05), elevated CRP (5% 
versus 11%, p<0.01), and preceding infection (4% versus 2%, p<0.05). 
The prevalence of sacroiliitis on MRI according to the ASAS definition was 21% (19-24). Of those 
MRI-positive patients, 42% (35-49) had a BMO sum-score of 1. There were no statistically significant 
differences between men and women. 
The prevalence of patients meeting the complete ASAS criteria for axial SpA was 10% (8-12). Of 
these, 91% (86-97) had sacroiliitis on MRI as the major criterion, and 22% (14-30) had HLA-B27 as 
the major criterion. There were no statistically significant differences between men and women. 
Association between spondyloarthritis features and MRI findings 
The prevalence of the MRI findings is provided in Table 3. 
In the multivariable analysis, a BMO sum-score of 1 was positively associated with higher age but not 
with any of the SpA features. A sum-score of 2 was positively associated with peripheral arthritis and 
higher age, and negatively associated with IBP according to ASAS. A sum-score of 3+ was positively 
associated with positive HLA-B27 and preceding infection (see Table 4). 
Of the structural SIJ findings, erosions were positively associated with good response to NSAID and 
younger age and strongly associated with positive HLA-B27. Sclerosis was associated with positive 
HLA-B27 and preceding infection and strongly associated with female gender. An FMD sum-score of 
1-2 was only associated with female gender, whereas an FMD sum-score of 3+ was associated with 
positive HLA-B27, female gender and younger age (see Table 5).  
Due to low prevalence of BMO (2%), FMD (1%) and mixed type (1%) of spinal corner lesions, BMO 
at the apophyseal joints (1%), and FMD at the apophyseal joints (2%) it was only possible to calculate 
crude OR’s for the associations with HLA-B27. Statistical significances were tested using Pearson’s 
Chi Square test. BMO, FMD and mixed type of spinal corner lesions and BMO at the apophyseal 
joints were associated with positive HLA-B27 with ORs of 4.9 (95% CI 1.8-13.5), 24.5 (6.2-96.9) and 
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18.0 (4.3-74.8) and 14.9 (3.4-64.2), respectively. FMD at the apophyseal joints was not associated 
with HLA-B27. Soft tissue oedema around the apophyseal joint, BMO at the costovertebral joints, 
syndesmophytes or fusion, and erosion of the vertebral corner could not be analysed due to a very low 
prevalence below 0.5%. 
DISCUSSION 
In the current study, we evaluated the items included in the ASAS criteria for axial SpA in a young 
cohort of patients with persistent LBP attending a secondary care unit specialising in non-
inflammatory back pain. Due to the cross-sectional nature of the study and the lack of a suitable gold 
standard for the early SpA diagnosis, it was not feasible to evaluate the criteria’s sensitivity and 
specificity. Instead, we performed an exploratory analysis based on the assumption that both 
sacroiliitis and clinical characteristics are strongly associated with the SpA disease entity, and that 
MRI findings related to sacroiliitis and SpA features would therefore also be associated. Although this 
assumption cannot be fully confirmed from this study, the results underline several important aspects 
in the early diagnosis of SpA, which calls for further attention.  
The prevalence of family disposition, good response to NSAID, and IBP according to ASAS were 
notably higher than the rest of the SpA features. Due to their high prevalence, these features were 
often the main reasons for patients being classified as having SpA in this study. Similar findings were 
found in a cohort of LBP patients recruited from a primary care setting in the Netherlands [14]. In the 
Spondyloarthritis Caught Early (SPACE) cohort consisting of chronic LBP patients referred for 
specialised rheumatological evaluation, the same three findings were also among the most prevalent 
[2]. In the SPACE cohort, the prevalence of SpA features was in general higher, which is to be 
expected in a cohort of patients with a higher suspicion of SpA. In the current study, good response to 
NSAID was weakly associated with erosions, but no other positive associations were found for these 
three prevalent SpA features. These results, suggest that the role of these SpA features in the diagnosis 
of SpA should be re-evaluated. Of the remaining SpA features positive HLA-B27, peripheral arthritis, 
and preceding infection were associated with MRI findings suggestive of sacroiliitis. This result 
indicates that preceding infection could be reincorporated into the criteria for axial SpA, although the 
result was based on few positive findings and require confirmation trough other studies. 
Sacroiliitis according to the ASAS definition of SpA-related sacroiliitis was identified in 21% of 
patients in this cohort. Case-control studies involving non-inflammatory back pain patients have 
shown a similar high prevalence of BMO in the SIJ [15-17]. In the current study, a substantial 
proportion (42%) of patients with sacroiliitis according to the ASAS definition had only a BMO sum-
score of 1. While these slight BMO findings were associated with higher age, no associations were 
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found with any of the SpA features. These results indicate that BMO at the SIJ also could be related to 
age-related degenerative and/or load-related changes, like it has been shown for BMO in other 
anatomical regions [18-22]. Furthermore, studies evaluating the predictive value of BMO report that 
only a minor portion of patients with slight or moderate BMO develop ankylosing spondylitis over 
time [17, 23, 24]. However, these studies were small and further longitudinal studies in large cohorts 
are needed. Collectively, these results should encourage a re-evaluation of the minimum requirements 
of MRI findings to be present for diagnosing sacroiliitis. 
Several of the structural findings, especially erosions, were associated with positive HLA-B27 and in 
addition, FMD and sclerosis were also associated with female gender. The association with female 
gender implies that pregnancy and/or birth-related strain could be another possible cause of FDM and 
sclerosis, as suggested for conventional radiographic findings at the SIJ [25]. While the results from 
the current study support inclusion of erosions as a part of the definition of sacroiliitis [26, 27], the 
study is not designed to identify the MRI findings with the best diagnostic utility for SpA. 
Nonetheless, the need for further studies of the predictive value of both active inflammatory and 
structural MRI findings in the SIJ regarding development of fulminant sacroiliitis is supported by the 
results in this study.  
Erosions and FMD sum-score of 3+ were both related to younger age. One possible explanation for 
this association could be selection bias, as a consequence of the Spine Centre’s referral criteria that do 
not include patients with suspicion of SpA. Patients with advanced stages of SpA, who are expected to 
have more severe structural findings of sacroiliitis, would be more likely to be of older age and seen 
elsewhere.  
Spinal corner lesions and BMO at the apophyseal joints were rare in this population, but all were 
strongly associated with HLA-B27, which supports the association between these findings and SpA 
shown in previously studies [28-30]. However, the importance of the number of corner lesions present 
and the association with other SpA features could not be assessed in the current study due to their low 
prevalence. 
In the current study population, 10% fulfilled ASAS criteria for axial SpA. The prevalence of the 
ASAS criteria for axial SpA has not previously been investigated in a similar setting, but the study 
from the Netherlands reports on the prevalence in primary care [14]. Of 364 chronic LBP patients 
aged 18-45 years consulting general practitioners, 24% fulfilled the criteria for axial SpA [14]. The 
lower prevalence found in our cohort of secondary care patients could be explained by the primary 
care physicians directly referring patients whom they suspected had SpA to rheumatological 
specialists and not to the Spine Centre as these were the recommended referral criteria. The prevalence 
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of ASAS criteria for axial SpA, in patients with chronic LBP or IBP referred to specialised 
rheumatological care, has been reported to be substantially higher, as 38% [2] and 67%, [31], 
respectively. 
The performance of the ASAS criteria for axial SpA has been sparsely investigated. The criteria were 
originally validated in a cohort of LBP patients referred for rheumatological assessment using expert 
opinion of the diagnosis of SpA as the reference standard [1]. This study reports relatively good 
diagnostic parameters with a sensitivity of 83% and a specificity of 84% [1]. Similar results have been 
reported in two other cohort studies also using expert opinion as the reference standard [2, 3]. 
However, caution should be taken in transferring these results into clinical practice, because the use of 
expert opinion as the reference standard introduces a relatively high risk of selection bias, as clinicians 
may use the same items that are included in the ASAS criteria in their expert opinion diagnosis of 
SpA.  
Both SpA features and MRI findings thought to be specific for SpA and included in ASAS criteria for 
axial SpA, were found to be relatively prevalent in this cohort. When symptoms are common and the 
disease itself is rare, it is less likely that a patient presenting such symptoms have the disease, 
regardless of an apparent association with the manifest disease. Including items that are relatively 
common in back pain patients will therefore reduce the specificity of a SpA classification or diagnosis, 
and should therefore be considered carefully. Further research is needed, including large-scale 
longitudinal studies investigating the predictive value of both MRI findings and clinical 
characteristics. In the meantime, to avoid over-diagnosing a relatively rare disease with serious 
consequences for the individual [32], high specificity is probably preferable to high sensitivity, 
especially as there is no treatment that has been shown to halt progression of the structural changes 
related to the disease [33]. 
The methodological strengths of this study are the cohort design and the independent interpretation of 
SpA features, blood samples and MRI findings, reducing the risk of bias. Other methodological 
strengths are the large number of patients, which strengthens the precision of the prevalence estimates. 
Finally, effort was taken in optimising the method used for identifying patients with SpA features. A 
small group of clinicians working in the multidisciplinary team were allocated to the study, and 
received in advance the requisite information about the project procedure and the characteristics of 
SpA features. During the study period, sessions were held repeatedly for the project team to ensure a 
uniform interpretation of SpA features. 
There are also important limitations of the current study. First, the analyses of associations between 
the MRI findings and the very rare SpA features (peripheral arthritis, heel enthesitis, uveitis, dactylitis, 
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psoriasis, inflammatory bowel disease, preceding infection) were underpowered and hence not 
conclusive. The prevalence of spinal corner lesions and SIJ erosions and sclerosis were likewise too 
low to allow for identification of different cut-points in severity. Furthermore, it cannot be ruled out 
that the additional value of structural findings in the definition of sacroiliitis is constrained, due to the 
correlation between the different SIJ findings. Finally, to avoid unnecessary exposure to radiation, 
conventional radiography of the SIJ was not included in this study and their contribution to the 
prevalence of fulfillment of ASAS criteria for axial SpA could not be estimated. 
In conclusion, the results from this study imply a need for a data-driven re-evaluation of ASAS criteria 
for axial spondyloarthritis in relation to the diagnostic utility of spondyloarthritis features and the 
minimum requirements of MRI findings to be present for diagnosing sacroiliitis. In the current cohort, 
several items in the criteria were relatively common, including three spondyloarthritis features and 
bone marrow oedema at the sacroiliac joint. Of the three most common SpA features, only one was 
weakly associated with erosions, while no other positive associations with MRI findings suggestive of 
sacroiliitis were found for the most common SpA features. Moreover, slight bone marrow oedema was 
not associated with any spondyloarthritis features. Thus, further research would be beneficial in the 
area including longitudinal studies investigating the predictive value of both MRI findings and clinical 
characteristics. 
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Table 1. Demographic and clinical characteristics of patients in the cohort 
  Characteristics   
Age in years, median (IQR), n Total=1020 33 (27-37) 
Women, n Total=1020  546 (54) 
BMI, n Total=935  
   Underweight, BMI <18.5 15 (2) 
   Normal range, BMI 18.5-24.9  419 (45) 
   Overweight, BMI 25-30  327 (35) 
   Obese, BMI >30  163 (18) 
Smoking, n Total=907 267 (29) 
Employed, n Total=949 672 (71) 
Sick leave1, n Total=894 449 (50) 
LBP duration in months2, median (IQR), n Total=955 11 (4-39) 
Previous LBP episode(s), n Total=958 712 (74) 
LBP intensity (0-10), median (IQR), n Total=964 6 (5-7) 
Leg pain, n Total=975 778 (80) 
Leg pain intensity (0-10), median (IQR)3, n Total=778 5 (3-6) 
Activity limitation (RMDQ 0-100), median (IQR), n Total=959 57 (39-74) 
General health, EQ VAS (0-100), median (IQR), n Total=973 52 (38-74) 
Unless otherwise indicated, data are numbers of patients, with percentages in 
parentheses, n Total, varies due to missing values 
IQR: Inter-quartile range, BMI: Body mass index, LBP: Low back pain  
LBP intensity is averaged 0–10 Numerical Rating Scales (NRS) on present LBP, 
worst LBP last 14 days and typical LBP last 14 days [34] 
Leg pain intensity measured in the same way as for LBP 
RMDQ: Roland Morris Disability Questionnaire [35] (calculated as a proportional 
score (0% = no activity limitation; 100% = maximum activity limitation) [36], EQ 
VAS: EuroQol visual analogue scale [37]  
1: Sick leave due to back pain 3 months before the first consultation 
2: Duration of current LBP episode at the first consultation 
3: For patients with leg pain  > 0 
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Table 2. Prevalence of patients with single items and patients meeting the complete ASAS criteria for 
axial spondyloarthritis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 n Total (n) Prevalence 
ASAS SpA features   
Positive HLA-B27 1020 (107) 10 (9-12) 
Elevated CRP 1020 (81) 8 (6-10) 
Peripheral arthritis 1017 (26) 3 (2-4) 
Heel enthesitis 1018 (26) 3 (2-4) 
Uveitis 1019 (11) 1 (0-2) 
Dactylitis 1018 (9) 1 (0-1) 
Psoriasis 1018 (55) 5 (4-7) 
Inflammatory bowel disease 1018 (10) 1 (0-2) 
Family disposition 1017 (169) 17 (14-19) 
Good response to NSAID 1020 (148) 15 (12-17) 
IBP according to ASAS 1001 (171) 17 (15-19) 
Preceding infection 1018 (31) 3 (2-4) 
Sacroiliitis on MRI, according to ASAS 1020 (217) 21 (19-24) 
≥ 1 of ASAS SpA features 1020 (537) 53 (50-56) 
≥ 2 of ASAS SpA features 1020 (196) 19 (17-22) 
Fulfilment of ASAS criteria for axial SpA 1020 (101) 10 (8-12) 
n Total varies due to missing values, n: Number of patients with the relevant item 
Prevalences are percentages, with 95% confidence interval in parentheses.  
SpA: Spondyloarthritis, CRP: C-reactive protein, NSAID: Non-steroid anti-
inflammatory drugs, HLA: Human leukocyte antigen, IBP: Inflammatory back 
pain 
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Table 3 Prevalence of patients with MRI findings used in the analyses of association between 
spondyloarthritis features and MRI findings 
 
 
 
 
 
 
 
 
 
 
 
 
  
MRI findings N Prevalence 
Sacroiliac joints   
Any BMO1 217 21 (19-24 ) 
BMO sum-score of 1 91 9 (7-11) 
BMO sum-score of 2 58 6 (4-7) 
BMO sum-score of 3+ 68 7 (5-8) 
Erosions 77 8 (6-9) 
Sclerosis 79 8 (6-9) 
Any FMD 146 14 (12-16) 
FMD sum-score of 1-2 65 6 (5-8) 
FMD sum-score of 3+ 81 8 (6-10) 
Spine   
Any corner lesions 23 2 (1-3) 
BMO 17 2 (1-2) 
FMD 11 1 (0-2) 
Mixed type 9 1 (0-1) 
BMO at the apophyseal joints 8 1 (0-1) 
FMD  at the apophyseal joints 18 2 (1-3) 
Soft tissue oedema2 1 0.1 (0-0) 
BMO at the costovertebral joints 4  0.4 (0-1) 
Syndesmophytes or fusion 5 0.4 (0-1) 
Erosions at the vertebral corner 1 0.1 (0-0) 
n: Number of patients with the relevant item, n Total= 1020 
prevalences are percentages, with 95% confidence interval in 
parentheses  
BMO: Bone marrow oedema, FMD; fatty marrow deposition 
1
 All BMO categories met the ASAS definition of sacroiliitis 
2 Soft tissue oedema around the apophyseal joints 
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Table 4. Association between sacroiliac joints bone marrow oedema and spondyloarthritis features, 
assessed with multiple logistic regression analyses, adjusted for age and gender. 
 
  
 
BMO sum-score of 1 
n=87§ 
BMO sum-score of 2 
n=58 
BMO sum-score of 3+ 
n=68 
Positive HLA-B27 1.4 (0.7-3.0) 
2.1 
(0.9-4.7) 
9.0 
      (5.1-15.8)** 
Peripheral arthritis 2.3 (0.7-7.2) 
5.4 
     (1.8-16.0)** 
1.0 
(0.2-5.2) 
IBP according to ASAS 1.1 (0.6-1.9) 
0.3 
   (0.1-0.9)* 
1.7 
(0.9-3.1) 
Preceding infection  1.5 (0.4-5.2) 
0.8 
(0.1-6.5) 
3.3 
   (1.2-9.7)* 
Gender (female) 1.3 (0.8-2.1) 
1.2 
(0.7-2.1) 
1.2 
(0.7-2.2) 
Age (years) 1.1 
    (1.0-1.1)** 
1.1 
  (1.0-1.1)* 
1.0 
(0.9-1.0) 
Values are odds ratios, with 95% confidence intervals in parentheses.  
BMO score of 0 is used as reference, n=786, § Differs from Table 3 due to missing data for the 
SpA features 
*
 p<0.05, ** p<0.01 
BMO: Bone marrow oedema, HLA: Human leukocyte antigen, IBP: Inflammatory back pain 
 
 THE USE OF MRI IN THE EARLY DIAGNOSIS OF SPONDLOATHRITIS 125 
 
Table 5. Association between structural MRI findings in sacroiliac joints and SpA features, assessed 
with multiple logistic regression analysis, adjusted for age and gender. 
 
  
   Fatty marrow deposition 
 
Erosions 
n =77§ 
Sclerosis 
n= 79§ 
Sum-score of 1-2 
n=65§ 
Sum-score of 3+ 
n=81§ 
Positive HLA-B27 8.1 
     (4.7-13.7)** 
3.1 
    (1.7-5.6)** 
1.9 
(0.9-4.0) 
6.1 
    (3.6-10.4)** 
Good response to NSAID 1.9 
   (1.1-3.5)* 
- 
 
- 
 
- 
 
Preceding infection - 2.8 
   (1.1-7.0)* 
- 
 
- 
 
Gender (female) 1.2 (0.7-1.9) 
7.6 
    (3.8-16.0)** 
1.9 
   (1.1-3.2)* 
2.2 
  (1.3-3.7)* 
Age (years) 1.0 
  (0.9-1.0)* 
1.0 
(1.0-1.1) 
1.0 
(1.0-1.0) 
1.0 
  (0.9-1.0)* 
Values are presented as odds ratios with 95% confidence interval in parentheses 
§Reference group is patients without any of the relevant MRI finding, for erosions; n=943, sclerosis; 
n=939, and fatty marrow deposition; n=874 
*p< 0.05, **p<0.01  
– not included in the final model 
HLA: Human leukocyte antigen, NSAID: Non-steroid anti-inflammatory drugs 
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Figure 1. Flow-chart of the inclusion in the cohort 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Initially allocated to the study (n=1619) 
Patients attending first consultation (n=1459) 
Finally included in the study (n=1020) 
 Reasons for exclusion before the first consultation:  
• Patient non-attendance (n=60) 
• Attended clinician outside the study (n=100) 
Reasons for exclusion after the first consultation: 
• Declined participation (n=94) 
• Less than 18 years or more than 40 years (n=12) 
• Did not understand Danish (n=10)  
• Primary complaint not LBP (n=37) 
• MRI within last year (n=64) 
• Contraindications for MRI (n=78) 
• Deemed unlikely to tolerate the one hour MRI (n=40) 
• Incomplete MRI due to logistic or technical 
difficulties (n=68) 
• Patient non-attendance to MRI (n=19) 
• Missing clinical data (n=17) 
 
n =160 
1640allocat
n = 439 
allocated 
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